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Abstract
The current demand on densitometry services has led to many patients at risk waiting long
periods of time, while other healthy individuals are scanned unnecessarily. This work sets
out to address the issue of pre-screening for DXA in a postmenopausal population. With
simple pen and paper assessments possible, the most important risk factors were selected
based on comparison with actual DXA T-Scores. This enabled the creation of a very
simple tool that may aid with the prioritisation of those most in need of investigation.
The success of commercial QUS devices prompted the inclusion of a number of ultrasound
measurements. When added to the simple tools the performance markedly improved.
Other known QUS parameters used at the proximal phalanx demonstrated very weak
links, if any, with DXA measurements suggesting they may not be useful when it comes to
screening large numbers of people. Energy measurements of the phalanx were shown to be
correlated to cortical thickness. As cortical thinning is known to advance as osteoporosis
worsens, these measurements are proposed as a method of predicting those with low bone
mineral density. Further examination found that the thickness was related to density at
the neck of femur. This strengthens the claim that energy measurements may accurately
choose those requiring immediate intervention.
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Chapter1
Introduction
Old age is, so to speak, the sanctuary of ills; they all take
refuge in it
Antiphanes
Hubert Humphrey remarked ‘It was once said that the moral test of government is how
that government treats those who are in the dawn of life, the children; those who are in the
twilight of life, the elderly; and those who are in the shadows of life, the sick, the needy
and the handicapped’. It is with this virtue foremost in mind that the work presented here
attempts to alleviate, at least in some part, current issues which directly aUect the daily
lives of many elderly members of society. It deals with the detection of osteoporosis, a
condition that if left untreated may result in an unexpected fracture and reduced mobility.
However, with early diagnosis and the appropriate treatment, the probability of suUering
an osteoporotic fracture is reduced. It is therefore imperative to strive to preserve the
quality of life for as many older people as possible.
Osteoporosis has aUected people for as long as evidence exists. It has been suggested
that osteoporosis caused fractures in the vertebral bodies of skeletons thousands of years
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old, which would have resulted in immobility in later life [Teschner, 2007]. However, the
disease was discovered much more recently. Firstly came the theory of bone remodelling
put forward by Dr. John Hunter who observed that bone growth depended on resorption
and deposition. This provided a better understanding of bone, as a living tissue, and a
platform for future research. The coining of the term osteoporosis is often credited to
Jean Georges Lobstein who observed that some bones contained holes that were larger
than normal. Astley Cooper also made a signiVcant contribution to the Veld, detailing
many of the fractures which result from decreases in bone content. He also observed
the deterioration of bone with age, noting that cortical bone thinned and spongy bone
could be marked using a penknife, which was not possible in bones of younger adults
[Cooper, 1851]. The next milestone was made by Fuller Albright who proposed the link
with menopause. Finally, from the mid-point of the last century accurate and precise
methods of measuring bone mineral density were developed. This enabled the in-vivo
determination of density, which has been used as a marker for bone resorption ever since.
Owing to large amounts of research, much more is now known about osteoporosis and
how it aUects the human body. It is a systemic condition which leads to reductions in the
thickness of cortical bone and the number and thickness of trabeculae in cancellous bone
[Seeman, 2003b]. These changes result in lower bone mass for those aUected. The two
dimensional nature of original absorptiometry techniques allowed for the calculation of
areal bone density. This is the measured bone mineral integrated for the scanned area. As
these measurements reWect the changes in mineral content they became the gold standard
for assessing skeletal condition. In an attempt to tie absorptiometric results to fracture
risk, a WHO study group suggested comparison with BMD or BMC of the ‘young healthy
2
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adult’. Any score greater than -1 SD of the young healthy mean represents normal, be-
tween -1 SD and -2.5 SD is osteopenic and less than -2.5 SD is osteoporotic [Alexeeva et al.,
1994]. A score less than -2.5 SD accompanied by a fragility fracture is considered severe
osteoporosis.
The resorption of cancellous bone and thinning of cortices culminate in an increased
risk of fracture, even for low energy impact. The major morbidity is fracture at the hip,
vertebral spine and wrist, all of which are comprised of both types of bone. The problem
facing the current health services is immense, the magnitude of which is probably best
demonstrated by the number of fractures that occur. Predictions made using data from
England and Wales suggest that the lifetime risk of fracture for females at the age of 50 is
53.2%, while for males at the same age the risk of fracture is 20.7% [Van Staa et al., 2001].
While fracture itself may be debilitating and cause distress for an individual, there also
exists secondary consequences. These include reduced mobility and possible mortality
associated with surgery. For example, exaggerated curvature of the spine and reduced mo-
bility, both of which may result from fracture of one or more vertebral bodies, have been
shown to be signiVcantly correlated to reduced quality of life [Miyakoshi et al., 2003].
More worryingly perhaps, are Vgures for the UK which show that rates of mortality fol-
lowing neck of femur fracture may be as high as 18% three months postoperatively [Todd
et al., 1995].
While the direct outcomes of osteoporosis are obviously endured by the individual,
there is also a substantial cost to the government. In terms of monetary value, the cost
of hip fractures in the UK has been estimated at almost £726 million [Anomymous, 2000].
However, many more pessimistic approximations have been put forward. Treatment also
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places a heavy burden on hospitals, ambulance services, social care and general practi-
tioners. Women recovering from osteoporotic fracture require signiVcantly more GP visits
(almost 14 in the case of vertebral fracture) and outpatient referrals (28 orthopaedic re-
ferrals in the case of hip fracture), compared with controls [Dolan and Togerson, 1998].
It is also estimated that 20% of all orthopedic beds are occupied by those aUected by hip
fracture [Kanis and McCloskey, 1998].
In light of the fact that changes in skeletal condition can be detected, and that drug
treatments have been shown to reduce the risk of fracture at the hip, vertebra and wrist
[Reginster et al., 2005, Ettinger et al., 1999], a prophylactic approach stands out as the most
appropriate means of tackling the issue. This oUers the opportunity to protect those at
highest risk and to reduce the costs involved with treating fractures. This has focussed the
attention of many to the earlier detection of deleterious changes in bone quality.
One of the Vrst means of diagnosing osteoporosis, radiogrammetry, relied on measur-
ing cortical thickness of metacarpals from X-ray Vlms [Barnett and Nordin, 1960]. This
enabled clinicians to quantify the loss in bone mass. Possibly the largest limitation to this
type of evaluation is the fact that details of the structure of the cortical bone are ignored;
porosity and resorption on the endocortical surface.
Radiogrammetry was superseded by Radiographic Absorptiometry (RA). Single Pho-
ton Absorptiometry (SPA), the original technique introduced by Cameron and Sorenson
[1963] used a single γ-ray source to measure the photons that cross the site of interest.
The attenuation of the beam is dependent on the amount of mineral present, and was
therefore used to calculate the BMC, or BMD based on the known dimensions of the bone.
SPA requires the site of interest to be surrounded by tissue equivalent material, water,
4
Chapter 1. Introduction
which limits its use to the peripheral skeleton. The use of a second source of γ radiation
of a diUerent energy level, Dual Photon Absorptiometry (DPA), meant that the soft tissue
could be corrected for, negating the need for a water bath. Measurements at the clinically
relevant axial skeleton could now be carried out.
The principles of Single energy X-ray Absorptiometry (SXA) and Dual energy X-ray
Absorptiometry (DXA) are similar to those for SPA and DPA, except that X-rays replace
γ-rays. DXA at the hip and lumbar spine is currently the gold standard absorptiometric
approach, with precision values of 0.5–2.0% for the lumbar spine and 1–5% for the prox-
imal femur [Adams, 1997]. The use of areal density of the axial skeleton as a means of
determining fracture risk may indeed be appropriate. For instance, changes in BMD may
indicate the same increase in risk of fracture as high diastolic blood pressure at predict-
ing stroke, or cholesterol or smoking at predicting coronary heart disease [Marshall et al.,
1996].
While BMD may give some indication as to the risk of subsequent fragility fracture, is
a simple measure of bone mass the best method of gauge the progress of osteoporosis? No
account is taken of the state of the bone that is investigated. DXA cannot provide informa-
tion about the continuity or thickness of the trabeculae within the region of interest. The
same can be said of the Young’s modulus, one of the most important factors in determining
the strength of a material. Another potential source of error is the over estimation of BMD
that results from osteoarthritis. The increased mineralisation present at the articulating
surface may mask the decreased bone mineral content in cancellous bone. This has been
linked with the misdiagnosis of osteoporotic individuals as osteopenic [Liu et al., 1997].
Kanis [2002] has suggested that indeed BMD may not be appropriate for the diagnosis of
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osteoporosis. Other risk factors exist, and only when these are evaluated with BMD can
the most accurate categorisation of risk be carried out.
Quantitative Ultrasound (QUS) has been proposed as an alternative means of predict-
ing fracture risk. As sound waves propagate, they are altered by the material properties
and the structure of medium through which they are travelling. Speed of Sound (SOS)
was the Vrst ultrasonic parameter to be studied clinically. SOS measurements are mostly
performed at the appendicular skeleton, where little soft tissue covers the bone surface.
The SOS values are related to the density [Knapp et al., 2001] and the Young’s modulus
[Muller et al., 2008] of the bone. As a result, good correlations have been observed be-
tween SOS and BMD, both close to measurement site [Louis et al., 1998] and at the axial
skeleton [Benitez et al., 2000].
Langton et al. [1984] proposed the use of Broadband Ultrasonic Attenuation (BUA)
across the calcaneus as a means of measuring bone quality. This involved performing a
fast Fourier transform on the waveform that crosses the heel. For better quality bone,
higher frequencies are more acutely attenuated. BUA is generally considered to depend
on the density [Rho et al., 1997] and the structure of the bone [Hans et al., 1995]. Many
researchers have found good agreement between BUA and BMD at the hip and spine
[Kovac et al., 2003, Cook et al., 2005]. It is proposed that this agreement stems from the
fact that the heel bone is mostly the metabolically active cancellous bone, where changes
in bone quality will be observable sooner, and that the heel undergoes similar stress cycling
as the hip and spine.
Many other QUS parameters have been studied as predictors of density, or in terms
of changes with age, with varying degrees of success. Wüster et al. [2000] found ‘Fast
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Wave Amplitude’, ‘Signal Dynamics’, ‘Time Frame’ between the Vrst and last amplitude
and overall ‘Signal Amplitude’ all decreased with age from the fourth decade. Using a
combination of the signal dynamics, fast wave amplitude and the time frame they created
the Ultrasound Bone ProVle Index (UBPI). UBPI showed a greater correlation with BMD
at the lumbar spine and hip than SOS at the same site. Another commonly used variable
is StiUness Index (SI). This is composite value based on BUA and SOS across the calcaneus
and not to be confused with mechanical stiUness.
Not only has QUS shown good correlation with BMD, it has also been shown to be
eUective at predicting fracture risk. Measurements from the heel [Njeh et al., 2000], radius
[Hans et al., 1999a] and Vnger [Mussolino et al., 1997, Reginster et al., 1998, Guglielmi et al.,
1999] have shown promising ability, even when compared to BMD measurements, with
regard to selecting those with an osteoporotic fracture. Furthermore, it has been shown
that risk of fracture for the hip based on QUS at the heel remains signiVcant even when
BMD at the hip was accounted for [Hans et al., 1996]. Similarly, ultrasound was shown to
be related to the mechanical properties, even when adjusted for density [Rho et al., 1997].
This supports the theory that QUS may provide important information about the quality
of bone, independent of the density.
This work sets out to investigate the most signiVcant risk factors for osteoporosis in a
British population. In addition, given that the International Quantitative Ultrasound Con-
sensus Group advocate the use of QUS for diagnosing osteoporosis, predicting fracture
risk and monitoring skeletal changes [Glüer, 1997], certain ultrasound measurements will
also be included as possible independent variables. Currently, reductions in bone mass are
determined via DXA analysis of the hip and spine. The reductions in bone mass are used
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to explain the decrease in mechanical competency of bone, which in turn is used to predict
the risk of fracture for an individual (Figure 1.1). It is proposed that QUS may provide a
simple screening tool for osteoporosis by determining the mechanical competency of the
skeleton. This raises the question whether or not QUS should be used independently of
DXA scanning. Indeed, Gregg et al. [1997] have suggested that QUS be used in combi-
nation with BMD because they are independent predictors of fracture risk. While ideally
it may be better to consider the results of both techniques, for the purposes of this work,
it was assumed that in certain cases only QUS may be available. Indeed, this is accepted
as a viable means of pre DXA scanning [Gambacciani et al., 2004]. Although, as DXA
results remain the clinically accepted gold standard, it is still necessary to compare the
results of all new techniques for predicting osteoporosis, including those presented here,
with densitometric T-scores.
The goals of this project are twofold: determine the most inWuential predictors of risk
factors for a British population and optimise the use of ultrasound as a means of ascertain-
ing bone quality. As such, it seems logical to divide the methodologies into two distinct
paths. The Vrst of these would be to collect patient data, via questionnaires, for those
whose DXA T-score are known. This would permit the use of regression analysis to Vnd
the risk factors which have the greatest inWuence on the BMD. In parallel with this study,
it is essential to document the correlation between DXA T-scores and currently available
QUS devices to ensure that the use of questionnaire analysis is not made obsolete by more
predictive ultrasound methods. The second part of the research deals with the optimisation
of ultrasound techniques for the same population. In order to achieve this, it is necessary
to design and manufacture a prototype device capable of scanning a region of interest
8
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Figure 1.1: Osteoporosis and the associated phenomenona. Currently, reductions in bone mass are
detected using DXA T-scores (Dashed Line). These are assumed to reWect the decreases
in mechanical competency and the increase in the likelihood of fracture (Dashed Line).
QUS may be useful for monitoring changes in risk of fracture as it has been shown
that QUS results are correlated to the mechanical competency and reduced mass of the
bone. Solid lines indicate previously investigated relationships.
deemed relevant. Whatever the manifestation of osteoporosis that is being monitored, it is
required that this be clearly analysed with respect to the ultrasound parameter. Therefore,
all experimentation using the prototype ultrasound device will be compared to CT data
from the same site. In order to be accepted by the densitometry community, comparison
to BMD values at clinically relevant sites is also of paramount concern. Therefore, where
possible, this will also be carried out.
The main deliverables of this research should aid with the prioritisation of those at
highest risk of suUering an osteoporotic fracture. The simplest and most straightforward
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product of this research would be an assessment tool capable of categorising people based
on risk of osteoporosis. This could help in areas where current facilities are under severe
pressure by selecting only those most in need of attention. As current QUS devices will
also be studied, this will allow for a more accurate assessment procedure. This may be of
beneVt where QUS services are already available. QUS and risk factor analysis could also
prove exceptionally useful if adopted by general practitioners and point of contact health
care professionals. Ideally, these services would be oUered as part of routine checkups,
which could allow for the earlier detection of bone mass loss which are currently left
unchecked in many cases. The Vnal stream, the development of a prototype scanning
system, has the potential to allow earlier, more appropriate, diagnosis of systemic changes
in the skeleton.
In conclusion, the end point of this work is to summarise the current early warning
systems for osteoporosis with a view to improving their accuracy and usefulness. The
potential beneVts are enormous to both to the individual, where one may avoid a serious
fragility fracture, and to the government, by reducing the cost of treating such fractures.
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Chapter2
Literature Review
The only good is knowledge and the only evil is ignorance
Socrates
In order to investigate the detection of osteoporosis it is important Vrst to understand
how healthy bone behaves and functions. This chapter brieWy introduces the idea of bone
as a material, describing the composition, structure and how it is created. The process of
bone loss and the changes associated with osteoporosis are then presented. Finally, the
way in which current diagnostic techniques operate and the method of assessing how new
tests are evaluated.
2.1 Bone
To truly understand the problem of osteoporosis and its detection, one must Vrst under-
stand the function, composition and structure of bone itself. Also, the way in which bone
regenerates is important as it may explain how bone is lost later in life. This section
describes healthy bone.
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2.1.1 Function
Bone, either as a single unit or as part of the skeletal system, performs a number of tasks.
By working together, bones allow for articulation by providing sites for muscle attachment
and acting as levers to allow muscular contractions to Wex or extend joints. The skeletal
system also protects the vital organs and delicate bodily systems, essential for survival, by
surrounding them. The other major function of bone is to act as a reservoir for many key
ions such as calcium, phosphorus and magnesium. Besides all this, many bones are hollow
structures which are Vlled with marrow, which produces required blood cells.
2.1.2 Structure
The all encompassing term bone tends to give the illusion that all bone is a simple, contin-
uous material. However, one must look at it as a hierarchical structure. Figure 2.1 demon-
strates this perfectly. On the smallest scale, it shows the arrangement of the collagen and
the bone crystals. Repeating sequences of these are the building blocks for collagen Vb-
rils, which are grouped to form collagen Vbres. Many of these Vbres are then arranged
in parallel to create lamellae. Osteons are made up of concentric sheets of these lamellae,
however the collagen Vbres in each layer are not parallel with Vbres of consecutive layers.
2.1.3 Macrostructure
The previous section describes how collagen and mineral are arranged, on the micro-
scopic level, to form lamellae and osteons. The next step on the hierarchical ladder is the
macrostructure, where bone is either cortical or cancellous in structure, the main diUer-
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Figure 2.1: The hierarchical structure of bone is evident from this depiction. The organisation of
successive levels, from collagen and mineral up to the osteon, is also clearly presented.
Reproduced with permission from Rho et al. [1998].
ence being the higher porosity of the cancellous bone. A threshold of 70% volume fraction
is used, with any values greater denoting cortical bone and values less denoting cancellous
bone [Carter and Spengler, 1978]. The apparent density of cortical bone is approximately
1.64 g.cm−3 at the femur and 1.54 g.cm−3 at the tibia [Yeni et al., 1998]. These are signiV-
cantly greater than apparent densities of cancellous bone which is 0.47 g.cm−3 at the femur
[Li and Aspden, 1997] and 0.22 g.cm−3 at the lumbar spine[Cendre et al., 1999]. Both of
these types of bone are visible to the naked eye. Figure 2.2 shows examples of these.
Figure 2.2: Cross section of a vertebral body. The cortical bone is present as a solid shell. The
cancellous bone is present in the spongy centre of the vertebral body.
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Cortical Bone
Cortical (or compact) bone is the most common type of bone, making up 80% of the skeletal
system. It may be considered solid, however some voids exist. These may be present as
canaliculi and erosion cavities or as cavities Vlled with osteocytes or blood vessels. The
porosity of this type of bone is in the range of 3.2–6.1% for healthy young adults [McCalden
et al., 1993]. However this can be greater, 7%, for older or osteoporotic subjects [Roschger
et al., 2001]. In this case, porosity was calculated from small sections of cortical bone
from within the cortex. Even greater values can be measured if trabecularisation of the
endocortical surface is included, ranging from 4.6–35.6% [Bayraktar et al., 2004]. The solid,
stiU nature of cortical bone makes it an ideal material for the shafts of long bones, allowing
the transfer of load between joints and ensuring that muscle contractions move bones that
hold their shape. It is also found covering the ends of long bones, forming a shell around
shorter bones and acting as the outer layers in sandwich bone.
Cancellous Bone
Cancellous (or trabecular) bone makes up remaining 20% of bone present. Cancellous bone
can be described as a tortuous network of plates and rods, roughly oriented along the major
axis of applied force. It is present at the end of long bones, in the central cavity of short
bones, in the vertebral bodies and often Vlling the gap between sheets of cortical bone in
sandwich bone. It is typically present where loads are distributed over large areas, where
solid cortical bone would make for over-engineering and unnecessary weight [Currey,
2002].
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2.1.4 Composition
From an engineering materials point of view, bone is classiVed as a composite. It is com-
posed of both an organic and inorganic phase. Each phase provides a speciVc property
which beneVts the overall structure. The organic component confers toughness while the
inorganic component ensures stiUness. The organic phase is mostly collagen, existing pri-
marily as type I collagen, with three tropocollagen strands arranged in a triple helical
arrangement [Currey,2002]. Smaller amounts of other types of collagen can also be found,
although these are more likely to come from the basement membranes used to attach in-
cluded cells or from the adventitia that surrounds blood vessels. Some non collagenous
proteins also exist, but their function is less well understood. These include proteogly-
cans and glycoproteins. Of note are osteocalcin and osteonectin, which are produced by
osteoblasts. Both are believed to play a role in mineralisation, while osteocalcin also con-
trols calcium ion homeostasis and osteonectin is associated with collagen binding [Kelm
et al., 1994]. Osteoblast activity is often measured by the determination of osteocalcin
levels [Delmas, 1995]. Other proteins of interest include osteopontin [Denhardt and Guo,
1993], a linking protein, and bone morphogenic proteins [Hodsman et al., 2000], which
instigate bone formation.
The inorganic material exists mainly as rods or plates of hydroxyapatite (Ca10(PO4)6(OH)2)
packed between the collagen helices. The hydroxyapatite is non-stoichiometric and im-
pure.
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2.1.5 Bone Remodelling
In order to ensure that the skeleton can continue performing its intended support and
protective functions, and maintain the optimal concentrations of stored ions, constant
maintenance is required. This maintenance is carried out by two types of cells, osteoclasts
and osteoblasts. Osteoclasts act by removing bone. This resorbed bone is then replaced
with new bone laid down by osteoblasts (Figure 2.3). An osteoclast working with an
osteoblast is referred to a Bone (Re)Modelling Unit (B(R or M)U). In healthy adults, both
types of cells seem to work at the same rate. However, during growth deposition exceeds
resorption, while beyond maturity resorption exceeds deposition.
(a)
(b)
(c)
(d)
Figure 2.3: The cycle of bone remodelling. The process begins with osteoclasts forming a cutting
cone within the space of a couple of days (a). This erosion channel increases in diameter
up to approximately 200µm (b), which takes two weeks. This then progresses along the
bone. When the resorption cavity is fully formed, osteoblasts begin to lay down new
bone in the form of lamellae (c). This process continues for around three months (d),
although mineralisation carries on much longer.
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2.1.6 Bone Mineral Content
For females, the population of interest in this body of work, bone mineral content follows
a characteristic curve with Vve distinct stages (Figure 2.4). The Vrst two steps represent
increases, Vrstly being a slow increase up to puberty, followed by a faster rate from puberty
to maturity. The increase at puberty is due to the increased estrogen levels and growth
hormones. The change in mineral content is correlated with the Tanner stage (physical
development), even when adjusted for age [Boot et al., 1997]. By late adolescence, bone
mineral content is approximately 90% of the peak value [Henry et al., 2004]. A relatively
stable period then continues to the age of menopause, with the possibility of consolidation
of the bone (an increase in mineral content with no associated change in bone size). It
has been demonstrated for a European sample that BMD does not change signiVcantly
between the ages of 20 and 49 [Lofman et al., 1997]. Finally, there is a rapid decrease
in BMD in the Vrst Vve to ten years immediately after menopause, due to the oestrogen
deVciency, which then continues but a lower rate [Geusens et al., 1986].
2.2 Osteoporosis
As was stated in Chapter 1, although it is accepted that as we age bones become thinner
and less dense, leaving us at a greater risk of a fragility fracture, it is diXcult to deVne the
exact stage of osteoporosis in an individual. In early experimentation, biopsy was used to
collect samples which could be studied and measured. While this approach may enable a
very detailed investigation of the morphology of a bone sample, it is hardly practical as
a means for screening the entire population. It is also unethical to expect any number of
17
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Figure 2.4: Bone Mineral Content (BMC) plotted against Age for females. The Vve typical stages
are divided by life events (horizontal light gray lines). The increase of BMC begins
slowly up to puberty, followed a faster rate up to maturity. BMC then remains relatively
stable until menopause. Immediately after menopause there is a sharp decrease in BMC
which usually last between Vve and ten years. Finally, BMC continues to decline, but
at a much lower rate.
healthy people to undergo such an invasive procedure. With the development of radio-
grammetry and absorptiometry, which will be explained later, clinicians and researchers
were able to measure a variety of parameters known to be aUected by osteoporosis. While
none of these are perfect, in so far as they only measure one manifestation of osteoporosis,
they have been accepted due to the lack of a better system.
The consensus from WHO is that absorptiometry of axial skeleton, by the use of DPA
or DXA, is the most signiVcant predictor of fracture risk, and therefore the most appropri-
ate means of predicting osteoporosis [Alexeeva et al., 1994]. Osteoporosis is deVned based
on BMD measurements (Table 2.1).
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Table 2.1: DeVnition of Osteoporosis
Degree T-score Values
Normal T-score > −1
Osteopenia −1 > T-score > −2.5
Osteoporosis T-score 6 −2.5
Severe Osteoporosis T-score 6 −2.5 with fracture
2.2.1 DeVnition
T-score
T-scores are calculated by comparing an individual’s measured BMD with values for a
young, healthy reference population (Equation 2.1).
T − score = BMDMeasured −BMDY oung Healthy
Standard DeviationY oung Healthy
(2.1)
Z-score
Another popular means of presenting densitometry results is using Z-scores. Z-scores,
unlike T-scores, compare an individual to an age matched population (Equation 2.2).
Z − score = BMDMeasured −BMDAgeMatched
Standard DeviationAge Matched
(2.2)
T-scores and Z-scores compare individuals to diUerent reference groups, and both sys-
tems may have their own particular beneVts. However, there still exists the question as to
‘which method is better?’. Due to the fact that the T-score is based on the comparison with
a young, healthy population, one could assume that this score is an ‘absolute’ score. The
Z-score on the other hand, uses a population for which it is accepted that BMD is already
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reduced. Therefore, that raises the question if we should compare people with those who
are already compromised? The author feels that this is not the best means of determining
risk of fracture or osteoporosis, and as a result analysis will be compared with T-score.
2.2.2 Manifestations
Cortical Bone
As osteoporosis progresses, the cortices of all bones begin to thin. This can continue to
the stage where there is a noticeable, visible decrease [Grampp et al., 1997]. It is gener-
ally accepted this thinning results from the trabecularisation of the inner surface of the
bone. This trabecularisation causes an increase in porosity and a reduction in the overall
strength. For men at least, it has been shown that deposition of bone on the periosteal
surface counteracts this thinning [Duan et al., 2001].
Cancellous Bone
For cancellous bone, mass is reduced by the process of the resorption of trabeculae. Whilst
it was originally thought that thinning of the trabeculae continued until ultimately the
entire strut is resorbed, some research has proposed that this may not be true. ParVtt et al.
[1983] measured the number and thickness of the trabeculae of the iliac crest. They found
that while the number of trabeculae certainly decreased, the thickness of the remaining
trabeculae did not decrease toward zero. It was proposed that thinning is rather more
localised, at the centre of the trabeculae, and causes the ends of the structure to become
separated. Then, the remaining bone is resorbed in a linear fashion along the original long
axis toward the nodes from which it originated. In any case, bone is lost from trabeculae
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which do not lie along the main direction of loading of the bone Vrst. This loss of bone,
with no loss in overall volume, is what results in the observed decrease in BMD. This is
now more broadly accepted [Seeman, 2008].
2.2.3 Changes in Mechanical Competency
These changes in bone mass and architecture are only important when we consider the
eUect of density on the mechanical properties of bone, and in particular cancellous bone.
It has been demonstrated that the elastic modulus and ultimate strength of cancellous bone
depends on the apparent density [Keaveny, 1993]. The elastic modulus follows a power-
law relationship, as per Equation 2.3 [Carter and Hayes, 1977]. In this equation a, b and
c are constants that depend on the structure of the bone and ρ is the hydrated apparent
density.
E = a+ bρc (2.3)
Keaveny [1993] have shown that the c coeXcient is in the order of 2. Figure 2.5 shows
the relationship between density and both modulus of elasticity and ultimate strength. The
major morbidity associated with osteoporosis is fracture at the hip, lumbar spine and wrist.
These sites are primarily cancellous bone whose mechanical properties may be altered
by the changes, such as the reduction in bone mass that accompanies the progression of
osteoporosis. Simplifying the formula to a more accessible example, a reduction of one
quarter of the bone density will represent a 50% decrease in the ultimate strength. Over a
relatively short time, say the Vrst Vve years post menopause, an individual may go from
having normal bones to much more fragile bones. It also reaXrms the need to screen the
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population as early as possible, in order to select those at greatest risk and prevent further
bone loss.
Figure 2.5: Work carried out by Keaveny [1993] and Zioupos et al. [2008] exempliVes the relation-
ship between the density and both the elastic modulus and the ultimate strength. For
both relationships the exponent was approximately two in the principle axis. Figure
reproduced with permission form Zioupos et al. [2008].
2.3 Detection of Osteoporosis
There are a very limited number of clinically accepted methods for diagnosing osteoporo-
sis. This is in part due to relatively recent deVnition for the condition [Alexeeva et al.,
1994]. The following section lists the methods that have been used in the past and those
used currently. The simplest guidelines for selecting those who require scanning are also
introduced.
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2.3.1 Guidelines for DXA screening
A number of large organisations, such as WHO and NOF, have guidelines for selecting
those who require DXA scanning. For example, the NOF suggest that anyone over the
age 65, anyone over the age of 55 with another risk factor or any postmenopausal woman
presenting with a fracture be sent for DXA scanning. Although these guidelines are simple
and easy to apply, they can lead to large numbers of women being sent for investigatory
scans when they are not required. Possibly the greatest beneVt of a quantitative ultrasound
screening based approach is the possibility to reduce the number of unnecessary scans. If
more, uncross-correlated, information can be determined about an individual, clinicians
could reduce the demand on the already overburdened scanning clinics by reducing the
number of perfectly healthy people sent for scans.
2.3.2 Radiogrammetry
As was mentioned in the previous chapter, radiogrammetry was the Vrst widely used
means of monitoring change in bone mass. It was introduced by Barnett and Nordin
[1960] who measured the cortical thickness of the metacarpal. Hand radiographs were
taken and measurements were performed at the midshaft of the metacarpal using cal-
lipers. One of the following calculations can then be carried out. The metacarpal length
can be divided by the width, to give the metacarpal index (MCI). Or the outer (bone) and
inner (medullary) diameter are measured, as per Figure 2.6. These are used to calculate
the width of the combined cortical bone thickness (CCT), which is bone diameter mi-
nus medullary diameter. This does indeed Vll the role as a means of monitoring skeletal
changes, as it can be used to quantify cortical thinning. However, there are a number
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of disadvantages associated with the use of radiogrammetry. The most notable of these
is the fact the investigated site is primarily cortical bone, initially of the metacarpal and
then more recently of the radius. This means that the more metabolically active cancel-
lous bone is not investigated, nor are the sites of clinical interest in terms of fracture risk.
Even in the cortical bone that is studied, intracortical porosity and trabecularisation of the
endocortical surface is not monitored. Possibly the greatest drawback to radiogrammetry,
however, is actually not any of these limitations, rather the precision of the measurements.
When MCI was Vrst introduced, the coeXcient of variation of MCI was 7.4% [Barnett and
Nordin, 1960]. Precision values did begin to fall as technology improved and techniques
became more computerised. However, even with digitised systems, the values for CCT
remained greater than 5% [Kalla et al., 1989]. The problem with poor precision for this
technique is that only large changes, at least as large as the coeXcient of variation, can be
conVdently conVrmed. This makes monitoring small changes impossible.
More recently there has been development of new measurements based on radio-
grammetry. Rosholm et al. [2001] used the bone width and thickness of the radius and
metacarpals derived from computerised radiogrammetric techniques to calculate the vol-
ume of the projected area, which was in turn used to calculate the estimate mineral density,
BMDDXR. This value was found to be signiVcantly correlated to the BMD at the hip and
spine, and of the same magnitude as the correlations between the BMD from DXA at the
site and the BMD at the hip and spine. Furthermore, the coeXcient of variations for these
estimated density values were 0.6% which makes this method more suited for monitoring
small changes.
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Figure 2.6: Radiogrammetry
2.3.3 SPA and DPA
Cameron and Sorenson [1963] introduced the use of single photon absorptiometry (SPA)
as a means of measuring bone mineral content. A beam of γ-rays are passed through the
region of interest and collected by a scintillator. The bone mineral determines the number
of photons that are transmitted. The diUerences in attenuation across the bone and soft
tissue and soft tissue alone are equivalent to the mineral content of the bone if the soft
tissue is of constant thickness. As this is not the case, the site of interest is scanned in a
water bath, where water is assumed to be a soft tissue equivalent. The results are divided
by the axial length to give units of g.cm−1 which is Bone Mineral Content (BMC). This
may also be divided by the area of the scanned region to give the areal Bone Mineral
Density (BMD).
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In order to enable the scanning of deeper sites, such as the lumbar spine, Krølner and
Nielsen [1980] proposed the use of a source that emits photons at two separate energy
levels. Collecting the photons at these two distinct energies level allows for the use of the
dual-photon transmission equation, which corrects for the soft tissue. This meant that no
tissue equivalent, i.e. water bath, was required and scanning could be performed on the
axial skeleton. Absorptiometry at the hip and spine has the obvious advantage of being a
direct measurement of sites frequently aUected by osteoporosis.
2.3.4 SXA and DXA
More recent advances in the Veld of absorptiometry has seen a replacement of radionu-
clide sources with X-ray tubes, leading to the development of Single Energy X-ray Ab-
sorptiometry (SXA) and Dual Energy X-ray Absorptiometry (DXA). This is to eliminate
the problems of long term precision associated with source decay. SXA has been shown
to have low coeXcient of variation for measurements at the radius [Berenson et al., 2001],
suggesting that it may be useful as a method of measuring skeletal condition. However, as
was the case with SPA, SXA requires a water bath as a means of correcting for soft tissue.
This makes it cumbersome to use and may add unnecessary time to the duration of scan.
DXA works on the same principle as DPA, except it uses x-rays instead of γ-rays. The use
of X-rays allows for faster, more precise measurements [Borders et al., 1988]. A sample
DXA printout showing the typical scan and results can be seen in Figure 2.7.
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Figure 2.7: Printout of results from Dual Energy X-Ray Absorptiometry scan. The BMC and BMD
are given at a variety of sites. The T-scores and Z-Scores are also provided. The graph
also plots the individual’s total hip BMD and the expected changes with aging.
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2.3.5 Screening Tools
Given the associated costs involved with these techniques, there is a need to make more
eXcient use of such services. Many diUerent research groups have developed simple,
questionnaire based tools for determining the risk of developing osteoporosis.
QUS
SOS Speed of Sound (SOS) measurements were one of the Vrst methods of character-
isation proposed employing the passage of ultrasound through bone. Over the years, a
number of slightly diUerent means of calculating these speeds have been developed. The
basic principles can be seen in Figure 2.8. These begin from the simplest approximation
of the Limb Velocity, calculated by dividing the distance between transducers placed ei-
ther side of the bone in question by the time taken for the emitted wave to be detected
by the receiver (Equation 2.4). To attempt to measure only the velocity through the bone
the Bone Velocity has also been suggested. This measurement depends on the thickness
and time required to cross the soft tissue (Equation 2.5). An extension of these has been
developed for use when the limb is placed in a water bath. The velocity of sound through
water and the exact separation of the transducers is required (Equation 2.6). Finally, the
axial velocity is used to measure the velocity along long, Wat areas of bone which are not
excessively covered with soft tissue. This velocity is calculated by measuring the time re-
quired for the sound wave to propagate along the bone and to be detected by the receiver.
The distance between the transmitter and receiver is Vxed. Each method has shown some
use as a predictor of low bone mineral density and relatively low coeXcients of variation.
An example of the performance and precision of devices that interrogate the Vnger can be
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Table 2.2: Performance of Speed of Sound Measurements at the Proximal Phalanx
Study Device Correlation with BMD Precision
Louis et al. [1998] DBM Sonic 1200 R = 0.45–0.62 < 2.7%
Guglielmi et al. [1999] DBM Sonic 1200 R = 0.56–0.74 < 2.3%
Scavalli et al. [1997] DBM Sonic 1200 R = 0.45 0.88%
Blanckaert et al. [1999] DBM Sonic 1200 R = 0.03–0.45 0.91%
seen in Table 2.2.
Limb Velocity =
x
tx
(2.4)
Bone Velocity =
Xb
tb
=
x− (xs1 + xs2)
t− (ts1 + ts2) (2.5)
TOF Velocity =
Vwx
x− (∆tVw) (2.6)
BUA Langton et al. [1984] published the theory of using Broadband Ultrasound Atten-
uation (BUA) as way of determining bone condition. A reference curve is produced by
collecting a wave that crosses water and plotting its fast Fourier transform. Then, waves
from scans of individuals are collected and compared to this reference curve. The dif-
ference of these curves are plotted and used to calculated the attenuation with frequency
(Figure 2.9). It was noted that greater attenuation was recorded in higher quality bone.
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(a) Contact Method
(b) Substitution Method
(c) Along The Bone
Figure 2.8: Speed of Sound may be calculated by means of through transmission (a and b) or along
the shaft of longer bones (c).
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(a) Amplitude plotted against Frequency (b)
Figure 2.9: Fast Fourier transforms of the waves through water and across the calcaneus are plotted
(a) and the diUerence between these is calculated. These diUerences are plotted and the
slope is the BUA (b).
2.3.6 Questionnaire Based Assessment Tools
A number of attempts have been made to derive very simple tools for diagnosing os-
teoporosis consisting only of a questionnaire administered by a health care worker. The
potential beneVts of this type of approach are obvious. The greatest advantage is the cost
of the ’test’. A simple questionnaire could be completed by all postmenopausal women
attending their general practitioner at virtually no cost. This could prioritise those po-
tentially at greatest risk, while deferring possible further investigation of those at lowest
risk.
The OST, developed by Koh et al. [2001], was one of the Vrst of this kind published.
The authors looked at postmenopausal sample of east Asian women recruited from the
community. Details of risk factors were self reported and BMD measurements were taken
the left femoral neck. With the suggested threshold, they found that the tool performed
moderately to well. However the authors suggest that the two separate cut-oUs should be
31
2.3. Detection of Osteoporosis
used, categorising those as either high, intermediate or low risk.
The SCORE tool was developed to predict those with low (T-score ≤ -2.0) at the
femoral neck [Lydick et al., 1998]. The sample in question was a Caucasian sample from
North America. Race, the presence rheumatoid arthritis, the use of oestrogen therapy, pre-
vious fractures, age and weight were all selected as signiVcant risk factors. A validation
study supported the promising results found during development.
The ORAI tool found that age, weight and oestrogen use were the most important
factors for a Canadian population [Cadarette et al., 2000]. Results from development and
validation sample showed the tool had good predictive ability. The test was designed to
discriminate between patients with normal and low (T-score ≤ 2.0) mineral density. It
performed the task quite well, with a speciVcity of approximately 50%. This means that
50% of all healthy individuals who are incorrectly sent for DXA scans could be asked to
return at a later date, thereby making more eXcient use the services.
The tool developed for a population closest to the British population is possibly the
OSIRIS. Sedrine et al. [2002] found that for postmenopausal, Belgian women between the
ages of 60 and 80 years old, weight, previous fracture and oestrogen use were best at
selecting those with osteoporosis. The Vrst implementation showed the tool had some use,
with good accuracy. However, the authors believe that it is best not to determine healthy
or osteoporotic, rather high, medium or low risk. Those with values in the low risk range
being reassessed later and those at high risk being immediately been prescribed treatment.
It was suggested that those at medium risk would be further investigated to determine if
treatment was necessary at that point.
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2.3.7 Questionnaire Based Tools for Predicting Fracture
Similar methods have been employed to predict fracture. In a study by Black et al. [2001]
the authors looked at questionnaire results along with measured variables to determine
which were the most signiVcant for predicting fracture at a number of sites. They found
that age, history of fracture, history of maternal fracture, weight, smoking status and the
need for help when getting out of a chair proved to be the most signiVcant and least inter-
correlated. In cases where BMD measurements are available, they also are added to the
model. The simple assessment performed moderately well, but signiVcantly better when
BMD was included.
The newest tools to be developed for determining the probability of fracture is FRAX
[Kanis et al., 2008]. Age, sex, BMI, history of fracture, family history of fracture, gluco-
corticoid use, presence of rheumatoid arthritis, secondary osteoporosis and smoking and
alcohol consumption were compared to osteoporotic fracture of any type. These were then
used to calculate the probability of hip fracture and fracture of any type. This may not
give an indication of the BMD, but long term studies might prove that making decisions
based on the probability of fracture are more appropriate than on density alone.
2.4 Statistics
The previous section describes the major techniques, past and present, which have been
used to determine changes associated with bone loss. Although these approaches measure
diUerent parameters at a variety of skeletal sites, it is imperative to evaluate how precise
a technique is in order to be able to have conVdence in the results it provides. There
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is also a need to be able to compare how well diUerent methodologies correctly diagnose
osteoporosis. This is to determine if, for example, new ideas or devices perform better than
existing ones. The following section describes the statistical techniques used currently in
the Veld of densitometry and the means of comparing tools that assess risk of osteoporosis
and risk of fracture.
2.4.1 Precision
Precision is a numeric expression of the reproducibility of a measurement. It can be imag-
ined as the variation and spread of the values when a set of measurements is taken by the
same, or diUerent, observer for the same input with repositioning between measurements.
This is not to be confused with repeatability which looks at the spread of data when there
is no repositioning between measurements. Although repeatability is important, as it can
tell if a machine is likely to produce reasonable results, the major sources of errors are ex-
pected to be due the inconsistent selection of the exact region of interest by one observer
and the diUering opinion of the exact region of interest between diUerent observers.
Precision for an Individual
The easiest means of calculating precision for a densitometric technique is to perform a
number of repeated scans on the same individual whilst repositioning the site of interest
before each scan. This allows for the calculation of precision error of that speciVc method
of measurement for that speciVc individual. This is simply the standard deviation of i
repeated measurements of individual j (See Equation 2.7).
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SDj =
√√√√ nj∑
i=1
(xij − x¯j)2
nj − 1 (2.7)
From this equation, xij refers to the ith measurement for individual j. Also, x¯j repre-
sents the mean of all measurements for individual j and nj corresponds to the number of
repeated measurements.
In order to make precision errors more intuitive, they may be expressed as a coeXcient
of variation (See Equation 2.8). This also has the advantage of incorporating the mean
measured value, which takes into account the scale of the precision error. To illustrate this
point, imagine one were investigating the speed of sound at the heel and the radius as a
means of predicting density. Imagine if the mean values were 1600m.s−1 and 2000m.s−1
respectively and the standard deviation were both 20m.s−1. Although the techniques have
an identical precision error, the coeXcient of variation is greater for the heel (1.25%), than
for the radius (1%). This simply reWects that fact that the standard deviation represents a
greater proportion of the mean heel value.
CVSDj =
SDj
x¯j
.100% (2.8)
However measuring only one individual limits what can be said about the precision
of the technique in general. It may be the case that the individual that was scanned
had an exceptionally symmetric, homogenous region of interest. Therefore the calculated
precision values may be overly optimistic, or pessimistic, compared the true value for the
entire population. Alternatively, the scanned subject may have suUered a fracture or other
deformity at the scan site without their knowledge, which could lead to extremely varied,
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imprecise results. Therefore, the precision of a technique is generally calculated by looking
at results from more than one subject.
Precision of a Technique
The precision error of the technique is the root-mean-square average of the precision errors
of each individual, as per Equation 2.9, where m is the number of subjects scanned. It is
important to note that the precision error of the technique is not the mean of all the
subjects’ precision errors, rather the squared precision error is given by the mean of their
variances [Glüer et al., 1995].
SD =
√√√√ m∑
j=1
SD2j
m
(2.9)
The coeXcient of variation for a technique is calculated using the standard deviation
found for the technique. The averages for each individual, x¯j , and the number of individ-
uals,m, are required for this computation (See Equation 2.10).
CVSD =
SD∑m
j=1
x¯j
m
.100% (2.10)
The above calculation of SD assumes that the same number of repeat measurements
are performed on all the subjects. In practice, this may not be the case and Equation 2.11
represents the general expression of the formula.
SD =
√√√√ m∑
j=1
nj∑
i=1
(xij − x¯j)2
df
(2.11)
The degrees of freedom, df from above, for the technique is the sum of the degrees of
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freedom of the scans for the individuals, as per Equation 2.12.
df =
m∑
j=1
(nj − 1) (2.12)
There are two important inWuences that need to be addressed when presenting the pre-
cision of a technique. The Vrst of these has been alluded to previously; the eUect of the
sample on the precision error. More speciVcally, how the health of the sample eUects the
calculation of precision. There is a general agreement, at least within densitometric cir-
cles, that the precision error will be smaller for healthy subjects compared to osteoporotic
individuals. Therefore when precision errors are quoted, it is important to also state the
health of the sample. The second inWuence that needs to be dealt with is the time frame of
the measurements. The above procedure is only appropriate for calculating the short term
precision of a technique. Generally, these repeated measurements are performed within
three to four weeks. It is obvious that if the window for scanning was years instead of
days or weeks, there may in fact be a signiVcant reduction in the parameter that was to be
measured, which would increase the recorded precision error.
Detectable DiUerences
While the precision errors and the coeXcients of variation provide very important infor-
mation about the measurements of a methodology, they are also used to calculate what
change can be deemed signiVcant and the length of time before a change might be notice-
able. An excellent review has been written by Glüer [1999], the main points of which are
presented here.
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Least SigniVcant Change As the name suggests, the Least SigniVcant Change (LSC) is
the smallest diUerence that can be attributed to actual changes in the skeletal quality. Of
course, the degree of conVdence that is most applicable needs to be decided to determine
this value. Assuming the certainty must be greater than 95%, then the minimum diUerence
that can be detected must be 2.8 times the value of the precision error (Equation 2.13).
LSC = 2.8× PE (2.13)
Trend Assessment Margin In a research setting, the use of the LSC can be used, for
example, to detect changes in BMD due to new drug treatments. In the clinical world
however, it may not be suitable to wait until this change has taken place. A clinician may
concede that detrimental changes are occurring at a lower conVdence level, if it is required
to prescribe treatment as soon as possible. This has led to the development of the Trend
Assessment Margin (TAM) (Equation 2.14). Trend implies that the certainty is less than
for a signiVcant change. Indeed, a certainty of 80% is usually accepted.
TAM = 1.8× PE (2.14)
Followup Intervals The LSC and TAM are also used to answer the question of what
period of time should there be between scans. It is intuitive that which input is used will
aUect the time. Which is used depends on whether it is important to guarantee that a
change is occurring, or whether there is a trend developing. The Monitoring Time Interval
(MTI) is the time point when it is expected that half of the population will display a change
greater than the least signiVcant change (Equation 2.15).
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MTI =
LSC
Median Change per Annum
(2.15)
The Trend Assessment Interval (TAI) is the time point when half the population will
display a change greater than the trend assessment margin (Equation 2.16). This will
be shorter than the monitoring time interval, but there is slightly less certainty that the
diUerence is real.
TAI =
TAM
Median Change per Annum
(2.16)
2.4.2 Evaluation of New Diagnostic Tools
One of the goals of this work is to produce assessment tools which evaluate an individual’s
risk factors and classiVes them as either healthy or osteoporotic. However, simply creating
these tools is not enough: each must be assessed to determine if it is more, or less, eUective
than similar tools. Typically, the results of new or proposed diagnostic tools or interven-
tions are compared for a sample of patients with and without the diseased state. This is
simple where one can easily distinguish between these states. For example, if a drug that
attempts to reduce blood pressure were being evaluated, simply measuring blood pressure
would indicate to the researcher if the drug had been successful or not.
This is not the case for judging the success of diagnostic tools for osteoporosis. The
problem lies in the fact that osteoporosis is not perfectly deVned. Although it is accepted as
a state of low bone mineral content that increases the risk of fragility fracture, there are still
no unequivocal guidelines when it comes to classifying somebody as osteoporotic. As was
discussed previously, absorptiometric T-scores are used in lieu of any better methodology.
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Therefore, DXA measurements are used to conVrm or deny the presence of the disease.
This type of test is referred to as a gold standard, and is common in medicine where
certain procedures are regarded as deVnitive.
Assuming then that DXA is the gold standard, the eUectiveness of a new test, let us
call it Test A, is assessed using binary classiVcation. Figure 2.10 shows a sample scenario
where Test A is evaluated. When both DXA and Test A identify an individual as positive
for osteoporosis, they are a True Positive (TP). Similarly, a True Negative (TN) comes about
when both tests indicate the absence of osteoporosis. There is also the possibility of two
distinct types of error; a type I error and a type II error. A type I error, also known as a
False Positive (FP), occurs when Test A suggests the presence of osteoporosis in a healthy
individual. A type II error, or False Negative (FN), arises when a diseased individual is
given a clean bill of health by Test A.
This type of plot allows the researcher to visualise how well the data are correlated,
but also helps in determining the appropriate threshold to set for the new test. Setting this
threshold is dependent on the possible outcomes of the above mentioned errors. Imagine
a simpliVed case where there are healthy and diseased individuals. There is also a cure for
this disease and a new diagnostic tool which may be used to test for it. Now imagine two
possible scenarios. The Vrst assumes that the symptoms of the disease are easily managed
and although the cure is eUective, it has some adverse side eUects. It is then extremely
important not to prescribe treatment to healthy individuals, type I errors. This is achieved
by setting the threshold for the new test such that all healthy individuals are selected as
such (in Figure 2.10, moving the vertical threshold to the left). In the second scenario
imagine that if the cure is not prescribed to a diseased individual they will suUer greatly
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Figure 2.10: Diagnostic Test A compared with DXA results. The dashed lines represent the thresh-
olds for either tool. This is normally a T-Score < -2.5 for DXA, while the threshold
for Test A is set by the investigator in order to minimise the number of False Positives
or False Negatives. Each cross represents the results for an individual (both for DXA
and for Test A).
and that the cure has no side eUects. Here the emphasis is on ensuring that no diseased
individuals are misdiagnosed as healthy, type II errors. This is accomplished by applying a
threshold that ensures diseased individuals are recognised as such (in Figure 2.10, moving
the vertical threshold to the right).
It is obvious that no test (expect one that is 100% accurate) can have a threshold that
will satisfy both of these conditions. Researchers must therefore judge which type of error
poses the greater problem and minimise this, at the expense of more of the other type of
error. It is not simply good enough to accept that some error will be present. There must
be some measurement of the proportion of False Negatives and False Positives. This is
done by constructing a confusion matrix like that in Table 2.3.
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Table 2.3: A Confusion Matrix. This type of matrix is used to display the diUerences between the
test values (Test A) and the true or gold standard values (DXA in this case).
Test A
+ − Total
DXA Evaluation
− False Positive (FP) True Negative (TN) TN + FP
+ True Positive (TP) False Negative (FN) TP + FN
Total TP + FP TN + FN TP + FN + FP + TN
With this data, the sensitivity and speciVcity are calculated. The sensitivity is a mea-
sure of how well a test diagnoses diseased individuals correctly (Equation 2.17). Con-
versely, the speciVcity of a test determines the ability of any test to select the healthy
individuals (Equation 2.17).
Sensitivity =
TP
(TP + FN)
, Specificity =
TN
(FP + TN)
(2.17)
In a clinical setting, there is also a desire to know the probability of a person having, or
not having, a disease based on a positive, or negative, results from a given test. The Positive
Predictive Value (PPV) and the Negative Predictive Value (NPV) are used to calculate these
probabilities (Equation 2.18).
PPV =
TP
(TP + FP )
, NPV =
TN
(FN + TN)
(2.18)
The above techniques were developed to analyse the errors associated with new di-
agnostic tests. They do not, however, measure the eUectiveness of the test. To do this,
this information must be manipulated further. Receiver Operating Characteristic (ROC)
curves, plots of sensitivity versus 1 - speciVcity, are used to monitor the eUect of moving
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the decision threshold (dashed, vertical line from Figure 2.10) of the test. This is done by
assuming that the decision threshold is to the left of all points, where sensitivity is 0 and
speciVcity is 1. Then by incrementally moving the threshold to the right, until sensitivity
is 1 and speciVcity is 0, as per Figure 2.11.
Figure 2.11: The solid curve represents the diseased population and the dotted curve represents
the healthy population. The decision threshold, the dashed line, is moved to the right,
whilst calculating the sensitivity and speciVcity at each step. These values are then
used to plot the ROC Curve.
Plotting the sensitivity versus 1 - speciVcity gives a ROC curve, something like Figure
2.12. For a test that performs very well, i.e. has very few errors of either type, the curve will
begin at (0,0), approach (0,1) and terminate at (1,1). This is because, if there are few false
positives or false negatives, sensitivity and speciVcity can both be high for most decision
thresholds. The Area Under the Curve (AUC) is calculated by integrating the ROC curve.
The test in Figure 2.12 has an AUC of 0.84. Similarly, a test that randomly diagnoses people
as normal or healthy, such as the dashed line in Figure 2.12, will have an AUC of 0.5. Tools
or tests with an AUC of 0.5–0.6 are considered to have little or no discriminatory ability.
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Figure 2.12: A sample ROC curve. The solid line represents the curve for a imaginary test. The
dashed line form (0,0) to (1,1) would be the performance of a test that randomly assigns
the result; for example if diagnosis was made based on a coin toss. A perfect test would
include the point (0,1), as this suggests that for a single decision threshold sensitivity
and speciVcity are both 1, with no false positives or false negatives.
Values of 0.6–0.7 are deemed poor, 0.7–0.8 moderate and 0.8–0.9 good. Any diagnostic tool
with an AUC value between 0.9 and 1 is considered excellent.
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Questionnaire Based Analysis
Make everything as simple as possible, but not simpler
Albert Einstein
One can tell quite a number of things by simply using a detective method and by
focussing on details and ‘tell tale’ signs of osteoporosis. By leading a person through a
set of questions, a GP can paint a picture of their overall risk. However, this may not
be reassuring enough for those who rely on expensive machinery to diagnose conditions.
The idea of just collecting patient responses may seem outdated when it is possible to
measure the attenuation of x-rays through their bones. Therefore, these ‘technophiles’
may be disappointed and surprised to Vnd out that such response based assessment tools
have a proven track record for distinguishing those with a higher probability of fragility
fracture. To add insult to injury, these most basic of assessments have also been shown
to select those with osteoporosis, based on absorptiometric techniques, quite well. This
chapter details an attempt to do just this for a cohort from within the British population.
It also describes how combinations of these risk factors and quantitative ultrasound may
be employed to improve the utility, over what can be achieved when either method is
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employed individually. Ultimately, the goal is to develop a future questionnaire which
will yield a numerical output, which is summative, that can be used to aid with decisions
regarding treatment or further diagnostic testing.
3.1 Introduction
The key to treating osteoporosis is to determine an individual’s risk as early as possible.
Ideally, all women would be assessed close to, or soon after, menopause in order to measure
their bone mineral density before the initial rapid decrease in bone mineral content. This
would allow clinicians to document a density starting point before the expected rapid
decrease, and determine if an individual began at a compromised level. Also, follow up
assessments at regular intervals would allow a physician to gauge the rate of bone loss and
to judge whether the individual had become, or was in danger of becoming, osteoporotic.
Although are there a number of means of diagnosing osteoporosis (Chapter 2), DXA
scanning of the spine and hip remains the gold standard. This method of densitometry is
widely used in assessing bone mineral density for many ethnic groups of all ages. There are
however a number of disadvantages which may limit the availability or appropriateness
of this technique. The most obvious of these is the associated costs. These machines
are very expensive to purchase, maintain and operate, meaning that they are not readily
available in all regions. In the UK alone there is a deVcit of such scanners, and in extreme
cases individuals may have to wait for up to 78 weeks to be seen [APPOG, 2005]. There
is also the issue of exposing people to sources of ionising radiation. Even if the doses
are relatively low [Njeh et al., 1999a], it may not be justiVed to perform repeat scans on
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healthy individuals. With these shortcomings in mind, there have been eUorts to minimise
the numbers sent for DXA scanning. These eUorts are very varied in approach.
Many groups and organisations suggest that all women who present with, or exceed, a
certain risk criteria should be sent for DXA scanning. These criteria may be quite simple,
for example all women over the age of 65 as prescribed by the National Osteoporosis
Foundation. However, even less speciVc tools have also been oUered. Weinstein and Ullery
[2000] suggested that women over the age of 65, OR with a weight of 140 lb or less at the
time of menopause OR those you have never used oestrogen be referred for investigation.
These rather crude techniques, coupled with an aging population would mean that these
tools have little use at decreasing the numbers sent for DXA scanning. In fact, every
woman would be selected eventually, whether they had osteoporosis or not. Therefore,
due to the overall ineXciency, this basic approach is not favoured.
The next advance, following this methodology, was to combine the diUerent risk fac-
tors in order to derive a scoring system that would allow for the categorising of people by
their perceived risk of osteoporosis. This type of system meant that fewer healthy people
would be sent for scanning. For example, one of the simplest tools based on more than
one risk factor was the OST (Osteoporosis Self-assessment Tool), developed by Koh et al.
[2001]. The authors looked a combination of weight and height of Asian women and com-
pared these to the BMD T-Score at the hip. The obvious advantage of this combinatory
approach is that it looks at more than one risk factor. This means that, for example, even
if a woman is over a certain threshold age, she may be protected from osteoporosis by her
body weight or vice versa. Implementing this test would reduce the number of unneces-
sary scans signiVcantly. However, the tool must be designed speciVcally for the population
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in question. Examples such as SCORE (Simple Calculated Osteoporosis Risk Estimation)
[Lydick et al., 1998] and OSIRIS (OSteoporosis Index of RISk) [Sedrine et al., 2002] exist
for North American and Belgian women.
For many years now, the use of ultrasound as a pre-screening tool for osteoporosis or
fracture has been studied in clinical environments. The speed of sound (SOS) through bone
was believed to alter with the density and elasticity, and thus could be used to select those
with low bone mineral density. Ever since Langton et al. [1984] Vrst introduced the use
of broadband ultrasound attenuation (BUA) as a means of quantifying bone health, it has
been shown to have a very good concordance with BMD at the hip and spine [Kung et al.,
2003, Hadji et al., 1999, Damilakis et al., 2004]. The attenuation depends on the density and
connectivity of the cancellous bone of the heel and alters with the resorption of trabeculae
[Hans et al., 1995]. Due to the fact that the heel is mainly composed of the metabolically
active cancellous bone and is weight bearing it is expected that there would such a good
agreement with DXAmeasures [Greenspan et al., 1997]. Indeed, the ability of velocity and
attenuation measurements, from two commercially available scanners, to predict BMD has
been recently been studied for a British population [Cook et al., 2005]. The authors found
signiVcant relationships between all QUS measurements and BMD T-scores.
The author felt that the next logical step was to combine a knowledge of risk factors
with an ultrasound measurement. This has been investigated to a much lesser extent.
Richy et al. [2004], for example, developed the ORACLE tool which combined UBPI at the
proximal phalanx with certain known risk factors. They found better results than could
be achieved with either technique alone. It was thought that while this may have saved a
number of unnecessary scans, even greater reductions could be noted if better performing
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ultrasound parameters were used.
This chapter outlines the process of identifying the most important risk factors for
an English population, creating assessment tools based on these factors and quantifying
the utility of such tools. Tools which combine these risk factors and a single ultrasonic
measurement will also be investigated.
3.2 Methods
3.2.1 Sample
Volunteers were recruited from those attending the DXA scanning clinic at The Great
Western Hospital, Swindon, UK. Ethical approval was granted by the hospital’s ethics
board prior to commencement. All volunteers were sent an information sheet prior to
arrival at the hospital and provided written informed consent (Appendix C) before they
were included in the study. A total of 274 postmenopausal (natural and surgical) Caucasian
women were scanned. Volunteers were excluded from the study if they presented with any
secondary cause of osteoporosis. This was the case for eight individuals (Vve with Coeliac
disease, two with hyperthyroidism and one with Cushing’s syndrome).
3.2.2 Design and Execution of Questionnaire
Each volunteer was asked to complete a questionnaire (Appendix A). The questionnaire
was based upon a previous NHS questionnaire and related to an individual’s physical
measurements, lifestyle, diet and medical and reproductive history. A breakdown of the
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questionnaire can be seen in Table 3.2.
Based on the responses of the questionnaires, 23 individuals were removed from fur-
ther study due to a lack of required responses. A further eight individuals were removed
from the study due to incomplete or ambiguous medical details. This resulted in a total
of 235 volunteers who were considered for analysis. Demographics of the Vnal sample are
presented in Table 3.1.
Table 3.1: Demographics of Sample for Development of Assessment Tools
Variable Mean (± SD) or Number (%)
Age (Years) 59.7 (± 10.8)
Weight (kg) 65.6 (± 12.4)
Height (cm) 161.0 (± 7.2)
BMI(kg/m2) 25.4 (± 4.6)
Current Smoker 32 (13.6%)
Age at Menarche (Years) 13.0 (± 1.9)
Age at Menopause (Years) 44.8 (± 8.0)
History of Non Traumatic Fracture† 76 (32.3%)
Use of Hormone Replacement Therapy‡ 109 (46.4%)
† Non Traumatic Fracture was deVned as a fracture resulting from minimal trauma based on the
questionnaire responses
‡ Hormone Replacement Therapy was assigned if the subject had been using it for ≥ 1 year and treatment
began before the age of 60
3.2.3 DXA Scanning
DXA scans for each individual were performed by one of two qualiVed radiographers.
The DXA scanning system was a Hologic QDR-4500C (Hologic Inc., Bedford, Mass.). The
system measured BMD values for the lumbar spine, femoral neck and total hip. It then
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Table 3.2: Breakdown of Questionnaire Used
Section Parameter
Volunteer Details Weight
Height
Age
Ethnicity
Physical Activity Activity at Work and Leisure
Exercise History
Lifestyle Smoker (Past or Present)
Alcohol Consumption
Medical History History of Fracture
Family History of Osteoporotic Fracture
Family History of Osteoporosis
ConVnement to Bed
Medical Problems
Steroid Use
Diet Weight Control
Calcium Supplements
Dietary Restrictions
Variety of Diet
Dietary Problems
Reproductive History Parity
Breast Feeding
Menarche
Menopause
Hysterectomy
Oophorectomy
Oral Contraception
HRT
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used the relevant system database to calculate the T-score for each site. It is these T-scores
which were used for analyses throughout this chapter.
3.2.4 QUS Scanning
Two QUS systems were used to measure parameters at a variety of skeletal sites. The
CUBA Clinical (McCue PLC, Winchester, UK) was used to measure Velocity of Sound
(VOS) and Broadband Ultrasound Attenuation (BUA) across the calcaneus. Speed of Sound
measurements were also taken at the proximal phalanx of the third digit (SOSPP ), the dis-
tal radius (SOSDR) and the mid-shaft tibia (SOSMT ) with the Sunlight Omnisense (Sun-
light Medical, Rehovot, Israel). Aquasonic R© Clear Ultrasound Gel (Parker Laboratories
Inc, FairVeld, N.J.) was used to guarantee coupling between the scanning systems and the
investigated sites.
Both devices were quality checked on each day of scanning using quality standards
provided with the machines. All QUS scans were taken by the same researcher who was
familiar with the operation of both scanning systems.
3.2.5 Statistics
The precision of all QUSmeasurement techniques was calculated. This entailed calculating
the coeXcient of variation (CV) for each of the methods, as described by Glüer et al. [1995].
Simple regression analysis was performed between all questionnaire responses and
DXA T-scores. This allowed for the determination of the most signiVcant risk factors. Re-
gression analysis was also performed between the QUS variables and the T-scores. Using
the most signiVcant risk factors (P < 0.2) for each DXA measurement site as a possible in-
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dependent variable, and the DXA T-scores as the dependent variables, stepwise (both for-
ward and backward) regression was performed. The stepwise regression involved adding
variables to, or subtracting variables from, a model in order to Vnd the best predictors. A
signiVcance level of P < 0.05 was chosen for addition to or removal from models.
ROC analysis was used to compute the clinical utility of the derived models. In order
to create these curves, the sensitivity and speciVcity values were calculated for varying
cutoU thresholds. Also, the cutoU which ensured a sensitivity of ≥ 90% was recorded. The
corresponding speciVcity, PPV and NPV were noted at this level at each DXA site.
3.2.6 SimpliVcation
In order to create tools with some clinical use, certain simpliVcations were required. The
Vrst step was to select the best performing models, based on AUC values, which use ques-
tionnaire responses or a combination of questionnaire responses and QUS parameters. The
model based on QUS alone was not simpliVed, as it was assumed if QUS was available then
a questionnaire could also be administered.
The simpliVcation process involved scaling and rounding the coeXcients of the step-
wise regression. This resulted in a more manageable multivariate regression. The AUC
values of the simpliVed models were also calculated to determine if utility had decreased
as a result of the simpliVcation. The cutoU which ensured a sensitivity of ≥ 90% was also
noted.
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3.2.7 Software
All questionnaire data were collected and stored in Microsoft R© Excel spreadsheets. Re-
gression analysis was performed using MINITAB TM Statistical Software release 13.31. All
other statistical analysis and graphing were carried out using SigmaPlot for Windows
10.0.
3.3 Results
3.3.1 DXA T-scores
Figure 3.1 shows the T-scores of the various DXA sites plotted against one another. The
correlations between the lumbar spine and the femoral neck and between the lumbar spine
and total hip were similar (R = 0.702 and R = 0.704, both at P < 0.001). The correlation
between the femoral neck and the total hip was higher (R = 0.910, for P < 0.001).
3.3.2 Simple Regression
The results of the simple regression can be seen in Table 3.3. Only variables signiVcant at
a level of P < 0.2 are shown. Even if two variables were derived from similar information
(for example frequency and quantity of alcohol consumption), both are presented. Step-
wise regression has the ability to determine if the two variables are cross-correlated, and
if so, choose the more signiVcant of the two.
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(a) Femoral Neck Plotted Against Lumbar Spine
(b) Total Hip Plotted Against Lumbar Spine
(c) Femoral Neck Plotted Against Total Hip
Figure 3.1: Comparison of DXA T-scores from measured sites.
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Table 3.3: Results of simple regression between questionnaire responses and DXA T-scores. Results
are given for lumbar spine, femoral neck and total hip
Variable Lumbar Spine Femoral Neck Total Hip
R P R P R P
Age -0.333 0.000 -0.453 0.000 -0.432 0.000
BMI 0.210 0.001 0.420 0.000 0.340 0.000
Height 0.253 0.000 0.202 0.002 0.249 0.000
Weight 0.333 0.000 0.510 0.000 0.457 0.000
Physically Active 0.226 0.007 0.197 0.026 - NS
Alcohol (Frequency) 0.200 0.023 0.190 0.037 0.190 0.035
Alcohol (Units per Week) -0.152 0.019 -0.138 0.033 - NS
History of Broken Bones -0.224 0.001 -0.200 0.002 -0.182 0.006
Broken Bones (Quantity) -0.155 0.017 -0.182 0.005 -0.184 0.005
History of Non Traumatic Fracture† -0.327 0.000 -0.281 0.000 -0.266 0.000
Seriously Controlled Weight - NS 0.158 0.015 0.170 0.009
Ca Supplements -0.205 0.002 -0.148 0.024 -0.158 0.015
Age at Menarche -0.182 0.005 -0.239 0.000 -0.217 0.001
Age at Menopause - NS -0.170 0.009 -0.173 0.008
Years Since Menopause 0.255 0.000 0.335 0.000 0.310 0.000
Oophorectomy 0.176 0.007 0.126 0.049 - NS
Oral Contraceptive Pill 0.228 0.000 0.245 0.000 0.212 0.001
Hormone Replacement Therapy‡ 0.319 0.000 0.266 0.000 0.261 0.000
† Non Traumatic Fracture was deVned as a fracture resulting from minimal trauma based on the
questionnaire responses
‡ Hormone Replacement Therapy was assigned if the subject had been using it for ≥ 1 year and treatment
began before the age of 60
3.3.3 Precision of QUS Devices
The CV for the Sunlight Omnisense and the CUBA Clinical measurements were all less
than 5%. The CV values for SOSPP , SOSDR and SOSMT were 1.06%, 0.67% and 0.67%
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Table 3.4: Simple Regression between QUS and DXA
Variable Lumbar Spine Femoral Neck Total Hip
R P < R P < R P <
BUA 0.566 0.001 0.616 0.001 0.642 0.001
VOS 0.505 0.001 0.503 0.001 0.551 0.001
SOSDR 0.339 0.001 0.283 0.001 0.319 0.001
SOSPP 0.330 0.001 0.374 0.001 0.393 0.001
SOSMT 0.221 0.005 - NS∗ - NS∗
∗ NS: Not SigniVcant at P < 0.05
respectively, while the values for VOS and BUA were 0.27% and 3.06%.
3.3.4 QUS
The results of the regression analysis between the QUS devices and the DXA are presented
in Table 3.4. The T-score at the lumbar spine was signiVcantly correlated to all QUS
measurements. BUA at the calcaneus showed the greatest correlation coeXcient with all
DXA measurement sites. The SOSMT showed the weakest correlation with the values for
lumbar spine (0.221 at P < 0.005) and showed no signiVcant relationship with BMD from
either the femoral neck or total hip.
3.3.5 Stepwise Regression
The stepwise regression provided three models to predict DXA T-score at each site. The
Vrst was based on the responses from the questionnaires. The second was created by using
the QUS measurements as the independent variables. The Vnal model was derived using
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a combination of questionnaire responses and QUS measurements.
All models based solely on the questionnaire responses selected age, weight, a history
of non traumatic fracture and hormone replacement therapy as signiVcant predictors. For
the QUS models, BUA was selected as the single predictor of T-score at all sites. The
models based on both questionnaire responses and QUS selected similar variables as those
for questionnaire responses alone. However, for the lumbar spine BUA was selected and
age became insigniVcant. For both the femoral neck and total hip, VOS replaced hormone
replacement therapy. These models can be seen in Table 3.5.
3.3.6 ROC Analysis
The ROC curves were plotted for the equations of Table 3.5. The resultant curves can be
seen in Figure 3.2. The AUC (95% ConVdence Intervals) values for the models using only
the questionnaire responses are 0.79 (0.71–0.87), 0.85 (0.78–0.92) and 0.85 (0.77–0.92) for the
lumbar spine, femoral neck and total hip respectively. Using the QUS variables, the values
were 0.79 (0.72–0.85), 0.90 (0.84–0.96) and 0.90 (0.84–0.96). The combination models had
the highest values; 0.82 (0.75–0.89), 0.92 (0.87–0.96) and 0.93 (0.89–0.97).
3.3.7 Sensitivity and SpeciVcity
The speciVcity, at a sensitivity of 90% or more, of the best performing models of each type
are presented in Table 3.6. The PPV and the NPVs are also presented. It can be seen that
the speciVcities are greatest when both questionnaire responses and QUS are used.
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(a) Questionnaires Responses Model
(b) QUS Parameters Model
(c) Combination Models
Figure 3.2: ROC analyses based on models generated using stepwise regression (see Table 3.5).
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Table 3.6: Sensitivity and SpeciVcity of the models generated using stepwise regression
DXA Site Sensitivity SpeciVcity PPV NPV
Questionnaire Responses
Lumbar Spine 0.92 0.32 0.25 0.94
Femoral Neck 0.91 0.44 0.21 0.97
Total Hip 0.91 0.66 0.22 0.99
QUS
Lumbar Spine 0.93 0.49 0.29 0.95
Femoral Neck 0.91 0.76 0.33 0.99
Total Hip 0.91 0.73 0.45 0.98
Combination of Questionnaire Responses and QUS
Lumbar Spine 0.90 0.49 0.29 0.95
Femoral Neck 0.91 0.79 0.42 0.98
Total Hip 0.91 0.84 0.33 0.99
The multivariate equations used for the calculations of these values are those from Table 3.5
3.3.8 SimpliVed Models
The simpliVed versions of the stepwise regressions are presented in Table 3.7. The AUC
values and speciVcities of these new tools are only very slightly diUerent from the original
models. For the models using only questionnaire responses the AUC and speciVcity were
0.79 (0.71-0.87) and 0.28 for the lumbar spine, 0.85 (0.77-0.92) and 0.45 for the femoral neck,
and 0.85 (0.76-0.93) and 0.68 for the total hip. For the combination models the values were
0.81 (0.74-0.89) and 0.44, 0.91 (0.87-0.96) and 0.78 and 0.91 (0.87-0.96) and 0.79. The ROC
curves for these models are shown in Figure 3.3.
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Table 3.7: SimpliVed forms of stepwise regression
DXA Site Model Cut-oU
Questionnaire Responses
Lumbar Spine (Weight ÷ 10) - (Age ÷ 10) - (2 × NTF) + (2 × HRT) 3.05
Femoral Neck (Weight ÷ 10) - (Age ÷ 10) - (NTF) + (HRT) 1.15
Total Hip (Weight ÷ 10) - (Age ÷ 10) - (NTF) + (HRT) 0.12
Combination of Questionnaire Responses and QUS
Lumbar Spine (BUA ÷ 10) + (Weight ÷ 10) - (2 × NTF) + (HRT) 13.65
Femoral Neck (VOS - 1400) + (3 ×Weight) - (Age) -(25 × NTF) 278
Total Hip (VOS - 1400) + (3 ×Weight) - (Age) - (25 × NTF) 250
3.4 Discussion
The good to excellent AUC values and the high speciVcities of the simpliVed models sug-
gest that a knowledge of a person’s risk factors and a simple QUS measurement may be a
very good means of screening for osteoporosis. This is especially noticeable for the femoral
neck and total hip. With a sensitivity set to at least 90%, the speciVcities were 78% and 79%,
which are very impressive. If these tools were used in a clinical setting they could help by
correctly selecting those who are not at risk of osteoporosis and suggest they be reassessed
at a later date. This would drastically reduce the numbers of unnecessary scans and ensure
that those at risk are prioritised.
The most important risk factors selected by the stepwise regression (age, weight, his-
tory of non traumatic fracture and history of HRT) agree with those selected by other
authors. Age and weight have consistently been chosen as the two most inWuential indica-
tors of low bone mineral density. They appear in risk indices for Asian [Koh et al., 2001],
European [Sedrine et al., 2002] and North American [Lydick et al., 1998, Cadarette et al.,
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(a) SimpliVed Questionnaires Responses Models
(b) SimpliVed Combination Models
Figure 3.3: ROC analysis based on the simpliVed models. The curves are generated using simpliVed
stepwise regression from Table 3.7.
2000] populations.
The most impressive, and reassuring, result was the Vnal group of risk factors chosen
by the stepwise regression. They are the same as those previously selected for another
European population. Sedrine et al. [2002] attempted to develop a very simple tool, OSIRIS,
for quantifying risk for postmenopausal, Belgian women. They selected age, weight, non-
traumatic fracture and HRT as the most signiVcant indicators of low density. There are,
however, a number of subtle diUerences between OSIRIS and the current proposed indices.
The Vrst of these is the predicted BMD site. For OSIRIS, the BMD regression models were
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compared to the lowest BMD T-score from the spine or hip. While this approach may help
to create a more generalised tool, some speciVcity may be sacriVced. For this work it was
deemed more appropriate to develop separate tools for each site. Although this means that
there are three formulae to apply, it is still relatively straightforward.
A second point to note is the diUerent age range of the samples. Sedrine and cowork-
ers dealt with an older sample; a mean age of 67.1 ± 5.2 years with a minimum age of 60
years. This is compared to 59.7 ± 10.8 years for this sample. This leads the author to be-
lieve that such tools can be used across a larger age range, without reducing eUectiveness.
Considering that the mean age at menopause in this group was 44.8 years, a tool designed
for those from 60 onward would be of little use.
All in all, the overall agreement in the selected determinants of low density in these
newly developed tools and other tools reaXrm their importance. It is possibly unsur-
prising that OSIRIS and these tools are so similar given that they were both created for
postmenopausal, European, Caucasian populations. The partial agreement with ORAI and
SCORE may also be explained, in part, by the North American, Caucasian populations
used in their creation. One point that Cadarette et al. [2000] evaluated but has not been
considered here is that of ethnicity. Many studies have presented diUerences in mean den-
sity values for various ethnic groups. This was not an issue with the present work because
all volunteers were White British.
As was stated above, there are a number of other risk assessment tools that have been
created for postmenopausal women. It was decided to calculate these indices for this
sample in order to compare their eXcacy. OST was computed Vrst and compared to the
BMD at the femoral neck (as per the original speciVcation) [Koh et al., 2001]. SpeciVcity
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was 0.45, which was identical to speciVcity of the model created here (for the femoral
neck) to discriminate between osteoporotic and normal. It is also interesting to note that
the OST tool, which is based on just age and weight and was developed for an Asian
population, performs as well a model which also considers non-traumatic fractures and
the use of HRT.
The OSIRIS tool was then applied. This was done in accordance with the original
author’s protocol. This meant only women between the ages of 60 and 80 years were in-
cluded (n = 104), and results were compared to lowest available DXA T-score. A speciVcity
of 0.36 was derived. This is in line with the 0.33 and 0.44 values found here for the lumbar
spine and the femoral neck, but less than the 0.66 found for the total hip. The choice of
tool is therefore dependent on the site the health care professional is most interested in.
In work carried out by Nevitt et al. [1994], hip BMD was seen to be the best predictor of
osteoporotic fracture at the hip. With each standard deviation decrease in BMD showing
the highest increase of relative risk of fracture. Similarly, Cummings et al. [2002] showed
that changes in hip and spine BMD resulted in similar changes in the risk of lumbar frac-
ture. This suggests that risk assessment tools for the femoral neck and total hip from the
current work may be more eUective as a screening tool than OSIRIS. However, if for any
reason a DXA measurement is not possible at the proximal femur, and lumbar scanning is
carried out instead, then it appears either tool would work equally well.
The SCORE and ORAI indices are not directly comparable with the current tools be-
cause they were initially designed to predict low BMD (T-score ≤ -2), as opposed to the
traditional T-score ≤ -2.5. For this reason, no analyses were calculated using these assess-
ment tools.
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The signiVcant relationships between the QUS variables and the DXA measurements
comply with previously published work. Whilst investigating the correlation between QUS
at the heel and DXA scores for a Belgian population, Boonen et al. [2005] documented
similar values. The stiUness index was compared with BMD values from the lumbar spine
a coeXcient of 0.48 was found. Although, the parameters are generated slightly diUerently,
they are comparable. A more direct comparison can be made with the work of Cook
et al. [2005], who found correlation coeXcients which are similar to those found for this
population.
The correlation coeXcients found for the Sunlight Omnisense in the present study are
less than those found in previous work using this device. Knapp et al. [2001] found values
of up to 0.48 between the speed of sound at the phalanx and the BMD at the femoral
neck. However, these values were calculated using both pre- and postmenopausal females.
The signiVcantly higher BMD and SOS values of the premenopausal sample led to, in this
author’s opinion, exaggerated results. If only the postmenopausal sample were used in the
computation of the coeXcients, it is expected that these would be much less impressive.
The good to excellent correlation coeXcients observed between the DXAmeasurement
sites are expected. It is also expected that the greatest correlation is between the femoral
neck and the total hip, given that there is some overlap in the regions of interest in the
scans used for calculating BMD at these sites. It is also expected that two sites that are
anatomically close would experience similar rates of bone turnover because they undergo
similar stress cycling.
Even though the lumbar spine and hip measurements have both proved to be good
predictors of osteoporotic fracture, not all of the variability of the BMD measurements
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of one, is explained by the other. Therefore, it is unrealistic to expect any measurement,
regardless of the technique, from any other skeletal site to predict low BMD perfectly.
This is one of the greatest supporting arguments why the assessment tools from this study
were not condensed into a single algorithm, as has been done previously. Instead, it was
acknowledged that a medical practitioner may be more interested in a particular site.
The improved speciVcity of the above tools, compared with that found for a single
model, is also an important issue with regard to reducing the strain on available DXA
services. For example, focussing on the total hip model, the high speciVcity would mean
that 79% of the healthy individuals sent for scanning, which represents 169 of the 235 in
total, could instead be selected for reassessment at some point in the future. This would
indeed result in the prioritisation of those at risk and more eXcient use of resources. This
speciVcity is considerably greater than that found when other tools were used on similar
populations.
Is it more important to detect those with the condition, even if healthy individuals are
misdiagnosed as diseased? Or, it is more beneVcial to remove as many people as possible
from further investigation, with the risk that some diseased people are denied treatment?
Decisions about the most important scenarios to detect were made. A cut-oU that ensured
a sensitivity of 90% was decided upon for this work. The main morbidity involved is a
fracture of the hip (and spine) which is very uncomfortable and very dangerous, with
many people dying even after hip replacement surgery [Cummings and Melton, 2002].
Therefore it was believed that it is better to spend money on the extra DXA scans. This
also raises the question ‘Why not set the sensitivity to 100%?’. The problem with making
a tool with very high sensitivity is that speciVcity suUers. One might arrive a a position
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where every diseased individual is selected, but very few people are actually excluded.
Therefore, the sensitivity of 90% was seen as the most appropriate balance.
3.5 Conclusions
The work presented here has shown that the judicious selection of risk factors collected
from questionnaires can be used to reduce to number of DXA scans performed on healthy
individuals. A simple cumulative system can help predict those at highest risk. Adding
QUS data to these signiVcantly improves the accuracy of tools. The ease of use and in-
expensive nature of both of these tools would suggest that the future of pre-screening for
osteoporosis lies in using both in tandem.
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Chapter4
Prototype Design
Complexity is one of the great problems in environmental
design
Christopher Alexander
The previous chapter has shown that the presence, or lack of, certain risk factors along
with QUS measurements allow for categorisation of people based on their risk of osteo-
porosis. The next step was to attempt to optimise QUS techniques to determine if the
utility, as a screening tool, could be improved for a Caucasian population. This chapter
outlines the design process and initial testing of a prototype device to scan with ultra-
sound.
4.1 Which site to choose?
The goal at the outset was to improve the diagnostic ability of QUS techniques. With this in
mind, the Vrst issue was choosing a site to measure. The most studied QUS measurement
sites are the calcaneus, the distal radius and the proximal phalanx. However, the capitate,
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clavicle, metacarpal, patella, thoracic spine and tibia have all been investigated as possible
scanning sites with various degrees of success.
Ideally, the site chosen for this work would have a track record of good correlation
with BMD T-score at clinically relevant sites, regardless of the exact parameter measured.
It also needed to be be easily accessible and would allow for repeatable measurements.
For this tool to be successful in the environment it is expected to perform in, a general
practitioner’s practice for example, this is very important. It is envisaged that a person
could receive a quick scan with very little preparation.
After examining the literature available on the topic and consultation with a rheuma-
tologist in The Great Western Hospital, Swindon, the proximal phalanx was chosen as the
most suitable site.
Published research has shown that speed of sound measurements along and through
the phalanx have promising relationships with BMD T-scores at the lumbar pine and hip.
They have also been seen to have the ability to discriminate between those with and
without osteoporotic fracture. The UBPI, an index based on parameters such as the speed
of sound, energy and amplitude of the Vrst arriving wave, has also been shown to correlate
with axial bone density.
The Vnger is also very accessible. It can be scanned very comfortably, with minimal
preparation time or eUort. Furthermore, it requires no clothes are removed. It is very
rarely damaged, so results are in no way aUected by previous fractures. Although some
people may have swelling of the joints due to arthritis, this does not inhibit transducer
contact with the diaphysis of the phalanx.
This was seen as suXcient evidence that changes were happening at the Vnger that
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were in line with changes at more metabolically active sites, and that it would provide a
comfortable, open, easy scanning site.
4.2 Design Constraints and Requirements
There are a number of constraints and requirements that needed to be satisVed. These are
listed here.
Scan across the Vnger One of the most fundamental requirements for the device is to
allow for scanning across the proximal phalanx, in a medio-lateral direction. This
is to allow for scanning of bone with the least amount of soft tissue between trans-
ducer and bone, reducing the possibility of excessive attenuation or scattering of the
wave. Also, the relatively Wat sides of the proximal phalanx would allow for easy
positioning of the transducers.
Allow accurate transducer placement In order to scan individuals in a standardised man-
ner, accurate marking and scanning of the region of interest is required. To achieve
this, it was decided to make the device with a platform to rest the hand upon dur-
ing scanning. This was envisaged to be more stable than a hand-held device, thus
reducing possible error due to relative movement of scanner and Vnger. Also, a pad
which constrains the Vnger in a vertical axis was also needed. This was designed so
that the Vnger could be rested against it by applying a light upward force.
Adjustable The device needed to be adjustable such that it is possible to align every Vnger
with the same angle to the transducer. This was to reduce the potential for error due
to misalignment. A hinged mechanism was designed to enable rotational correction.
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Open design The population most at risk of osteoporosis, and which this device is aimed,
is postmenopausal women. In order to facilitate scanning of this population there
are a couple of considerations regarding the scanning site which need to taken into
account. Firstly, some of those to be scanned may also have arthritis at the Vnger
joints. This will mean inWamed joints that need to be avoided when scanning. To
combat this, an open design was adopted. Another issue was the fact that many
individuals will have reduced mobility of the Vnger. Therefore the device was de-
signed so that minimal movement and positioning was required on the part of the
person being scanned.
4.3 Prototype Design
With the above constraints and requirements accounted for, a relatively straightforward
setup was decided upon. This consisted of a pair of collinear ultrasound transducers con-
nected to a linear variable diUerential transducer, allowing for the transmission and col-
lection of the ultrasonic wave, with simultaneous measuring of the separation distance.
This was then attached to a panel which was hinged to the base platform, upon which
individuals could rest their hand. The envisaged prototype can be seen in Figure 4.1. A
complete set of mechanical drawings of the prototype can be viewed in Appendix F.
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Figure 4.1: Three dimensional CAD drawing of prototype. The transmitter (a) and receiver (b)
are collinear. The plunger mechanism (c) allows for control over the separation of the
transducers. The pad to control the position of the Vnger in the vertical axis (d) is
visible. The height of this pad can be adjusted by screwing it up or down. The LVDT is
hidden under the housing (e).
4.4 Software Used
The software used was provided by McCue Plc (Southampton, UK). With this software,
the parameters of the measurement can be selected, such as the desired number and time
interval between scans. Certain thresholds required can also be set from this screen, such
as the trigger level used to calculate time of Wight and time to stop collecting information.
Finally, there is a section where the user can save the results Vle generated, the received
waveform and the data used to calculate the BUA.
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4.5 Testing of Prototype
When the prototype had been built, it was decided to test it on a number of members of
staU at CranVeld University in order to see if the device could be used easily and if it was
comfortable for those being scanned. A sample of men and women between the age of 22
and 65 years of were scanned. The scans were completed as if they were being performed
in a clinical setting.
From an operator point of view the prototype performed well. Individuals could be
positioned easily and accurately. The only issue encountered was the loose sliding of the
plunger which closed the transducers. This was easily remedied by tightening this part of
the device.
Those scanned were asked for feedback about the scan, especially about how simple
it was to position their Vnger initially and hold it in that position. All those scanned
remarked that both positioning and remaining still were hampered by the pad designed to
prevent movement in the vertical axis. This can be seen in Figure 4.2.
It was decided to replace this pad with a cushioned block on which individuals could
rest their Vnger. The theory was that it would be easier for people to rest their Vnger on a
block and bring the scanner into position, than to move the Vnger into position and keep
applying a constant force on the positioning pads.
After this modiVcation, the same group of individuals were scanned a second time. All
participants agreed that second scan was more comfortable, felt more secure and required
much left eUort than the Vrst.
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Figure 4.2: All volunteers experienced diXculty holding their Vnger against the upper pad, whilst
being scanned. In this picture the Vnger has already begun to slide out of position
(within the red circle).
4.6 Conclusions
A prototype ultrasound scanning device had been designed, manufactured and tested for
usability. Initial tests showed that the device was easy to operate and comfortable. It was
now ready to be tested in a research environment.
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Chapter5
In vivo Testing of the Proximal Phalanx
For each of us who appear to have had a successful
experiment there are many to whom their own experiments
seem barren and negative
Melvin Calvin
There are a number of ultrasound measurements that are used to predict axial density.
Over the past couple of decades, the list of parameters for the Vnger has increased. While
these may have been introduced to aid clinicians make informed choices, the choice of the
appropriate measurement may be diXcult. The developed prototype would allow for the
collection of these parameters, along with a number of new ones. This chapter describes
the process of collecting these data and comparing it to density to determine which method
performs best.
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5.1 Introduction
A previous chapter (Chapter 3) demonstrated that ultrasound measurements along with
known risk factors could be used to select patients most requiring DXA screening and
possible treatment. QUS at the calcaneus showed the greatest promise, remaining signif-
icant even when the questionnaire responses were accounted for. However, only a small
number of QUS inputs were used. There are other which were not included that may have
performed better.
QUS at the Vnger has for a long time been an attractive site to scan with ultrasound
devices. It is easy to access, not covered by a great deal of soft tissue and has relatively Wat
sides. This has led to the development of many ultrasound parameters believed to reWect
the condition of the skeleton [Wüster et al., 2000].
These parameters were not collected for the sample of the previous chapter (Chapter
3) because the technology was not available to do so. However, because the measurements
proposed for QUS at the phalanx seemed to perform so well in published work, it would
be shortsighted to completely exclude these. The prototype device was designed such that
every waveform could be collected. Post processing would then allow the calculation for
any number of parameters. With T-Scores of the same individuals, the usefulness of these
parameters can be determined.
Also, the collection of data for a large cohort would allow for possible validation of the
assessment tools presented earlier. Therefore, volunteer data required to calculate the risk
indices was also recorded.
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Table 5.1: Demographics of Sample from the Great Western Hospital
Variable Mean (± SD) or Number (%)
Age (Years) 57.6 (± 12.2)
Weight (kg) 71.4 (± 16.1)
Height (cm) 164.9 (± 8.1)
BMI(kg/m2) 26.37 (± 5.7)
Current Smoker 18 (10.5%)
Age at Menarche (Years) 13.1 (± 1.7)
Age at Menopause (Years) 46.1 (± 7.4)
History of Non Traumatic Fracture 19 (11.0%)
Use of Hormone Replacement Therapy 73 (42.9%)
Non Traumatic Fracture was deVned as a fracture caused as a result of minimal trauma based on the
questionnaire responses
Hormone Replacement Therapy was assigned if the subject had been using it for ≥ 1 year and treatment
began before the age of 60
5.2 Methods
5.2.1 Sample
An initial cohort was gathered from a DXA scanning clinic in the Great Western Hospital
(Swindon, UK). Ethical approval was granted for the study by the ethics committee in the
hospital prior to commencement of testing. All volunteers were sent an information sheet
(Appendix C) along with their appointment notiVcation. This information sheet explained
the study hypothesis and the procedure involved, should they choose to participate. All
volunteers were given the opportunity to ask any questions with the main researchers
before any testing took place. Written informed consent was collected at the time of
scanning. The demographics of the sample (n=123) can be seen in Table 5.1.
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5.2.2 DXA
All volunteers underwent DXA scanning as part of their visit to the clinic. Bone mineral
density measurements were taken at the lumbar spine, femoral neck and total hip. All
femoral neck and total hip scans were taken of the left hip except where hip fractures or
hip replacements were present. All DXA results are given as T-Score values.
5.2.3 Questionnaire Data
Each volunteer was given a questionnaire to complete (Appendix A) pertaining to activity,
lifestyle, medical history, diet and reproductive history. Advice was available in the form
of a brief discussion with the main researcher if necessary. Weight and height details was
also taken at this time.
5.2.4 Quantitative Ultrasound
QUS measurements were taken using three machines, varying in their design and mea-
surement site. Two commercially available devices were used. The Vrst was the Sunlight
Omnisense (Sunlight Medical, Rehovot, Israel) which measured the axial speed of sound
at the distal radius (SOSDR) and the third proximal phalanx (SOSPP ). The CUBA Clin-
ical was used to measure through velocity (VOS) and broadband ultrasound attenuation
(BUA) at the calcaneus. The developed prototype device was also used which measures
the through velocity at the second proximal phalanx (V OSPP ). The prototype was used to
measure the Time of Flight Velocity (VOSTOF ), Energy of the First Wave (EFW ), Velocity
of First Peak (VOSFP ), Velocity of the Slow Wave (VOSSW ) and Time Frame (TF). Figure
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Figure 5.1: This Vgure show how the QUS variables are computed. The Time of Flight Velocity,
Fast Wave Velocity and Slow wave Velocity and calculated based on the distance across
the digit and the crossing times as demonstrated. The Energy of the First Wave is
represented the shaded area. Finally, the Time Frame between the fast and slow wave
is also visible.
5.1 show how these parameters are calculated. Measurements were taken at 60 and 70% of
the length of the proximal phalanx of the second digit of the non dominant hand.
Aquasonic R© Clear Ultrasound Gel (Parker Laboratories Inc, FairVeld, N.J.) was used
to ensure coupling between sites of measurement and transducers. The commercially
available devices were quality checked on each day of scanning using phantoms provided
with the systems. The prototype device was quality checked using manufactured phan-
toms.
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5.2.5 Validation of Risk Factor Indices
The results of all questionnaires were input into a spreadsheet. Those with secondary
causes of osteoporosis were not included. Those with essential information missing from
their questionnaires were not included as accurate scores could not be calculated. The
index scores were calculated for n = 121 individuals using only the responses and n = 78
using questionnaire responses and QUS values, as per the published equations and cut-oUs
[Minnock et al., 2008].
5.3 Results
5.3.1 DXA
The DXA results were within the range for a postmenopausal sample. The comparison of
the values from each site are presented in Figure 5.3. The correlation between the lumbar
spine and femoral neck (R = 0.722 P, < 0.001) and lumbar spine and total hip (0.721, P
< 0.001) were comparable. The correlation between the total hip and femoral neck was
greater (R = 0.891, P < 0.001).
5.3.2 QUS Devices
The calculated coeXcient of correlation between the commercial QUS devices and the
DXA measurement sites can be seen in Table 5.2. BUA at the calcaneus had the highest
correlation with all T-scores. SOSDR was not signiVcantly correlated to the T-score at any
site.
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(a) Femoral Neck versus Lumbar Spine
(b) Total Hip versus Lumbar Spine
(c) Total Hip versus Femoral Neck
Figure 5.2: T-scores form the lumbar spine, femoral neck and total hip plotted against one another.
The correlation coeXcient is greatest between the total hip and femoral neck (R = 0.891,
P < 0.001).
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Table 5.2: Results of simple regression between commercial QUS devices and DXA T-scores. Re-
sults are given for lumbar spine, femoral neck and total hip
QUS Variable Lumbar Spine Femoral Neck Total Hip
R P R P R P
VOS 0.226 P < 0.05 0.326 P < 0.005 0.333 P < 0.005
BUA 0.273 P < 0.05 0.407 P < 0.001 0.375 P < 0.001
SOSPP 0.249 P < 0.01 0.259 P < 0.01 NS NS
The VOSTOF was signiVcantly correlated to the DXA T-scores of the lumbar spine
and femoral neck. However, the correlation coeXcients were low (Figure 5.3). The other
proposed QUS parameters (EFW , VOSFP , VOSSW and TF) were not signiVcantly correlated
to the DXA T-scores at any site.
5.3.3 Validation Study
Plots of the measured DXA T-scores against the risk indices can be seen in Figure 5.4. The
sensitivity and speciVcity values were computed using the cut-oU thresholds used in the
published work and are presented in Table 5.3. The sensitivity was greater than 90.0% for
all indices. The speciVcity of both the hip risk indices were higher, 57.4% at the femoral
neck and 76.5% at the total hip, than that at the lumbar spine, 24.1%.
For the models that include a QUS variable, the sensitivity values were all less than
90% for the proposed cut-oU. This is below the acceptable level set out at the beginning of
this work.
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(a) VOSTOF versus Lumbar Spine T-score
(b) VOSTOF versus Femoral Neck T-score
Figure 5.3: The weak correlations between the TOF Velocity (VOSTOF ) and the T-scores of the
lumbar spine and femoral neck are presented. There was no signiVcant correlation
between the TOF Velocity and the T-scores of the total hip.
5.4 Discussion
The correlation between the DXA values and the QUS parameters from the commercial de-
vices are within the normal range for a British population. The QUS at the Vnger however
appeared to perform however less impressively than previously thought. The VOSTOF was
the only parameter that appeared to have a signiVcant relationship with the DXA values.
Unfortunately this was much less than for published work (Chapter 2). There are two very
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(a) Lumbar Spine
Calculated Femoral Neck Index
-4 -2 0 2 4 6 8 10
F e
m
o
r a
l  N
e
c k
 
T -
s c
o
r e
-4
-3
-2
-1
0
1
2
(b) Femoral Neck
Calculated Total Hip Index
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(c) Total Hip
Figure 5.4: T-scores form the lumbar spine, femoral neck and total hip are plotted against the
calculated risk indices. The horizontal dashed lines represent a T-score of -2.5.
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Table 5.3: Performance of risk indices with a validation study.
Calculated Index Sensitivity (%) SpeciVcity (%)
Lumbar Spine 100.0 24.1
Femoral Neck 92.3 57.4
Total Hip 100.0 76.5
important diUerences between the samples that must be considered.
Wüster et al. [2000] investigated the age related changes that were observed for ve-
locity. There are changes in axial density that occur with aging. It is these very changes
that have led to the deVnition of osteoporosis. However, assuming that these changes may
be related to changes in QUS parameters at appendicular sites, or indeed that using one,
the other may be predicted is not ideal. Indeed, Faulkner et al. [1999] have reported the
diXculties associated with this type of assumed link. The authors measured the changes
in DXA and QUS around the body, and found that the decrease in measurements was not
uniform. Therefore, depending on the measurement type, many individuals were misclas-
siVed. This is the reason that the all results here are compared to density and not age.
The second major diUerence between this study and others is the fact that only post-
menopausal women were investigated. In the past, when QUS parameters were being
investigated for changes with aging, authors tended to look at people from 20 years to 80
years. Almost always, great diUerence were noted between the groups in their twenties
and thirties and those much later in life. These decreases allowed for the calculation of the
annual rate of change. However, this present sample was all postmenopausal, the range
of ages was much smaller (closer to 30 years). This may have meant that the diUerence
between the best and worst values were much less. This appears to lead to the situation
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where these measurements may not be used to predict changes in axial density.
The assessment tools described in Chapter 3 were tested using responses provided by
the volunteers. The simple tools using only the risk factors proved very useful, with high
speciVcity values. In fact, the tools for predicting T-Score at the femoral neck and total hip
actually outperform the original expectations.
The tools that included QUS at the calcaneus did not match the performance of the
development study, with sensitivity values less than 90% at all sites. This does not mean
that these are incorrect, but rather the cut-oU values that were suggested were not appro-
priate. Further work is required in order to determine the ideal threshold that ensures a
high sensitivity for these.
5.5 Conclusions
Validation of the very simple assessment tools have shown that they are indeed an ex-
cellent means of prioritising those most in need of DXA services. The addition of QUS
however did not increase the accuracy of these tools. Further work is required to select
the appropriate thresholds for use. QUS at the Vnger was not able to predict T-Scores at
the most relevant clinical sites. Improvement of these parameters or examination of novel
measurements is necessary if bone quality is to be determined from simple ultrasonic in-
vestigation of the phalanx.
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Chapter6
Modelling and Simulations: In vivo
There’s two possible outcomes: if the result conVrms the
hypothesis, then you’ve made a discovery. If the result is
contrary to the hypothesis, then you’ve made a discovery
Enrico Fermi
The design and manufacture of the prototype device would allow for the collection
of ultrasonic data. Whilst recognised parameters could be measured with ease, novel and
more applicable data could also be recorded. In order to test a new ultrasound variable,
it was deemed necessary to test the basic principles on a smaller sample Vrst. To investi-
gate the ultrasonic parameters and their dependencies on the density and morphology of
the scan site, it was decided to simulate the scenario. This way the geometries, material
properties and input signal could be controlled and the eUect on the waveform could be
monitored.
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6.1 Introduction
The proposition of optimising ultrasound scanning for the British population can be tack-
led in a variety of ways. Of these, two stand out as potentially the most viable options.
The Vrst is to look at the current techniques used, Vnd the elements that aUect the accu-
racy and precision of the measurements, and reduce or remove theses. One assumption of
this approach is that the theory of the measurement process is completely understood. For
example, a person’s height will reWect how tall they are. Furthermore, more accurate and
precise means of calculating height will enable better measurements.
The author feels that the method of optimisation of speed of sound measurements is
not appropriate. The reason for this is the lack of agreement over what the speed of sound
measurements are a function of. Many investigators have suggested that the velocity mea-
surements are suitable for forecasting the likelihood of osteoporosis because they reWect
changes in density and elasticity [Lee et al., 1997, Hans et al., 1999b, Prevrhal et al., 2001].
The close relationship between the density and the elasticity in bone, as described earlier,
may allow us to assume that it would be foolish to investigate either of these entirely in-
dependently. Thus predicting one by means of ultrasound, the other could be calculated.
This may be the case when measuring large, geometric, perfectly isotropic samples. How-
ever, the human skeleton does not provide such sites for investigation. This may explain
why in the above studies the variability of the velocity was not completely explained by
either the density or the elasticity.
Njeh et al. [1999b] studied the eUects of sample thickness on axial velocity of perspex
and bovine bone. They noted that the measured velocity depended on thickness up to a
certain threshold, and thereafter remained constant. They proposed that the velocity being
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measured was the phase velocity of Wexural waves, as phase velocity depends on thickness
(indirectly, via the radius of gyration). Therefore, there is confusion over what aUects
these velocity measurements and what is being predicted when velocity measurements
are taken. Does it depend on density or thickness, or a combination of these two? Indeed,
Sievänen et al. [2001] have demonstrated signiVcant correlations between velocity and
density and between velocity and cortical thickness in vivo at the tibia. For these reasons,
it was believed that optimising velocity measurements was not the most appropriate way
to proceed.
The second approach is to look at the manifestations of osteoporosis and attempt to
predict these using quantitative ultrasound. The author felt that this method showed the
most promise. The reason is that there is more scope for investigating what is thought to
be important, and not what has been proposed in the past.
The manifestations of osteoporosis in cortical bone, the type of bone present in the dia-
physis of the phalanx, are varied: decreased density [Boonen et al., 2005], increased poros-
ity [Marcus, 1996], trabecularisation of the endocortical surface [Keshawarz and Recker,
1984] and thinning of the cortex [Grampp et al., 1997]. The development of large pores
and trabecularisation may be localised, and would therefore make meaningful predictions
based on these parameters diXcult. As density depends on porosity, it too may prove over
optimistic or pessimistic depending on the exact site and pathway interrogated. Cortical
thinning, on the other hand, is thought to progress at a relatively uniform rate around the
Vnger. It was therefore decided to attempt to monitor the changes in the thickness of the
cortex.
This begs the question of how to determine and monitor cortical thinning. Cadossi
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and Cane [1996] looked at the eUect of drilling in the medullary cavity on the waveform
that interrogates pig phalanges. They noted that as the medullary cavity was expanded the
wave changed shape. More speciVcally, total normalised energy decreased, and the dis-
tribution of energy according to various energy velocities changed. Although the authors
propose that fast arriving signal originates from the cortex, they oUer little explanation as
to the rest of the waveform. This is understandable, given that it is not possible to view
the ultrasonic wave in transit. This was the case until researchers began to simulate the
process. When Barkmann et al. [2000] presented their Vndings on simulation work, they
dismantled the waveform by the pathways taken through the Vnger. They documented
three main paths. The Vrst was the fast arriving signal that travels through the cortex. The
second is the part of the signal that crosses the cortex into the medullary cavity before ex-
iting via the cortex on the other side. The Vnal part of the signal is that which the crosses
the Vnger via the soft tissue. The three separate waves can be seen in Figure 6.1.
Figure 6.1: The pathways of the ultrasonic wave through the phalanx are visible when the simula-
tion software is frozen at diUerent times. The ultrasonic wave may travel through the
cortex (a), the cortex and the medullary cavity (b) or the soft tissue (c). These waves
arrive in this order at the receiving transducer.
By using this theory to explain the collected waveforms, it was postulated that each in-
dividual part of the waveform reWects changes in the structure of the Vnger. It also allows
the possibility of dividing the wave into logical partitions, instead of the more arbitrary
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separations used by Cadossi and Cane [1996]. A simple means of analysing the wave-
form is essential if this theory is to be used in a clinical device where all calculations are
computed automatically. It is proposed that thicker walled phalanges, those with greater
cortical areas, would allow more of the wave to be propagated as part of the fast arriving
energy. Therefore by comparing this fast arriving energy to the energy of the rest of the
wave, cortical area could be predicted.
This hypothesis is tested in the following section. To do this, pQCT scans were taken
along the proximal phalanges of group of volunteers. This enabled the collection of cortical
density and area data. The images from the scans also allowed the simulation of ultrasound
through the Vngers. It was then possible to determine any relationship between the struc-
tural parameters of the bone and the simulated ultrasound parameters. The simulations
also enabled the testing of diUerent frequency pulses as input signals. This was carried out
to determine if the originally proposed frequency of 1MHz was indeed the correct choice.
6.2 Methods
6.2.1 Sample
The study sample comprised 14 volunteers (8 females and 6 males) from the staU and stu-
dents of the Alsager campus of Manchester Metropolitan University. Ethical approval was
granted by the ethics committee of the university before the study commenced (Appendix
D). All volunteers were given an information sheet explaining the hypothesis of the study
and what was involved, should they take part (Appendix E). Written consent was obtained
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Table 6.1: Demographics of Sample for in-vivo Testing
Variable Female Male
Mean (Range or ± SD) Mean (Range or ± SD)
Age (Years) 47.1 (26–64) 46.0 (24–63)
Weight (kg) 68.1 (± 20.4) 84.8 (± 23.9)
Height (m) 1.63 (± 0.07) 1.77 (± 0.05)
BMI (kg/m2) 25.6 (± 7.3) 26.7 (± 6.4)
before inclusion in the study. Participants were able to exclude themselves at any time.
The sample demographics can be seen Table 6.1.
6.2.2 Questionnaire
Before any scanning took place, each volunteer completed a questionnaire relating to phys-
ical activity, diet, lifestyle, medical and reproductive history (Appendix A). There was an
opportunity to clarify any queries with the researcher if required. Special attention was
paid to the section relating to medical history and any medications been taken. No volun-
teers were seen to have any conditions or be taking any medications known to aUect bone
metabolism or which may lead to secondary osteoporosis.
6.2.3 pQCT Measurements
pQCT was used to measure the cortical area and cortical density along the proximal pha-
lanx of the second digit of the non-dominant hand. Measurements were taken using a
STRATEC XCT-2000 pQCT R© (Stratec, 75217 Birkenfeld, Germany). The resolution of the
device is 0.2mm. Measurements were taken at sites corresponding to 50, 60 and 70% of
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the total length of the phalanx. The scanned images (Figure 6.2) were used to generate the
input geometries required for the Wave2000 simulation package.
Figure 6.2: Sample pQCT Slice of the phalanx. Cortical bone is deVned as tissue with a density
greater than or equal to 710mgHA.cm−3. The Vrst two phalanges appear to have a
D-shaped proVle of cortical bone. The third and fourth phalanges appear not to have
a complete ring of cortical bone. This is because the scan plane is much closer to the
inter-phalangeal joint for these Vngers.
6.2.4 Wave2000
Wave2000 (CyberLogic Inc, New York, NY, US) was used to simulate the passage of the
ultrasonic waves through the proximal phalanges. In order to use the images obtained from
the pQCT, some manipulation was required. Firstly, soft tissue needed to be disregarded.
This was accomplished by removing all tissue with a pQCT density below the threshold
density for cortical bone (710mgHA.cm−3). The remaining tissue was assumed to be a
cortical ring surrounding a medullary cavity. This structure was then modelled in an
idealised Vnger (16 mm × 16 mm as per Figure 6.3).
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(a) 50% (b) 60% (c) 70%
Figure 6.3: The cortical bone that remained after the soft tissue is removed can be seen. The black
area represents the medullary cavity. Darker areas in the cortical bone represent regions
of higher density.
Two sets of simulations were carried out. The Vrst assigned all bone present the default
material properties of ‘Bone, human cortical’ from the library of materials in Wave2000,
hereafter referred to as simple bone. The second calculated the material properties based
on the pQCT densities, hereafter referred to as complex bone. Areas of similar density,
as per the density bands, were set to the same material properties. The densities of hy-
droxyapatite, collagen and water were assumed to be 3.00 g.cm−3, 1.14 gm.cm −3 and 1.00
g.cm−3 respectively. Using the prediction of ρApparentDry (Equation 6.1) by Keller et al.
[1990], tissue density was calculated.
ρApparentDry = 0.043 + 1.45× ρAsh (6.1)
These values for tissue density (g.cm−3) allowed for the prediction of Young’s Modulus
(GPa) using the prediction put forward by Snyder and Schneider [1991] (Equation 6.2).
E = 1010.59ρ2.39T issue (6.2)
With the values for Young’s Modulus, the Lamé coeXcients (Equations 6.3 and 6.4)
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were calculated, assuming ν = 0.33. The Lamé constants are required by the Wave2000
program for any materials to be modelled which are not found in the library of materials.
λ =
E(x)ν
(1 + ν)(1− 2ν) (6.3)
µ =
E(x)
2(1 + ν)
(6.4)
The soft tissue surrounding the bone was modelled as ‘Sea Water @ 25 deg C’, while
the tissue within the medullary canal was modelled as ‘Fat, pig’, both of which are avail-
able in the Wave2000 materials library. The transmitter and receiver were represented as
transducers on opposite sides of the created geometry such that the ultrasonic wave would
travel across the phalanx, much like how it would in real life. These were set to 12.7 mm
in length and single pulse of 1 MHz was used as the input signal.
Time of Flight Velocity
The simulated time of Wight velocity (VOSTOF ) was computed as per Equation 6.5. For the
calculation of this velocity, the velocity of sound through water (VOSWater), the separation
between the transducers (x) and the time diUerence between a measurement with bone
present and without (∆t) are required.
V OSTOF =
V OSWaterx
x− (∆tV OSWater) (6.5)
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Proportion of Fast Energy
The proportion of fast to slow arriving energy was calculated. This was done by calcu-
lating energy of various parts of the received waveform. A simulation was run with no
bone present. This was used to calculate the time of Wight through soft tissue. The fast
arriving signal was deVned as the waveform up to this point and the slow arriving signal
was from this point thereafter. These two were integrated to calculate the energy of each
respective part. Figure 6.4 shows a waveform after the signal has passed through a geom-
etry with no bone present (a). This was used to determine the slow wave start and end
point (the vertical dashed lines). Everything prior to this point was consider to be part of
the fast wave. Part (b) of Figure 6.4 shows a rectiVed sample waveform through a Vnger.
The shaded areas under the curves are the fast wave energy and the slow wave energy
repectively. Finally, the proportion of fast to total energy (PRO) was computed.
6.2.5 Frequency Testing
In order to test the eUect of frequency on the resultant waveforms, the simple bone models
were also run at 0.5, 2.0 and 5 MHz. All other material properties and model parameters,
including the duration, remained the same. These repeat tests at diUerent frequencies were
carried out on each geometry for all of the participants in the study.
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(a) Waveform through Geometry
(b) Waveform through Sample Phalanx
Figure 6.4: The wave through the geometry with no bone present, Figure (a), was used to determine
the start and Vnish points (the dashed grey lines) of the wave travelling through the soft
tissue. These were then used to determine the fast and slow waves, Figure (b), of the
rectiVed wave of samples with bone present.
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6.3 Results
6.3.1 pQCT
The pQCT results are presented here. Because the density proVles, changes in geometries
with age and manifestations of osteoporosis diUer for males and females, the pQCT results
are dealt with separately. All future results will combine male and female data.
Cortical Density
For the females in the sample, there appeared to be a quadratic relationship between den-
sity and age at each of the measurement sites (Figure 6.5). The R2 values were 0.774 (P <
0.05) and 0.828 (P< 0.05) at 60% and 50% of the length of the phalanx. The relationship was
not signiVcant at 70%, with R2 = 0.462 (P = 0.21). Based on the Vtted curves, the maximum
density is reached in the Vfth decade.
No signiVcant relationship, linear or quadratic, was found for the male volunteers.
Cortical Area
No signiVcant relationships were observed between the cortical area and the age for either
females or males.
6.3.2 Wave2000 Simulations
The VOSTOF was found to be signiVcantly correlated to the cortical area at each of the
investigated sites for the models using simple and complex bone. For the simple bone
the correlation coeXcients were R = 0.89, R = 0.88 and R = 0.89 (All at P < 0.001) for the
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Figure 6.5: Cortical density plotted versus Age at 50, 60 and 70% of the overall length of the proxi-
mal phalanx (Data is for females only).
complex bone and R = 0.91, R = 0.90 and R = 0.88 for the complex bone (All at P < 0.001).
VOSTOF can be seen plotted against cortical area in Figure 6.6.
The PRO measurements were also seen to be correlated to the cortical area. The cor-
relation coeXcients were R = 0.87, R = 0.94 and R = 0.88 (All at P < 0.001) for the models
using the simple bone. The correlations were lower when complex bone was modelled;
R = 0.82, R = 0.80 and R = 0.88 (All at P < 0.01). Figure 6.7 displays PRO plotted against
cortical area at each site.
6.3.3 Varying Frequency
Each waveform collected using the simple bone models 0.5, 1.0, 2.0 and 5.0MHz was plot-
ted. A sample of each frequency for the same individual at the same site is presented
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(a) 50% Simple Bone (b) 60% Simple Bone (c) 70% Simple Bone
(d) 50% Complex Bone (e) 60% Complex Bone (f) 70% Complex Bone
Figure 6.6: The above images show the relationship between the time of Wight velocity (VOSTOF )
and cortical area. Plots (a), (b) and (c) are for the simple bone, whereas (d), (e) and (f)
are for the complex bone.
(a) 50% Simple Bone (b) 60% Simple Bone (c) 70% Simple Bone
(d) 50% Complex Bone (e) 60% Complex Bone (f) 70% Complex Bone
Figure 6.7: The above images show the relationship between the proportion of fast to total energy
(PRO) and cortical area. Plots (a), (b) and (c) are for the simple bone, whereas (d), (e)
and (f) are for the complex bone.
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in Figure 6.8. As the frequency increased from 1.0–5.0MHz the signals become more in-
coherent. ReWections and scattering caused the received waveform to become less well
deVned. This makes it impossible to discriminate between the parts of the signal arising
from diUerent structures in the Vnger.
(a) 0.5MHz (b) 1.0MHz
(c) 2.0MHz (d) 5.0MHz
Figure 6.8: Sample waveforms collected by the receiving transducer for the same individual at 0.5,
1.0, 2.0 and 5.0MHz. All other properties and parameters were kept constant.
6.4 Discussion
The received waveforms appear to be similar in shape to those documented by Barkmann
et al. [2000], suggesting that both sets of simulations were closely matched. Indeed, given
that almost the same site was investigated and identical, or at least similar, material prop-
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erties and simulation parameters were used, any major diUerences would be considered
most unexpected.
From the Wave2000 simulations in this study, signiVcant relationships can be seen
between both the through velocity and the proportion of fast arriving energy, and cortical
area. It is possibly expected that this is the case for the velocity measurements with the
simulation. The thicker cortical walls would allow for the more direct crossing of the
Vnger via the cortex. This more direct crossing through the bone, with a higher velocity
than the surrounding soft tissue and marrow, may have explained the higher time of Wight
velocities observed for those with greater cortical area. This may even be accentuated by
the partial volume eUects, due to the resolution of the initial pQCT images [Anomymous,
2002]. Even where extremely small areas of soft tissue are incorrectly selected as cortical
bone, due to their position within a voxel, they may allow for an unrealistic pathway
across the phalanx.
It would be much more diXcult to use this hypothesis in the real world because of
the controversy over the eUect of cortical thickness on the nature of the waves being
propagated [Njeh et al., 1999b], and thus being received by transducers. It was therefore
felt that while this approach provided promising results here, it was not appropriate for
further investigation using the prototype.
The estimated Young’s modulus values based on the CT densities ranged from 12.7–
22.1 GPa. These appear to be consistent with values found in the literature [Zysset et al.,
1999], and conVrm that the properties calculated for the bone were reasonable. However,
with the exception of the fast and slow wave energy at 60% of the bone, the simple and
complex models were closely matched. This suggests that the investigation using bone
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with diUerent properties for regions of diUerent densities may be an unnecessary compli-
cation.
Perhaps the more interesting point to notice is the positive relationship that exists
between the proportion of fast arriving energy and the cortical area. This seems to cor-
roborate the results found by Cadossi and Cane [1996], who suggested that the proVle of
the early part of the wave was dependent on the thickness of the cortical bone. Using the
above results, it seems possible that QUS could be used as a very simple, cheap means
of determining bone condition. At the outset of this chapter, it was decided that cortical
thinning, or cortical area, was the property of interest. Area is important as there is much
evidence to suggest that reduced area is associated with an increased of osteoporosis. In
work carried out recently looking at cortical area of metacarpals of healthy women and
those with osteoporotic fracture, Crespo et al. [1998] showed that cortical area was signif-
icantly lower for the fracture sample. This was also the case for those with either Colles’
or vertebral fracture, suggesting that this type of measurement is ideal for determining
the systemic risk of osteoporosis. The site used by Crespo et al. [1998], the metacarpal, is
anatomically similar to the proximal phalanx and experiences similar loading patterns.
In other research investigating age-related changes in cortical bone, Iwamoto et al.
[1998] studied metacarpal measurements of Japanese women from 42-94 years. In 229 vol-
unteers, they noted no signiVcant changes in bone width but a signiVcant increase in mar-
row width from the 6th decade. This led to the signiVcant decrease in cortical bone width,
Vrst detectable between 61-70 years, which equates to a reduction in cortical bone area.
Similar eUects were noted in this work, with a decrease from the Vfth decade, however
the small number of volunteers makes it impossible to determine signiVcance. Another
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interesting point to the work by Iwamoto et al. [1998] was the change in density. The cor-
relation coeXcient was greater for the change in cortical thickness than for cortical density
with aging. Therefore, there is a greater expected annual decrease in thickness meaning
that changes could be detected quicker than if density were used. In a comparative study
that looked at similar changes in men, Iwamoto et al. [2000] found that reductions in thick-
ness and density were less pronounced. This does not mean that thinning of the cortices
does not occur for the males. Rather, males are protected by periosteal formation. This
was documented by Duan et al. [2001], who found that bone formation on the periosteal
surface resulted in a smaller net bone loss for men, when compared to women.
It therefore seems logical that the proximal phalanx may prove as useful as a site to
investigate using QUS. Whilst velocity is not ideal for predicting material or morphological
changes, energy measurements may prove useful. However, one major limitation of this
work is the lack of evidence that cortical thinning at the proximal phalanx actually mirrors
changes at the sites of interest from a densitometry point of view. Even though thinning of
the cortex may be accepted as a manifestation of osteoporosis [Seeman, 2003b], predicting
or monitoring changes are pointless if the results are not in line with the changes of BMD
at the femoral neck or the lumbar spine. Therefore, it is proposed that before any large
scale experimentation is undertaken, the relationship between cortical area at the phalanx
and density at the femur or lumbar spine is investigated.
The trends observed for density as a function of age in the females in this study appear
to mimic the expected proVle. Although the sample was relatively small, there appeared
to be an increase in density up to 45 years followed by a decrease after the approximate
age at menopause. The small number of males (n=6) in the present study meant that no
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worthwhile conclusions could be drawn about density changes with age.
The waveforms from repeat scans with varying frequency show that as frequency is
increased, the output becomes more compact. This suggests that higher frequency scans
would prove more problematic when it comes to deVning and selecting the fast and slow
waves. Indeed, visual inspection of the 2.0 and 5.0MHz results from Figure 6.8 show that
almost impossible to tell where this changeover occurs. The scans at 0.5 and 1.0MHz
remain as the best choice. By comparing the simulation at the exact time points when the
bone wave, the medullary wave and the soft tissue wave arrive, the 1.0MHz models gave
the cleanest breaks. This was consistent for the simulations on all of the volunteers. This
suggests that the initial choice of a 1.0MHz signal was correct.
A second limitation with the above simulations is two dimensional nature of the input
geometries. Although the cross section of the Vnger can be measured and plotted, the ef-
fects of the third dimension are ignored. The greatest expected eUect of this simpliVcation
is that reWections and divergence into and out of the plane in question are missed. This
was not seen as a major concern because the region of interest is the beginning of the
received waveform. Both the time of Wight velocity and the fast arriving energy are both
computed from the earliest deviations from the zero amplitude.
The resolution of the pQCT scans was relatively crude, at 0.2mm. Even if trabeculari-
sation was occurring on the endosteal surface, this detail may not be captured. However,
this level of resolution was deemed adequate for this initial hypothesis testing. The author
acknowledges that further simulation, with more intricate geometries are necessary. It
is suggested that this be done with cadaveric phalanges, which would allow exposure to
higher levels of ionising radiation, resulting in much greater resolution. It may also help
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reduce any errors caused by movement on the part of the volunteers.
6.5 Conclusions
It has been demonstrated that energy measurements may indeed be the key to predicting
skeletal condition. If the area of the cortical bone can accurately determined, then the
amount of thinning and progress of osteoporosis may be gauged. This theory however
needs to be tested with more accurate CT scans and with the emphasis on comparison to
the lumbar spine or femoral density.
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Chapter7
Modelling and Simulation: Cadavers
All exact science is dominated by the idea of
approximation.
Bertrand Russell
Previous simulations have shown that the basic morphology of the Vnger could be
predicted by QUS. The following chapter attempts to address the limitations of the original
study and expand the hypothesis to include a comparison with axial bone density. The goal
was to reinforce the initial Vndings and determine their usefulness in a clinical setting.
7.1 Introduction
Chapter 6 investigated the possibility of predicting the morphology of the proximal pha-
lanx with a view to monitoring changing bone quality. Although the results of this pre-
liminary study were promising, there were a number of limitations that needed to be
addressed before this link can be conVrmed.
Of these, possibly the greatest drawback was the low resolution of the original CT
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scans. For the preliminary study the resolution was deemed adequate, in so far as it gave
an estimate of the shape and thickness of the bones of the Vnger at the exact region of in-
terest. However, the precise detail of the cortical bone, especially as the endosteal surface
was not properly recorded. This meant that the simulations may not be matched to real life
measurements. Furthermore, partial volume eUects may have led to inaccurate determi-
nation of cortical area and cortical thickness. This may have had signiVcant consequences
on the correlations found between the simulated QUS values and the morphology.
In addition to the issue of the resolution, there was no calculation of how well the
thickness values matched the density of the axial skeleton. Whilst it may be fair to suggest
the cortical thinning of the phalanx is a sign of bone loss, the fracture sites of interest are
those at the hip and lumbar spine and it is density that these sites that is used to predict
fracture. Therefore, before this method is accepted by clinicians there must be some study
to determine the relationship between thickness of the phalanx and the density at these
sites. In the past, the ultrasound parameters at the phalanx have been compared directly
to DXA values (Chapter 2). The correlations have been shown to be signiVcant, but this
does not imply that this approach is best. Without comparing the structure of the Vnger
and the femur or spine, the correlations could be assumed to be due to another unrelated
systemic change.
In the previous simulations, the input geometries came from both men and women.
Although there is bone lost on the inner surface for both sexes, the rate of loss and the
formation of bone on the outer surfaces is diUerent [Oyster, 1992]. To guarantee that the
gender eUects were not altering the waveform it is necessary to investigate a female only
sample.
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Finally, though results have proved positive to date, there has been no direct compar-
ison between simulated values and measured values. The exact implementation of the
simulation is not possible in real life, because it is assumed that all Vngers are the same
width. Therefore, no matter how well the simulations work, the approach would be point-
less if the results could not be replicated in practice.
To address the issues raised, another, more accurate simulation study was proposed.
The idea was to generate more detailed input geometries which could give more exact
waveforms. Along with this, DXA values would be found to allow comparison with the
density of the hip for the same individuals. Finally, the prototype device would be used
to measure the Vnger at the same region of interest to determine if the results could be
replicated in practice.
7.2 Methods
7.2.1 Sample
The right femur and the entire second digit (including the distal section of the metacarpal)
from the right hand were collected from 14 female cadavers (aged between 81 and 95 years)
from the Academic Medical Center in Amsterdam. Ethical approval was granted by the
university for all tests carried out on the specimens. All samples were stored in formalin.
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7.2.2 µCT
The Vngers were prepared for scanning by removing them from formalin and patting dry
in a fume cupboard. They were then wrapped in tissue and placed in a specimen bag. The
metacarpophalangeal and interphalangeal joints were marked to aid positioning in the
sample holder and allow for investigation of the correct region of interest. The samples
were placed in the sample holder of the vivaCT 40 machine (SCANCO Medical AG, Brüt-
tisellen, Switzerland). With the door locked, the software was prepared for the scan. Each
sample was given a unique label which was based on the original hospital sample number.
The same control Vle was used for all scans. This included all the parameters required to
complete the scan. The resolution for the scan on each sample was 35 µm; resulting in
voxels with edge length of 35 µm. A preliminary scan was carried out in order to Vnd the
area of interest on the phalanx. Using this scan, the phalanx length was measured and the
region from 50% to ≥ 70% was selected for more extensive examination.
Evaluation of each section was performed using the in-built Bone Midshaft Evaluation
function that is supplied with the vivaCT 40. This function evaluates the selected bone
with the assumption that it approximates a ring of cortical bone. This was assumed to be
appropriate for this work given that the bone is generally observed as an oval or D-shaped
structure. Examples of this can be seen in Figure 7.1.
In order to perform the evaluation, the cortical bone must be properly deVned. Con-
touring was performed along the outer and inner surfaces to accurately select the borders.
The outer border was picked up by drawing a spline roughly approximating the periosteal
surface in a counter-clockwise direction. The inner surface was picked up by drawing a
spline approximating the endosteal surface in a clockwise direction. The original splines
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(a) Cross section at 50% (b) Cross section at 60% (c) Cross section at 70%
Figure 7.1: The Vgures show slices of the proximal phalanx within the region of interest. The
images are all taken from the same individual. The inner white structure is the cortical
bone. This is surrounded by soft tissue which is seen here as the grey area. The outer
white circle shows shows the inner diameter of the sample holder.
and the results of contouring can be seen in Figure 7.2. Unconnected trabeculae and trabec-
ulae extending from the endocortical surface into the medullary cavity were not included.
Contouring using these two splines resulted in the correct choice of bone for each slice.
The areas created were manually inspected to ensure no bone was excluded and no soft
tissue was erroneously included. The evaluation process uses these approximations of the
shape of the cortical bone and the knowledge that slices are 35 µm apart to create the
volume to test.
The results of the evaluation are presented in an output Vle along with a reconstruction
of the section investigated. An example of an output Vle can be seen in Figure 7.3. The
calculated bone and tissue density are both presented. Tissue density is the density value
based on the density of the bone and included pores. The results of direct and plate analysis
are also printed to the Vle. Only the thickness values from the plate method analysis are
used. Area is assumed to be cortical thickness times the curve equidistant from the inner
and outer surface (Centre Curve). Volume is calculated using the area times the length of
the scan in the axis of scanning (Length). Rearranging these we get Equation 7.1.
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(a) Before Contouring
(b) After Contouring
Figure 7.2: The software used by the vivaCT 40 machine. Sample splines (green lines) drawn close
to the periosteal and endosteal surface can be seen (a) along with the curves generated
as a result of automatic contouring (b).
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Bone Volume = Cortical Thickness× Centre Curve× Length (7.1)
The bone surface is calculated by multiplying the inner and outer circumference by
Length. Therefore, the Centre Curve multiplied by Length is equal to half the bone surface.
Using this information, Equation 7.1 can be written in terms of Cortical Thickness, Bone
Volume and Bone Surface, as per Equation 7.2.
Cortical Thickness =
Bone Volume× 2
Bone Surface
(7.2)
The direct method thickness would be greatly aUected by pores. For example, imagine
both techniques used on the same sample of bone. Then a small pore was added to the
centre of the cortex. The bone surface would change by a small amount, thus the plate
model thickness would not be altered greatly. However, the direct model thickness would
be halved because there is now a pore between the inner and outer surface.
The cortical thickness, cortical area, bone density, tissue density and the porosity were
recorded for each phalanx. These were then used for comparison with one another, with
simulated QUS parameters, prototype QUS parameters and with DXA data from the femur
of the same individuals.
7.2.3 Simulation
The simulations were carried out using Wave2000 (CyberLogic Inc, New York, NY, US).
The input geometries used for simulation were taken from ISQ Vle. This is a Vle which
contains all the slices images stacked in the sequence they were scanned. This was decon-
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Figure 7.3: Sample results Vle forMid Shaft Evaluation. Both bone and tissue density are presented
along with the results of direct model and plate model analysis.
structed into the original slice images, in TIF format, and those of interest were used for
further analysis.
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Image Processing
In order to use the images from the µCT scans some preparation was required. This
included rotating the Vnger to the expected orientation, thresholding the image so that soft
tissue was removed and cropping the image to the area of interest. Images were rotated
based on visual examination such that medial and lateral sides were on aligned left and
right, and the dorsal and ventral surfaces were aligned top and bottom. Thresholding
was then performed, using ImageJ. The lower and upper limits were set to zero and 100
respectively. This resulted in an image where each pixel is set to one or zero based on its’
grayscale value. One represents cortical bone and is Vlled white, and zero is soft tissue
and is Vlled black . Finally, the area containing the ring of cortical bone was cropped to a
square area 16 mm × 16 mm.
The images created above were used as the input geometries for the simulations. The
resolution was set to 28.571 pixels/mm. This is equivalent to the scanning resolution of the
µCT; 35 µm. All other model parameters were set to recreate those of the prototype. The
transmitter and receiver were modelled as straight lines on the left and right hand sides of
the geometry. The input was a signal with a frequency of 1 MHz run for 1 µsec. Snapshots
of a sample simulation can be viewed in Figure 7.4.
Measuring Simulated QUS Parameters
The energy of the fast and slow wave were calculated. In order to separate these into
their component parts, the wave through a sample without bone was simulated. The
resultant waveform can be seen in Figure 7.5. The start and end of the wave that crosses
the geometry where noted and used to determine the start and Vnish of the slow wave.
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(a) 1 µs (b) 3 µs (c) 5 µs
(d) 7 µs (e) 9 µs (f) 11 µs
Figure 7.4: The passage of ultrasound through the Vnger can be seen in these images. The pulse
originates from the transmitter on the left hand side (a) and is detected by the receiver
on the right hand side. Figures (b) and (c) show the waves travelling faster through
the cortical bone and medullary canal. In Vgure (d) the cortical wave approaches the
receiver. This is followed by the wave that has travelled through the medullary cavity
(e) and the soft tissue (f).
The slow wave energy was the integral of this section of the rectiVed waveform. The fast
wave energy was the integral of the rectiVed wave up to the start of the slow wave.
7.2.4 QUS
The prototype scanner was connected to the controlling computer and setup to allow for
scanning each Vnger as would be for live volunteers (see Figure 7.6). Each Vnger was
removed from the formalin and patted dry with tissue. The proximal phalanges were
measured on the dorsal side with both the metacarpophalangeal and interphalangeal joints
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(a) Waveform through Geometry
(b) Waveform through Sample Phalanx
Figure 7.5: The wave through the geometry with no bone present, Figure (a), was used to determine
the start and Vnish points (the dashed grey lines) of the wave travelling through the soft
tissue. These were then used to determine the fast and slow waves, Figure (b), of the
rectiVed wave of samples with bone present.
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Wexed. Using a permanent marker 50, 60 and 70% length of the phalanx were marked (see
Figure 7.6). The Vnger was then placed in the prototype scanner, with the Vrst marker (50%
length) in line with the centre of the silicone pads, and aligned as it would be in ‘normal’
use, i.e. the long axis parallel with the table surface. The Vnger was then allowed to rest
for 30 seconds to allow the soft tissue to stabilise, tissue Wuid to relocate and any unusual
settlings to disappear. Three repeat measurements were then taken with repositioning
between scans. This was then repeated for each marked sites.
(a) Setup of prototype
(b) Finger with markings
Figure 7.6: Setup of the prototype scanner and Vnger for QUS scanning. The Vnger is marked at
the regions of interest as detailed previously and then placed between the transmitter
and receiver.
The energy arising from diUerent paths was then computed. The computation involves
determining the trigger point, the time of the Vrst amplitude above a threshold, and the
time of the maximum amplitude. An example of a received waveform can be seen in Figure
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7.7 with both the trigger point and maximum amplitude marked. The maximum amplitude
was found, along with the times where the slope of the wave changes sign before and after
this point. This part of the wave, the slow wave, is then integrated, giving the slow wave
energy. The wave from the trigger point to the beginning of the slow wave, the fast wave,
was also selected and integrated. This gave the fast wave energy. The proportion of the
fast wave energy to fast and slow wave energy was then calculated.
Figure 7.7: The area under the peak of the maximum amplitude, Vlled with the dotted pattern, is
called the slow wave energy. The area under the wave from the trigger point to this
area, Vlled with the zig-zag pattern, is call the fast wave energy.
Plotted Against
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7.3 Results
7.3.1 µCT
There was a signiVcant, negative correlation between the intra-cortical porosity and the
average cortical thickness of the region evaluated. The correlation coeXcient based on this
sample was R = 0.943 (P < 0.001). This relationship can be seen in Figure 7.8.
Figure 7.8: Intra-cortical porosity plotted against the cortical thickness. The cortical thickness is
an average value for the entire region evaluated.
There was a signiVcant positive correlation between both the tissue density and the
bone density with average cortical thickness. The correlation was greater for the tissue
density. The coeXcients of correlations were R = 0.963 and R = 0.753 (P < 0.001 and P <
0.05 respectively). These are both plotted in Figure 7.9.
Porosity displayed negative relationships with tissue density and bone density. The
correlation coeXcient was greater for the relationship with tissue density, R = 0.994 (P <
0.001), than for bone density, R = 0.817 (P < 0.01).
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(a) Tissue Density
(b) Bone Density
Figure 7.9: Tissue Density (a) and Bone Density (b) plotted against the average cortical thickness
for the region investigated.
Tissue density and bone density were related R = 0.868 (P < 0.005), as can be seen in
Figure 7.11.
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(a) Porosity Plotted Against Tissue Density
(b) Porosity Plotted Against Bone Density
Figure 7.10: Intra-cortical porosity plotted against tissue density (a) and bone density (b).
7.3.2 Simulated QUS
There were signiVcant, positive correlations between the simulated PRO values and the
cortical areas at all sites. These can be seen in Figure 7.12. The correlation coeXcients
were R = 0.6976 P < 0.05, R = 0.6775 P < 0.05 and R = 0.8231 P < 0.05.
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Figure 7.11: Tissue Density is plotted against Bone Density.
7.3.3 QUS
The signiVcance of the correlations between the PRO from the prototype and the measured
cortical thickness was varied. For 50% R = 0.6739 (P < 0.05), for 60% R < 0.05 (P = < 0.05)
and for 70% R = 0.7250 (P < 0.05). The precision for PRO measurements was 5.4%.
7.3.4 Cortical Thickness Plotted Against DXA
There was a positive relationship between the cortical thickness at the proximal phalanx
and the density as measured using DXA at the neck of femur (Figure 7.14). The correlation
coeXcient was R = 0.918 (P < 0.001).
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(a) PRO at 50%
(b) PRO at 60%
(c) PRO at 70%
Figure 7.12: PRO as calculated using the waveforms collected from the simulations plotted against
the cortical thickness.
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(a) PRO at 50%
(b) PRO at 60%
(c) PRO at 70%
Figure 7.13: PRO as calculated using the waveforms collected using the prototype plotted against
the cortical thickness.
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Figure 7.14: Comparison of cortical thickness of the proximal phalanx and density at the neck of
femur in the same individuals.
7.4 Discussion
The observed increase in porosity as cortical thickness is reduced is expected and agrees
with common beliefs [Seeman, 2003a]. It supports the theory that resorption of bone,
especially on the endocortical surface, causes trabecularisation which leads to expansion
of the medullary canal. This phenomenon has been observed at many skeletal sites [Duan
et al., 2001], and up to this point was assumed to be occurring at the proximal phalanges. It
has been shown that these assumptions were indeed correct and that thickness may prove
useful as a measure of bone integrity.
The fact that both tissue and bone density showed a positive correlation with cortical
thickness is important. This tells us that all the material and morphological properties of
the bone are changing. One of the goals of this chapter was to show that one could accu-
rately predict cortical thickness with the use of a quantitative ultrasound. It is reassuring
to know that as the cortical bone is thinning the other expected changes, such as a decrease
in density, are also occurring.
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The greater correlation of the tissue density with cortical thickness is due to the eUect
of porosity. As tissue density is greatly aUected by pores, the increased porosity results
in lower density. The fact that the bone density also appeared to be correlated with the
cortical thickness may be more surprising. What has been observed here suggests that
both the amount of bone and the density of the reamining bone alter.
The strong correlation found between the tissue density and the porosity can be ex-
plained by the fact that the increase in porosity results in pores in the bone which reduce
the measured tissue density. The correlation, although slightly weaker, between the poros-
ity and bone density is more diXcult to explain. One possible explanation is that the im-
balance between the bone resorption and deposition leaves a large number of resorption
cavities.
All in all, the µCT analysis suggests that these measurements are cross correlated.
Therefore, by being able to determine one, for example by the use of quantitative ultra-
sound, one can be conVdent that the others are also changing at the proximal phalanx.
There were strong correlations between the PRO from the simulations and the cortical
thickness of the phalanges. The correlations were as strong as those found in the prelimi-
nary simulation study (Chapter 6). It is important to realise that this study was compared
to the cortical thickness, not the cortical area. It was deemed acceptable to use cortical
thickness here, as the resolution allowed for accurate measurements. This conVrmation
of the dependency of the energy measurements on the structure of the Vnger supports
the original hypothesis that QUS at the Vnger could be used to predict changes in skeletal
condition.
The PRO measured using the prototype showed signiVcant positive correlations with
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the measured cortical thicknesses at all sites, however these correlations were slightly less
than for the simulated values. The values may be expected to be less than those of the
simulations, as there are certain issues associated with measuring the Vngers in the real
world. For example, within the simulation software it is possible to align the Vnger so
that the transducers are perfectly aligned on the left and right of the Vnger. In practice,
of course, it is impossible to align the transducers perfectly on either side of the bone.
Similarly, there is a potential to measure the incorrect region of interest due to the fact
that the soft tissue is marked and then measurements are made. The soft tissue does move
during the positioning of the transducers, and therefore the marking may not remain of
the desire area of the phalanx. Whilst every eUort is made to ensure the Vnger is positioned
accurately, some error is expected. The error due to alignment issues is not excessive, as
demonstrated by the coeXcient of variation of 5.4% for the PRO.
Again, as with the previous simulation, there is also the limitation that the simulation
only works in two dimensions. The prototype measures a three dimensional proVle, and
some noise in the received waveform may be due to dispersion or reWections along the
bone. These were however considered negligible as the results from the prototype were in
the same range as the simulated values.
The other major diUerence is the techniques used to calculate PRO. Because the sim-
ulations place the Vngers in geometries of the same size, time thresholds can be used to
separate the energy from diUerent pathways. However, because in real life the Vngers are
diUerent sizes the same technique cannot be used by the prototype. The idea of using the
largest peak as the pick up point of the slow wave was used to combat this. Although
this allows the calculation of ‘an’ estimation of the fast and slow energy, it is slightly dif-
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ferent than that one from the simulations. However, this is the only possible means of
diUerentiating between the two at the moment.
Finally, although the simulations attempt to recreate what was happening in the real
world, the choice of material properties meant that this was not entirely true. Although
those material selected seemed like fair substitutes, the acoustic properties were not exactly
the same.
7.5 Conclusions
QUS may be used to predict cortical thickness. This may prove to be an extremely use-
ful tool given that cortical area decreases with osteoporosis. The fact that the prototype
matched the results from the in vivo work and the results of the simulation here allow us
to believe that this methodology has some future.
130
Chapter8
Conclusions and Future Work
I seldom end up where I wanted to go, but almost always
end up where I need to be.
Douglas Adams
8.1 Conclusions
One of the goals set out at the beginning of the research project was to identify the most
signiVcant risk factors for osteoporosis for a British population. This were achieved in a
manner of speaking, but a number of other questions have been raised along the way.
A simple questionnaire based risk index was developed. By measuring age and weight
and asking if an individual has suUered a non traumatic fracture or taken hormone re-
placement therapy, a clinician may better decide on the best course of action. These tools
performed quite well in both the development and validation stages. They had high sen-
sitivities and high speciVcities, meaning that those with the highest and lowest risk of
osteoporosis could be dealt with in the best possible manner. Indeed, the very high speci-
Vcities at the femoral neck and total hip in particular meant that a large percentage of the
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unnecessary scans that clog the health service at the moment could be prevented.
The addition of QUS at the calcaneus seemed to increase the utility of these tools in
the development stages, by removing even more healthy people. However, the validation
of these suUered due to the fact that the threshold that was selected previously did not
allow for the correct selection of those at greatest risk. This does not mean that there is no
place for a system that combines these two techniques, but a method that does not suUer
if one systems fails would be safer. For example, using the simple assessment tool and
QUS separately and then assigning osteoporosis, or rather risk of osteoporosis, if either
technique suggests so may prove more eUective.
Traditional QUS measurements at the Vnger proved unsuccessful at predicting den-
sity at the hip or spine. This is most probably due to the discordance already discussed
[Faulkner et al., 1999]. There may be decreases in measured QUS parameters at all sites
of interest, however the rate of change does not always match the change in density at
other sites. The fact that QUS was not able to discriminate between those with high or
low density at either the lumbar spine and hip for a postmenopausal sample is concerning.
One might argue that by including young, healthy individuals the results become more
appealing. However, is it correct to include these? The author feels that it is not, as the
young and healthy can be assumed to be free from the risk of osteoporosis, with the ex-
ception of those who present with secondary causes. Therefore, if the changes in QUS do
not reWect changes in DXA for an entirely postmenopausal population they will have little
practicality as screening tools.
The disappointing correlations between the DXA and QUS prompted the testing of
the proportion of fast to slow wave energy (PRO) at the proximal phalanx. The initial
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results seemed very promising, with a very strong correlation between PRO and cortical
area along the diaphysis of the phalanx. Cortical area was used in this case as a surrogate
for cortical thickness, as partial volume eUects would have inWuenced thickness values
to a greater extent. The relationship between these values did not take into account the
exact processes that were taking place on the endosteal surface, but were assumed to be
representative.
The second set of simulations carried out using cadaveric specimens supported the
claims that energy measurements could be used to monitor cortical thinning. PRO was
strongly correlated to the thickness as computed by the µCT machine. µCT also allowed
the representation of pores and the trabecularisation, which appeared not to aUect the
results.
It seems that in terms of clinical densitometry we have gone full circle to a time where
the principles of radiogrammetry are once again in fashion. However, this time the cortical
thickness can be found very quickly and cheaply using QUS. One of the major limitations
of radiogrammetry - the ignoring of what is happening in the bone - also seems to be dealt
with. From the second set of simulations it appears that the energy measurements used to
predict the thickness hold true even with the presence of large pores on the endocortical
surface.
Furthermore, this time around, the cortical thickness is not the deVnitive measurement,
it is simply an indication that overall skeletal quality is altered. DXA T-scores remain the
gold standard for diagnosing osteoporosis and for this reason the results were compared to
the density at the femoral neck. The excellent correlation between the cortical thickness
of the phalanx and the density at the femur suggest that the use of such measurements is
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appropriate. This is much more than can be said for the QUS parameters tested in Chapter
5, where there was almost no agreement with axial density.
There is also some evidence in the literature that changes in cortical thickness at sites
similar to the those observed in the proximal phalanx are signiVcantly diUerent in those
who have suUered a fragility fracture [Crespo et al., 1998]. The link between thickness
and the risk of fracture has been alluded to here, via the common association with low
DXA T-scores. Of even greater importance, these values were seen to be signiVcantly
diUerent in postmenopausal women. During the course of the work done in the Great
Western Hospital in Swindon, it was shown that the current QUS measurements struggle
to categorise people based on risk because of the error in the measurements. This ability
to select those with fracture and the large diUerences between healthy and osteoporotic
subjects provides further evidence that energy measurements may be the way forward
when it comes to prescreening for DXA.
8.2 Future Work
There are many questions yet to be answered with regard to QUS in postmenopausal
women. Whilst the assessment tools that used QUS in the development study performed
exceptionally well, the results were not repeated in the validation study. The author sug-
gests that in the future, risk assessment tools and QUS are used together, but instead of
combining the outputs, it may be better to deal with them in a parallel fashion. This way,
the operator can get an idea of how well a patient performs in each, instead of relying on
a single result.
134
8.2. Future Work
The development of energy measurements to predict structure at the Vnger may be
the most fruitful deliverable. Although the sample was small in both the simulations
and in the prototype testing of this technique, the results were impressive. It is accepted
that a much larger study is needed to conVrm these results. It is also suggested that any
such analysis continue looking at only postmenopausal women, as including completely
healthy subjects may give over optimistic predictions.
Furthermore, there is deVnite scope to develop this method to predict those most likely
to suUer a fracture. As was mentioned previously, cortical thickness at the metacarpal
was signiVcantly reduced for those with an osteoporotic fracture. This remained true
when investigating only postmenopausal individuals. Therefore, if accurate predictions
of thickness (or thinning) are possible, the potential for warning those at greatest risk is
immense.
135
Bibliography
J. E. Adams. Single and dual energy x-ray absorptiometry. European Radiology, 7:S20–S31,
1997.
L. Alexeeva, P. Burkhardt, C. Christiansen, C. Cooper, P. Delmas, O. Johnell, C. Johnston,
J. A. Kanis, P. Lips, L. J. Melton, P. Meunier, E. Seeman, J. Stepan, and A. Tosteson. As-
sessment of fracture risk and its application to screening for postmenopausal osteoporo-
sis. Assessment Of Fracture Risk And Its Application To Screening For Postmenopausal
Osteoporosis, 843:1–129, 1994.
Anomymous. The economic cost of hip fracture in the UK. Technical report, University
of York, June 2000.
Anomymous. Addendum: pqct as an investigation tool. Acta Orthopaedica Scandinavica,
73:44–52, 2002.
APPOG. Falling short: Delivering integrated falls and osteoporosis services in england.
Technical report, National Osteoporosis Society, 2005.
R. Barkmann, S. Lusse, B. Stampa, S. Sakata, M. Heller, and C. C. Gluer. Assessment of the
136
BIBLIOGRAPHY
geometry of human Vnger phalanges using quantitative ultrasound in vivo. Osteoporosis
International, 11(9):745–755, 2000.
E. Barnett and B. E. Nordin. The radiological diagnosis of osteoporosis: a new approach.
Clin Radiol, 11:166–74, July 1960.
H. H. Bayraktar, E. F. Morgan, G. L. Niebur, G. E. Morris, E. K. Wong, and T. M. Keaveny.
Comparison of the elastic and yield properties of human femoral trabecular and cortical
bone tissue. Journal of Biomechanics, 37(1):27 – 35, 2004. ISSN 0021-9290.
C. L. Benitez, D. L. Schneider, E. Barrett-Connor, and D. J. Sartoris. Hand ultrasound for
osteoporosis screening in postmenopausal women. Osteoporosis International, 11(3):
203–210, 2000.
A. B. Berenson, C. M. Radecki, J. J. Grady, V. I. Rickert, and A. Thomas. A prospective,
controlled study of the eUects of hormonal contraception on bone mineral density. Ob-
stetrics and Gynecology, 98(4):576–582, 2001.
D. M. Black, M. Steinbuch, L. Palermo, P. Dargent-Molina, R. Lindsay, M. S. Hoseyni, and
O. Johnell. An assessment tool for predicting fracture risk in postmenopausal women.
Osteoporosis International, 12(7):519–528, 2001.
F. Blanckaert, B. Cortet, P. Coquerelle, R. M. Flipo, B. Duquesnoy, and B. Delcambre. Ul-
trasound velocity through the phalanges in normal and osteoporotic patients. CalciVed
Tissue International, 64(1):28–33, 1999.
S. Boonen, J. Nijs, H. Borghs, H. Peeters, D. Vanderschueren, and F. P. Luyten. Identifying
postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digi-
137
BIBLIOGRAPHY
tal x-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative
study. Osteoporosis International, 16(1):93–100, 2005.
A. M. Boot, M. A. J. deRidder, H. A. P. Pols, E. P. Krenning, and S. M. P. F. D. Keizer-
Schrama. Bone mineral density in children and adolescents: Relation to puberty, cal-
cium intake, and physical activity. Journal Of Clinical Endocrinology & Metabolism, 82
(1):57–62, Jan. 1997.
J. Borders, D. J. Sartoris, J. A. Stein, M. Andre, E. Ramos, and D. Resnick. Dual-energy
projection radiographic bone densitometry - comparison to dual-photon absorptiometry
in patients. Investigative Radiology, 23(9):S47–S47, Sept. 1988.
S. M. Cadarette, S. B. Jaglal, N. Kreiger, W. J. McIssac, G. A. Darlington, and J. V. Tu.
Development and validation of the osteoporosis risk assessment instrument to facilitate
selection of women for bone densitometry. Canadian Medical Association Journal, 162
(9):1289–1294, 2000.
R. Cadossi and V. Cane. Pathways of transmission of ultrasound energy through the distal
metaphysis of the second phalanx of pigs: An in vitro study. Osteoporosis International,
6(3):196–206, May 1996.
J. R. Cameron and J. Sorenson. Measurement of bone mineral in vivo: An improved
method. Science, 142:230–2, Oct. 1963.
D. R. Carter and W. C. Hayes. Compressive behavior of bone as a 2-phase porous structure.
Journal Of Bone And Joint Surgery-American Volume, 59(7):954–962, 1977.
138
BIBLIOGRAPHY
D. R. Carter and D. M. Spengler. Mechanical-properties and composition of cortical bone.
Clinical Orthopaedics And Related Research, 135(135):192–217, 1978.
E. Cendre, D. Mitton, J. P. Roux, M. E. Arlot, F. Duboeuf, B. Burt-Pichat, C. Rumelhart,
G. Peix, and P. J. Meunier. High-resolution computed tomography for architectural char-
acterization of human lumbar cancellous bone: Relationships with histomorphometry
and biomechanics, 1999.
R. B. Cook, D. Collins, J. Tucker, and P. Zioupos. The ability of peripheral quantitative
ultrasound to identify patients with low bone mineral density in the hip or spine. Ultra-
sound in Medicine and Biology, 31(5):625–632, 2005.
A. Cooper. A Treatise on Dislocations and Fractures of the Joints. King & Baird, Philadel-
phia, First American Edition, 1851.
R. Crespo, M. Revilla, J. Usabiago, E. Crespo, J. Garcia-Arino, L. F. Villa, and H. Rico.
Metacarpal radiogrammetry by computed radiography in postmenopausal women with
Colles’ fracture and vertebral crush fracture syndrome. CalciVed Tissue International,
62(5):470–473, May 1998.
S. R. Cummings and L. J. Melton. Epidemiology and outcomes of osteoporotic fractures.
Lancet, 359(9319):1761–1767, May 2002.
S. R. Cummings, D. Bates, and D. M. Black. Clinical use of bone densitometry - scientiVc
review. Jama-Journal of the American Medical Association, 288(15):1889–1897, 2002.
J. D. Currey. Bones: structure and mechanics. Princeton University Press, second edition,
2002.
139
BIBLIOGRAPHY
J. Damilakis, G. Papadokostakis, K. Pertsinakis, T. Maris, P. Dimitriou, A. Hadjipavlou,
and N. Gourtsoyiannis. Discrimination of hip fractures by quantitative ultrasound of
the phalanges and the calcaneus and dual x-ray absorptiometry. European Journal of
Radiology, 50(3):268–272, 2004.
P. D. Delmas. Biochemical markers of bone turnover. Acta Orthopaedica Scandinavica, 66:
176–182, Oct. 1995.
D. T. Denhardt and X. J. Guo. Osteopontin - a protein with diverse functions. Faseb
Journal, 7(15):1475–1482, Dec. 1993.
P. Dolan and D. J. Togerson. The cost of treating osteoporotic fractures in the United
Kingdom female population. Osteoporosis International, 8(6):611–617, 1998.
Y. B. Duan, C. H. Turner, B. T. Kim, and E. Seeman. Sexual dimorphism in vertebral
fragility is more the result of gender diUerences in age-related bone gain than bone loss.
Journal Of Bone And Mineral Research, 16(12):2267–2275, Dec. 2001.
B. Ettinger, D. M. Black, B. H. Mitlak, R. K. Knickerbocker, T. Nickelsen, H. K. Genant,
C. Christiansen, P. D. Delmas, J. R. Zanchetta, J. Stakkestad, C. C. Gluer, K. Krueger, F. J.
Cohen, S. Eckert, K. E. Ensrud, L. V. Avioli, P. Lips, and S. R. Cummings. Reduction of
vertebral fracture risk in postmenopausal women with osteoporosis treated with ralox-
ifene - results from a 3-year randomized clinical trial. Jama-Journal Of The American
Medical Association, 282(7):637–645, Aug. 1999.
K. G. Faulkner, E. von Stetten, and P. Miller. Discordance in patient classiVcation using
t-scores. Journal Of Clinical Densitometry, 2(3):343–350, 1999.
140
BIBLIOGRAPHY
M. Gambacciani, D. de Aloysio, D. Elia, M. J. van der Mooren, P. Hadji, and C. Wuster.
Quantitative ultrasound (qus) of bone in the management of postmenopausal women.
Maturitas, 47(2):139–149, Feb. 2004.
P. Geusens, J. Dequeker, A. Verstraeten, and J. Nijs. Age-related, sex-related, and
menopause-related changes of vertebral and peripheral bone - population study us-
ing dual and single photon-absorptiometry and radiogrammetry. Journal Of Nuclear
Medicine, 27(10):1540–1549, Oct. 1986.
C. C. Glüer. Quantitative ultrasound techniques for the assessment of osteoporosis: Expert
agreement on current status. Journal Of Bone And Mineral Research, 12(8):1280–1288,
Aug. 1997.
C. C. Glüer. Monitoring skeletal changes by radiological techniques. Journal Of Bone And
Mineral Research, 14(11):1952–1962, Nov. 1999.
C. C. Glüer, G. Blake, Y. Lu, B. A. Blunt, M. Jergas, and H. K. Genant. Accurate assess-
ment of precision errors - how to measure the reproducibility of bone densitometry
techniques. Osteoporosis International, 5(4):262–270, 1995.
S. Grampp, E. Steiner, and H. Imhof. Radiological diagnosis of osteoporosis. European
Radiology, 7:S11–S19, 1997. Suppl. 2.
S. L. Greenspan, M. L. Bouxsein, M. E. Melton, A. H. Kolodny, J. H. Clair, P. T. Delucca,
M. Stek, K. G. Faulkner, and E. S. Orwoll. Precision and discriminatory ability of cal-
caneal bone assessment technologies. Journal Of Bone And Mineral Research, 12(8):
1303–1313, Aug. 1997.
141
BIBLIOGRAPHY
E.W. Gregg, A. M. Kriska, L. M. Salamone, M. M. Roberts, S. J. Anderson, R. E. Ferrell, L. H.
Kuller, and J. A. Cauley. The epidemiology of quantitative ultrasound: A review of the
relationships with bone mass, osteoporosis and fracture risk. Osteoporosis International,
7(2):89–99, 1997.
G. Guglielmi, M. Cammisa, A. De Serio, A. Scillitani, I. Chiodini, V. Carnevale, and
S. Fusilli. Phalangeal US velocity discriminates between normal and vertebrally frac-
tured subjects. European Radiology, 9(8):1632–1637, 1999.
P. Hadji, O. Hars, C. Wuster, K. Bock, U. S. Alberts, H. G. Bohnet, G. Emons, and K. D.
Schulz. StiUness index identiVes patients with osteoporotic fractures better than ultra-
sound velocity or attenuation alone. Maturitas, 31(3):221–226, 1999.
D. Hans, M. E. Arlot, A. M. Schott, J. P. Roux, P. O. Kotzki, and P. J. Meunier. Do ultrasound
measurements on the os calcis reWect more the bone microarchitecture than the bone
mass - a 2-dimensional histomorphometric study. Bone, 16(3):295–300, Mar. 1995.
D. Hans, P. DargentMolina, A. M. Schott, J. L. Sebert, C. Cormier, P. O. Kotzki, P. D.
Delmas, J. M. Pouilles, G. Breart, and P. J. Meunier. Ultrasonographic heel measurements
to predict hip fracture in elderly women: The epidos prospective study. Lancet, 348
(9026):511–514, Aug. 1996.
D. Hans, S. K. Srivastav, C. Singal, R. Barkmann, C. F. Njeh, E. Kantorovich, C. C. Gluer,
and H. K. Genant. Does combining the results from multiple bone sites measured by a
new quantitative ultrasound device improve discrimination of hip fracture? Journal of
Bone and Mineral Research, 14(4):644–651, 1999a.
142
BIBLIOGRAPHY
D. Hans, C. Wu, C. F. Njeh, S. Zhao, P. Augat, D. Newitt, T. Link, Y. Lu, S. Majumdar, and
H. K. Genant. Ultrasound velocity of trabecular cubes reWects mainly bone density and
elasticity. CalciVed Tissue International, 64(1):18–23, Jan. 1999b.
Y. M. Henry, D. Fatayerji, and R. Eastell. Attainment of peak bone mass at the lumbar
spine, femoral neck and radius in men and women: relative contributions of bone size
and volumetric bone mineral density, Apr. 2004.
A. B. Hodsman, M. Kisiel, J. D. Adachi, L. J. Fraher, and P. H. Watson. Histomorphometric
evidence for increased bone turnover without change in cortical thickness or porosity
after 2 years of cyclical hpth(1-34) therapy in women with severe osteoporosis. Bone, 27
(2):311–318, Aug. 2000.
J. Iwamoto, T. Takeda, T. Otani, and Y. Yabe. Age-related changes in cortical bone in
women: metacarpal bone mass measurement study. Journal of Orthopaedic Science, 3
(2):90–94, 1998.
J. Iwamoto, T. Takeda, S. Ichimura, Y. Tsukimura, and Y. Toyama. Age-related changes in
cortical bone in men: metacarpal bone mass measurement study. Journal of Orthopaedic
Science, 5(1):4–9, 2000.
A. A. Kalla, O. L. Meyers, N. D. Parkyn, and T. J. V. Kotze. Osteoporosis screening -
radiogrammetry revisited. British Journal Of Rheumatology, 28(6):511–517, Dec. 1989.
J. A. Kanis. Diagnosis of osteoporosis and assessment of fracture risk. Lancet, 359(9321):
1929–1936, June 2002.
143
BIBLIOGRAPHY
J. A. Kanis and E. V. McCloskey. Risk factors in osteoporosis. Maturitas, 30(3):229–233,
Nov. 1998.
J. A. Kanis, O. Johnell, A. Oden, H. Johansson, and E. McCloskey. Frax (tm) and the
assessment of fracture probability in men and women from the UK. Osteoporosis Inter-
national, 19(4):385–397, Apr. 2008.
W. C. Keaveny, T.M. & Hayes. Bone. A Treatise, volume 7. CRC Press, 1993.
T. S. Keller, Z. Mao, and D. M. Spengler. Young’s modulus, bending strength, and tissue
physical properties of human compact bone. Journal of Orthopaedic Research, 8(4):
592–603, 1990.
R. J. Kelm, N. A. Swords, T. Orfeo, and K. G. Mann. Osteonectin in matrix remodeling -
a plasminogen-osteonectin-collagen complex. Journal Of Biological Chemistry, 269(48):
30147–30153, Dec. 1994.
N. M. Keshawarz and R. R. Recker. Expansion of the medullary cavity at the expense of
cortex in postmenopausal osteoporosis. Metabolic Bone Disease & Related Research, 5
(5):223–228, 1984.
K. M. Knapp, G. M. Blake, T. D. Spector, and I. Fogelman. Multisite quantitative ultra-
sound: Precision, age- and menopause-related changes, fracture discrimination, and
t-score equivalence with dual-energy x-ray absorptiometry. Osteoporosis International,
12(6):456–464, 2001.
L. K. H. Koh, W. Ben Sedrine, T. P. Torralba, A. Kung, S. Fujiwara, S. P. Chan, Q. R. Huang,
144
BIBLIOGRAPHY
R. Rajatanavin, K. S. Tsai, H. M. Park, and J. Y. Reginster. A simple tool to identify asian
women at increased risk of osteoporosis. Osteoporosis International, 12(8):699–705, 2001.
D. Kovac, J. Lindic, A. Kandus, and F. A. Bren. Quantitative ultrasound of the calca-
neus and dual x-ray absorptiometry of the lumbar spine in assessment and follow-up
of skeletal status in patients after kidney transplantation. Osteoporosis International, 14
(2):166–170, 2003.
B. Krølner and S. P. Nielsen. Measurement of bone-mineral content (bmc) of the lum-
bar spine .1. theory and application of a new two-dimensional dual-photon attenuation
method. Scandinavian Journal Of Clinical & Laboratory Investigation, 40(7):653–663,
1980.
A. W. C. Kung, A. Y. Y. Ho, W. Ben Sedrine, J. Y. Reginster, and P. D. Ross. Comparison of
a simple clinical risk index and quantitative bone ultrasound for identifying women at
increased risk of osteoporosis. Osteoporosis International, 14(9):716–721, 2003.
C. M. Langton, S. B. Palmer, and R. W. Porter. The measurement of broadband ultrasonic
attenuation in cancellous bone. Eng Med, 13(2):89–91, Apr. 1984.
S. C. Lee, B. S. Coan, and M. L. Bouxsein. Tibial ultrasound velocity measured in situ
predicts the material properties of tibial cortical bone. Bone, 21(1):119–125, July 1997.
B. H. Li and R. M. Aspden. Composition and mechanical properties of cancellous bone
from the femoral head of patients with osteoporosis or osteoarthritis. Journal Of Bone
And Mineral Research, 12(4):641–651, Apr. 1997.
G. Liu, M. Peacock, O. Eilam, G. Dorulla, E. Braunstein, and C. C. Johnston. EUect of
145
BIBLIOGRAPHY
osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of
osteoporosis in elderly men and women. Osteoporosis International, 7(6):564–569, 1997.
O. Lofman, L. Larsson, I. Ross, G. Toss, and K. Berglund. Bone mineral density in normal
swedish women. Bone, 20(2):167–174, Feb. 1997.
O. Louis, X. Moreels, and M. Osteaux. Reproducibility of phalanx osteosonography and
relation with forearm peripheral quantitative computed tomography: single Vnger ver-
sus average measurement on the last four Vngers. European Journal of Radiology, 28(3):
270–275, 1998.
E. Lydick, K. Cook, J. Turpin, M. Melton, R. Stine, and C. Byrnes. Development and
validation of a simple questionnaire to facilitate identiVcation of women likely to have
low bone density. American Journal of Managed Care, 4(1):37–48, 1998.
R. Marcus. Clinical review 76: The nature of osteoporosis. J Clin Endocrinol Metab, 81(1):
1–5, 1996.
D. Marshall, O. Johnell, and H. Wedel. Meta-analysis of how well measures of bone min-
eral density predict occurrence of osteoporotic fractures. British Medical Journal, 312
(7041):1254–1259, May 1996.
R. W. McCalden, J. A. McGeough, M. B. Barker, and C. M. Courtbrown. Age-related-
changes in the tensile properties of cortical bone - the relative importance of changes
in porosity, mineralization, and microstructure. Journal Of Bone And Joint Surgery-
American Volume, 75A(8):1193–1205, Aug. 1993.
E. Minnock, R. Cook, D. Collins, J. Tucker, and P. Zioupos. Using risk factors and quanti-
146
BIBLIOGRAPHY
tative ultrasound to identify postmenopausal caucasian women at risk of osteoporosis.
Journal Of Clinical Densitometry, 11(4):485–493, Oct. 2008.
N. Miyakoshi, E. Itoi, M. Kobayashi, and H. Kodama. Impact of postural deformities
and spinal mobility on quality of life in postmenopausal osteoporosis. Osteoporosis
International, 14(12):1007–1012, Dec. 2003.
M. Muller, D. Mitton, P. Moilanen, V. Bousson, M. Talmant, and P. Laugier. Prediction
of bone mechanical properties using qus and pqct: Study of the human distal radius.
Medical Engineering & Physics, 30:761–767, 2008.
M. E. Mussolino, A. C. Looker, J. H. Madans, D. Edelstein, R. E. Walker, E. Lydick, R. S.
Epstein, and A. J. Yates. Phalangeal bone density and hip fracture risk. Archives Of
Internal Medicine, 157(4):433–438, Feb. 1997.
M. C. Nevitt, O. Johnell, D. M. Black, K. Ensurd, H. K. Genant, and S. R. Cummings.
Bone-mineral density predicts non-spine fractures in very elderly women. Osteoporosis
International, 4(6):325–331, Nov. 1994.
C. F. Njeh, T. Fuerst, D. Hans, G. M. Blake, and H. K. Genant. Radiation exposure in bone
mineral density assessment. Applied Radiation and Isotopes, 50(1):215 – 236, 1999a. ISSN
0969-8043.
C. F. Njeh, D. Hans, C. Wu, E. Kantorovich, M. Sister, T. Fuerst, and H. K. Genant. An in
vitro investigation of the dependence on sample thickness of the speed of sound along
the specimen. Medical Engineering & Physics, 21(9):651–659, 1999b.
C. F. Njeh, D. Hans, J. Li, B. Fan, T. Fuerst, Y. Q. He, E. Tsuda-Futami, Y. Lu, C. Y. Wu, and
147
BIBLIOGRAPHY
H. K. Genant. Comparison of six calcaneal quantitative ultrasound devices: Precision
and hip fracture discrimination. Osteoporosis International, 11(12):1051–1062, 2000.
N. Oyster. Sex-diUerences in cancellous and cortical bone strength, bone-mineral content
and bone-density. Age and Ageing, 21(5):353–356, 1992.
A. M. ParVtt, C. H. E. Mathews, A. R. Villanueva, M. Kleerekoper, B. Frame, and D. S. Rao.
Relationships between surface, volume, and thickness of iliac trabecular bone in aging
and in osteoporosis - implications for the microanatomic and cellular mechanisms of
bone loss. Journal Of Clinical Investigation, 72(4):1396–1409, 1983.
S. Prevrhal, T. Fuerst, B. Fan, C. Njeh, D. Hans, M. UUmann, S. Srivastav, and H. K. Genant.
Quantitative ultrasound of the tibia depends on both cortical density and thickness.
Osteoporosis International, 12(1):28–34, Feb. 2001.
J. Y. Reginster, M. Dethor, H. Pirenne, W. Dewe, and A. Albert. Reproducibility and di-
agnostic sensitivity of ultrasonometry of the phalanges to assess osteoporosis. Interna-
tional Journal of Gynecology & Obstetrics, 63(1):21–28, 1998.
J. Y. Reginster, E. Seeman, M. C. De Vernejoul, S. Adami, J. Compston, C. Phenekos, J. P.
Devogelaer, M. D. Curiel, A. Sawicki, S. Goemaere, O. H. Sorensen, D. Felsenberg, and
P. J. Meunier. Strontium ranelate reduces the risk of nonvertebral fractures in post-
menopausal women with osteoporosis: Treatment of peripheral osteoporosis (tropos)
study. Journal Of Clinical Endocrinology & Metabolism, 90(5):2816–2822, May 2005.
J. Y. Rho, D. Flaitz, V. Swarnakar, and R. S. Acharya. The characterization of broadband
ultrasound attenuation and fractal analysis by biomechanical properties. Bone, 20(5):
497–504, May 1997.
148
BIBLIOGRAPHY
J. Y. Rho, L. Kuhn-Spearing, and P. Zioupos. Mechanical properties and the hierarchical
structure of bone. Medical Engineering & Physics, 20(2):92–102, Mar. 1998.
F. Richy, F. Deceulaer, O. Ethgen, O. Bruyere, and J. Y. Reginster. Development and valida-
tion of the oracle score to predict risk of osteoporosis. Mayo Clinic Proceedings, 79(11):
1402–1408, 2004.
P. Roschger, S. Rinnerthaler, J. Yates, G. A. Rodan, P. Fratzl, and K. Klaushofer. Alendronate
increases degree and uniformity of mineralization in cancellous bone and decreases the
porosity in cortical bone of osteoporotic women. Bone, 29(2):185–191, Aug. 2001.
A. Rosholm, L. Hyldstrup, L. Baeksgaard, M. Grunkin, and H. H. Thodberg. Estimation
of bone mineral density by digital x-ray radiogrammetry: Theoretical background and
clinical testing. Osteoporosis International, 12(11):961–969, 2001.
A. S. Scavalli, M. Marini, A. Spadaro, D. Messineo, A. Cremona, F. Sensi, V. Riccieri, and
E. Taccari. Ultrasound transmission velocity of the proximal phalanxes of the non-
dominant hand in the study of osteoporosis. Clinical Rheumatology, 16(4):396–403, 1997.
W. B. Sedrine, T. Chevallier, B. Zegels, A. Kvasz, M. C. Micheletti, B. Gelas, and J. Y.
Reginster. Development and assessment of the osteoporosis index of risk (osiris) to
facilitate selection of women for bone densitometry. Gynecological Endocrinology, 16
(3):245–250, 2002.
E. Seeman. Reduced bone formation and increased bone resorption: rational targets for
the treatment of osteoporosis. Osteoporosis International, 14:S2–S8, 2003a. Suppl. 3.
149
BIBLIOGRAPHY
E. Seeman. Invited review: Pathogenesis of osteoporosis. Journal Of Applied Physiology,
95(5):2142–2151, Nov. 2003b.
E. Seeman. Bone quality: the material and structural basis of bone strength. Journal Of
Bone And Mineral Metabolism, 26(1):1–8, Jan. 2008.
H. Sievänen, S. Cheng, S. Ollikainen, and K. Uusi-Rasi. Ultrasound velocity and cortical
bone characteristics in vivo. Osteoporosis International, 12(5):399–405, 2001.
S. M. Snyder and E. Schneider. Estimation of mechanical properties of cortical bone by
computed tomography. Journal of Orthopaedic Research, 9(3):422–431, 1991.
M. Teschner. Histomorphometric analysis of bone tissue from a neolithic skeleton. Journal
Of Archaeological Science, 34(7):1130–1134, July 2007.
C. J. Todd, C. J. Freeman, C. Camilleriferrante, C. R. Palmer, A. Hyder, C. E. Laxton, M. J.
Parker, B. V. Payne, and N. Rushton. DiUerences in mortality after fracture of hip - the
East-Anglian audit. British Medical Journal, 310(6984):904–908, Apr. 1995.
T. P. Van Staa, E. M. Dennison, H. G. M. Leufkens, and C. Cooper. Epidemiology of
fractures in England and Wales. Bone, 29(6):517–522, Dec. 2001.
L. Weinstein and B. Ullery. IdentiVcation of at-risk women for osteoporosis screening.
American Journal of Obstetrics and Gynecology, 183(3):547–549, 2000.
C. Wüster, C. Albanese, D. De Aloysio, F. Duboeuf, M. Gambacciani, S. Gonnelli, C. C.
Glüer, D. Hans, J. Joly, J. Y. Reginster, F. De Terlizzi, and R. Cadossi. Phalangeal os-
teosonogrammetry study: Age-related changes, diagnostic sensitivity, and discrimina-
tion power. Journal of Bone and Mineral Research, 15(8):1603–1614, 2000.
150
BIBLIOGRAPHY
Y. N. Yeni, C. U. Brown, and T. L. Norman. InWuence of bone composition and apparent
density on fracture toughness of the human femur and tibia. Bone, 22(1):79–84, Jan.
1998.
P. Zioupos, R. Cook, and A. M. Coats. Bone quality issues and matrix properties in OP
cancellous bone. Stud Health Technol Inform, 133:238–45, 2008.
P. K. Zysset, X. E. Guo, C. E. HoYer, K. E. Moore, and S. A. Goldstein. Elastic modulus
and hardness of cortical and trabecular bone lamellae measured by nanoindentation in
the human femur. Journal Of Biomechanics, 32(10):1005–1012, Oct. 1999.
151
AppendixA
Volunteer Questionnaire
152
    
 
A6
LIFESTYLE/QUESTIONNAIRE INTERVIEW 
 
 
Patient Number      Weight…………………….. 
 
Date of Birth…………………..   Height…………………….. 
 
Age……………………………   
 
 
 
Q1 Which of the following best describes your daily work or other daytime 
activity that  you usually do?  
 
T1 I am usually sitting and do not walk about much 
   
T2 I stand or walk about quite a lot, but do not have to carry or lift things very often
  
T3 I usually lift or carry light loads or have to climb stairs or hills often 
   
T4 I do heavy manual work or carry heavy loads often  
 
 
Q2 On average, how often do you engage in vigorous physical activity in leisure 
time? 
 (activity that makes you breathless and sweat e.g. jogging, aerobics, football, tennis, 
squash,  competitive sports etc) 
 
T1 Rarely / infrequently 
   
T2 Once / twice a month  
   
T3 Once / twice a week  
  
T4 Daily 
 
 
Q3 How do you rate your present physical fitness for your age?  
 
T1 Below average 
   
T2 Average 
   
T3 Good  
   
T4 Very good 
    
 
A7
Q4 In the following age groups did you take exercise for 20 mins or more a 
day?  
       (tick as appropriate)  
 T1 under 20yr 
   
 T2 between 20 and 35yr 
   
 T3 between 35-55yr 
   
 T4 over 55 yrs 
 
 
Q5 How often and how much do you smoke? 
 
T1 I smoke every day   (number of cgrts/day) ________ 
  
T2 I smoke occasionally, but not every day  
   
T3 I used to smoke, but do not smoke at all now  (fill in next question as well)  
   
T4 I have never smoked  
 
 
Q6 In the following age groups how much did you smoke? 
      (number of cgrts/day)  
 T1 under 20yr 
   
 T2 between 20 and 35yr 
   
 T3 between 35-55yr 
   
 T4 over 55 yrs 
 
Q7 How often and how much alcohol do you consume?   
(Estimate of the number of units per week e.g. a unit is ½ pint of beer, 1 glass of wine 
or 1 measure of a spirit) 
        (estimate of units/week) 
T1 I drink alcohol every day of the week   ___________ 
  
T2 I drink alcohol about 3 or more days a week   ___________ 
  
T3 I drink alcohol about once or twice a week   ___________ 
  
T4 I do not drink alcohol      ___________ 
 
    
 
A8
Q8 In the following age groups how much alcohol did you consume?  
(Estimate of the number of units per week e.g. a unit is ½ pint of beer, 1 glass of wine 
or 1 measure of a spirit) 
        (estimate of units/week) 
 T1 under 20yr      ___________ 
   
 T2 between 20 and 35yr     ___________ 
   
 T3 between 35-55yr     ___________ 
   
 T4 over 55 yrs      ___________ 
 
 
Q9 Have you had any previous broken bones?   
 
 Yes/No       ______ 
 
If yes, which bone did you break?  (Please state whether left or right if extremity) 
 
 
 
 
Q10 When and how did the break occur? 
 
 
 
 
 
Q11 Have any members of your family suffered from broken bones as a result of 
 osteoporosis? 
 
 Yes/No       ______ 
 
 Fracture site………………………………..………………………….. 
 
Q12 Have any members of your family suffered from osteoporosis? 
 
 Yes/No       ______ 
 
 Relationship to interviewee……………………………………..….. 
 
 
Q13 Have you ever been confined to your bed for more than two months? 
 
 Yes/No       ______ 
 
 If so, why and for how long?……………………………………….. 
    
 
A9
Q14 Have you ever had any other health problems? 
 
 Yes/No       ______ 
 
 Details……………………………..………………………………… 
 
Q15 Have you ever taken Steroids? 
 
 Yes/No  At what age………………………………….. 
 
    For how long?……………………………….. 
  
 FOOD STUDY 
 
Q16 Have you ever seriously controlled your weight?  
 
 Yes/No  At what age………………… 
 
    For how long?……………… 
 
 
 
Q17 Do you take calcium supplements? 
 
 Yes/No       ______ 
 
 For how long?……………………………………………………….. 
 
 
 
Q18 Do you have any specific dietary restrictions/requirements? 
 
 Yes/No       ______ 
 
 Details……………………………………………………………….. 
 
Q19 Do you eat the following foods – milk, cheese, yoghurt, fish, eggs and nuts? 
      (Please tick as appropriate.) 
 T1 never     
 
 T2 once a week    
 
 T3 2-4 times a week   
   
 T4 daily    
 
    
 
A10
Q20 Do you eat the following foods daily?   (tick as appropriate) 
 
 Vegetables      ___________ 
 Fruit       ___________ 
 Bread, cereals, rice and pasta    ___________ 
 Milk, yoghurt and cheese    ___________ 
 Meat, poultry and nuts    ___________ 
 
 
Q21 Have you ever had any problems with your diet during your life?  
 If so, at what age?       (details) 
          
 T1 under 20yr      ___________ 
   
 T2 between 20 and 35yr     ___________ 
   
 T3 between 35-55yr     ___________ 
   
 T4 over 55 yrs      ___________ 
 
 
Q22 How do you rate your diet compared with your peers?  
 
 T1 Below average 
   
 T2 Average 
   
 T3 Good  
   
 T4 Very good 
 
 
    
 
A11
 FOR  FEMALE  PATIENTS  ONLY 
 
 
Q23 Do you have any children?    
 
 Yes/No    How many?…………..…. 
 
Q24 Did you breast-feed your children? 
 
 Yes/No    For how long?…………… 
 
 
Q25 At what age did your periods start? 
 
 ………………….years old 
 
 
Q26 At what age did your periods stop? 
 
 ………………… years old 
 
 
Q27 Have you had a hysterectomy? 
 
 Yes/No  How long ago?………. 
    at an Age of …………. 
 
Q28 Have you had your ovaries removed? 
 
 Yes/No  How long ago?………. 
    at an Age of …………. 
 
Q29 Have you ever taken the oral contraceptive pill?  
 
 Yes/No  How long ago? ……… 
    For how long? ………. 
    at an Age of …………. 
 
Q30 Have you ever used/Are you still using  HRT?  
 
 Yes/No  How long ago? ……… 
    For how long? ………. 
    at an Age of …………. 
AppendixB
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INFORMATION SHEET 
Re: QUS scanning for new finger scanner prototype project 
 
Study title 
Measurement of quantitative ultrasound through the proximal phalanx. 
 
What is the purpose of this study? 
The purpose of this study is to determine the utility of the proximal phalanges (first bone of 
the finger) as a site for Quantitative Ultrasound (QUS) scanning. With this information it is 
hoped that a scanning system that investigates the proximal phalanges can be developed 
to get a quick, accurate description of the skeletal condition. 
 
Study Hypothesis 
Velocity of Sound (VOS) and Broadband Ultrasound Attenuation (BUA) of bone have been 
studied in order to determine the relationship of Quantitative Ultrasound (QUS) with bone 
parameters. Within the field, it is believed that VOS measurements are determined by the 
density and elasticity of the bone. BUA, on the other hand, is considered to depend on the 
density and microarchitecture. 
The most studied skeletal site in terms of QUS is the calcaneus. Both the VOS and the 
BUA of the calcaneus have been shown to have a significant correlation with the measured 
Bone Mineral Density (BMD) at the spine and proximal femur. They have also displayed 
promising ability at differentiating between people with osteoporotics fractures and those 
without. 
Most of the research regarding QUS measurements at the proximal phalanges concern 
VOS. In previous investigations, the VOS has shown a significant correlation with spinal 
BMD. Some researchers suggest that the recorded waveform can be divided into separate 
segments which represent the pathway of transmission through different structures. Given 
that these structures change with aging and the progression of various bone conditions, it is 
hypothesised that by measuring the energy of various parts of the waveform the overall 
skeletal condition can be predicted. 
 
What is Bone Mineral Density (BMD)? 
Bone Mineral Density (BMD) is simply a measure of mineral density in an individual’s 
bones. Peak BMD is reached in the third or fourth decade of life. After this peak, there is a 
natural decline in BMD. While this is expected, in some cases the decline in bone density 
occurs at a much higher rate. 
 
What is osteoporosis? 
Osteoporosis is defined as having a BMD of less than 2.5 standard deviations below the 
BMD of a young healthy adult at the hip or spine. Those with osteoporosis are at an 
increased risk of suffering a fracture, even with minimal trauma. The manifestations of the 
condition include thinning and weakening of the bones. Osteoporosis is a condition which 
affects large numbers of older people, particularly women. Unfortunately this means that 
more people suffer from fractures (bone breaks) as the bone weakens. We are now 
discovering better ways of both preventing and treating this condition, however we need 
better and easier means of detecting osteoporosis. 
 
What is Quantitative Ultrasound (QUS)? 
Ultrasound is a mechanical vibration that travels through a medium. The wave that 
propagates is altered by the material properties and the geometry of the medium. QUS is 
the measuring of the specific parts of the wave in order to quantify the effect of the medium 
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 Application for Ethical Approval for the Use of Humans in Research 
 
In designing research involving humans, investigators should be able to demonstrate that the 
research is based on sound scientific principles. These criteria will be considered by the Ethics 
Committee before approving a project.  Please note that ethical approval for studies that 
involve clinical populations will not be granted unless accompanied by a letter granting 
ethical approval from the appropriate regional health authority ethics committee.  ALL of 
the following details must be provided and answered under each subheading, preferably 
typewritten or word-processed. 
 
 
1. Name of responsible investigator(s). 
 
 Dr. Keith Winwood 
 Dr. Peter Zioupos (DMAS Cranfield University) 
 Mr. Enda Minnock (PhD research student, DMAS Cranfield University) 
 
 
2.  Title of investigation. 
 
Bone density of the finger (proximal phalange) using peripheral quantitative computed 
tomography (pQCT) scanning and subsequent comparison with Quantitative Ultrasound 
(QUS) with other peripheral site measurements. 
 
 
3.  Is this:  
 (a) a teaching exercise?  
 (b) an undergraduate project? 
 (c) a post-graduate (e.g. M.Sc.) taught project? 
          (d) a staff or PhD programme research project?    
 
Staff research project in corporation with Cranfield University for completion of a final 
grant report in May 2007 which will also possibly lead to future collaborative grant 
applications. 
 
 
4.  Have the full details of the procedure been appended: Yes 
           
Please see attached Cranfield documentation and ethical permission accepted from 
Swindon Research Ethics Committee. 
 
 
5.  Provide a brief description (500 words maximum) and purpose of the investigation.  This 
should include a rationale for the study and a statement of the hypothesis to be tested.  It 
must include information on whether the study is collaborative, replication or new. 
 
This study is a collaborative project with colleagues from Cranfield University regarding 
a new finger prototype scanner by the use of quantitative ultrasound (QUS) technology 
for measurement of bone density. The purpose of this study is to gain validated density 
values from peripheral quantitative computed tomography (pQCT) in comparison to the 
obtained data from the new prototype, and for the completion of a final grant report (May 
2007).  The hypothesis is that data obtained from the pQCT will validate the new scanner 
finger prototype.  The participant will have a pQCT of the proximal phalange and have an 
ultrasound scan of the finger, wrist, tibia, and calcaneus by both a CUBA Clinical 
(McCUE PLC) and Sunlight Omnisense (Sunlight Ultrasound Technologies Ltd.).  The 
ultrasound equipment is commercial and portable and will be transported and operated 
by Enda Minnock (PhD student, Cranfield University) at the Alsager campus for a 
period of approximately 2-3 days.   The results are to validate a new prototype scanner 
for a final grant report, thus if valid may create future grant applications with both 
institutions. (Please see attached information from Cranfield University and ethical 
acceptance from there institute).   
  
 
6.  (a) How will the participants be recruited? 
 
The participants will be recruited from a previous study conducted by Dr. K Winwood 
(smoking study) who said that they would be available for future studies, as well as from 
the university campus. 
 
 (b) Provide details on the number and type of participants likely to be involved? 
 
We require just approximately 10-20 people aged over the age of 18 from a spectrum of 
age ranges to validate the density values obtained with the new finger scanner prototype 
in relation to density values obtained by peripheral quantitative computed tomography 
(pQCT) 
  
(c) What inclusion and exclusion criteria will be employed in the selection of  
 participants? 
 
Participants must be over the age of 18years and not taking any medication that is known 
to effect bone metabolism. 
 
 (d) What criteria have been employed to determine the number of participants for the 
study? 
 
 The participants are just required for the validation of the new finger scanner prototype 
 (please see above). 
 
 
7.  Likely duration of project and location of study. 
 
The duration of the study is for a 2-3day period where Enda (Cranfield PhD student) will 
scan by the use of ultrasound the participants by both the commercially available 
ultrasound and the new prototype.  Dr Keith Winwood will scan the participants by 
pQCT.  The equipment will be located in the Harold Frost Laboratory (pQCT machine) 
and the ultrasound will be brought up from Cranfield University where full ethics have 
been accepted (please see attached). 
 
 
8. Specify the particular procedures that involve human participants. 
 
    A bone scan will be obtained by the use of a pQCT by the Stratec XCT 2000 scanner 
(Stratec Medizintechnik GmbH, Pforzheim, Germany) of the first phalange, this will be 
operated by Dr Keith Winwood.   
 
An ultrasound scan (QUS) will be obtained of the participant at the proximal phalange, 
tibia, wrist and calcaneus.  This involves the participant remaining sitting comfortably 
whilst a scan takes place, no discomfort or pain is occurred to the participant please see 
information from Cranfield University (attached).  This procedure will be preformed by 
Mr Enda Minnock (Cranfield University)   
 
 The participant will be asked to fill out a questionnaire regarding items related to 
osteoporosis and health that has been previously used at a previous study at Cranfield. 
 
9. Are any novel procedures involved in this study?  If so, full details must be attached. 
 
 There are no new novel procedures endorsed within this study. 
 
 
10. Clearly state all substances or materials to be administered or applied. State their potential 
hazards, if any, and the precautions to be taken. 
  The only item that will be applied to the participant is a manufacturer’s conductive gel for 
the ultrasound procedure.  This will be applied to the area going to be scanned, no 
potential hazard will be involved. 
 
For the pQCT scan however there is a potential risk of exposure to radiation that has to be 
considered within this study.   A single pQCT bone scan has an expected radiation dose of 
approx. 0.9 µSievert per scan.  In comparison a return flight to the Canary Islands is 
approx. 80µSievert and the annual natural exposure being 2400 µSievert, the received 
dose is very low.  The XCT 2000 is CE certified and is safe regarding electrical and 
mechanical risks for the participants. 
 
 
11. State the degree of discomfort in terms of apprehension, pain, stress and disturbance in 
terms of alternation to routine. 
 
 There will be no degree of discomfort, apprehension, pain, stress, or disturbance in terms 
of alteration to routine for any of the participants. 
 
 
12. State your experience or that of the supervisor or other investigators in this type of 
investigation. 
 
 I have previously had a vast amount of experience at Manchester Metropolitan University 
regarding pQCT both with undergraduate,  post graduate, and research studies (Miss 
D.Wilks study’s, Smoking study, and Dancers study)_ .  I also went on a course regarding 
ionising radiation and pQCT.  Both Enda Minnock and Dr Peter Zioupos have had 
several years experience in ultrasound technology and Peter had a PhD student complete 
his thesis within this area Dr Richard Cook (University of Dunedin, New Zealand) within 
this subject area (Recent papers below). 
 
• R.B.Cook, D.Collins, J.Tucker, P.Zioupos. ‘The ability of peripheral 
quantitative ultrasound to identify patients with low bone mineral density in 
the hip or spine.’ Ultrasound in Medicine and Biology, 31(5): 625-632, 2005. 
• R.B.Cook, D.Collins, J.Tucker, P.Zioupos. ‘Comparison of Questionnaire and 
Quantitative Ultrasound Techniques as screening tools for DXA’  
Osteoporosis International, 16(12): 1565-1575, 2005 
 
Ethics proposals have also been completed and accepted at Cranfield University for 
ultrasound (Please see attached Faxes from Dr David Collins Consultant 
Rheumatologist: Swindon Research Ethics Committee).  
 
  
13. You must indicate clearly that the participant's informed consent will be obtained and, 
where necessary, in the presence of a parent (for minors only).  You must also attach a 
sample of the informed consent form (typewritten) which will be presented to participants 
(Appendix IV).  In the case of participants with learning difficulties, you must state the 
procedures that have been undertaken to ensure that the consent is, indeed, informed 
consent. 
 
 All participants will complete an informed consent form for both MMU and Cranfield 
University (See attached for both establishments). 
 
 
14.   How and where is the data to be stored? 
  
 The data will be stored on a password controlled PC by both institutions; all data will be 
anonymised for QUS scans. 
 Will the data be securely stored?   
Yes   
 
Where? 
On password controlled PC’s that are only used by the investigators.  
           
 Will information which could identify participants be coded?   
 Yes (see above) 
 
Will the data be destroyed at the end of the study?   
No the data will not be destroyed due to the investigators own interest. However it will 
be securely stored and all back up will be locked away in a safe place. 
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 Informed Consent Form (to be retained by the investigator for MMU)  
 
Participant:   
 
Name:    Sex: Male / Female 
 
Date of Birth:     
       
        
 
Supervisor/Principal Investigator:  Dr Keith Winwood (Manchester Metropolitan University) 
 
Investigator/Collaborators: Dr Peter Zioupos (DMAS, Cranfield University), Mr Enda Minnock 
(PhD Research Student, DMAS, Cranfield University)  
 
Ethics Committee Approval Number:  
 
Project Title: Bone density of the finger (proximal phalange) using peripheral quantitative 
computed tomography (pQCT) scanning and subsequent comparison with Quantitative 
Ultrasound (QUS) with other peripheral site measurements. 
 
 
Purpose of study and brief description of procedures.  
 
The purpose of the study is to determine the utility of the proximal phalanges (first bone of the 
finger) as a site for a new Quantitative Ultrasound (QUS) scanning prototype in collaboration 
with Cranfield University.  With this information it is hoped that a scanning system that 
investigates the proximal phalanges can be developed to get a quick, accurate description of the 
condition of the skeleton.  You will be asked to sit comfortably and have your fingers scanned 
by peripheral quantitative computed tomography (pQCT) to obtain your bone density for 
validation of the new QUS device.  You will then have your finger, tibia, wrist and calcaneus 
bone scanned by a commercially QUS device.  Finally you will be asked a short questionnaire 
of which all information obtained will be treated confidentially.   
 
 
 
Participant Statement. 
 
I fully understand what is involved in taking part in this study. Any questions I have about the 
study, or my participation in it, have been answered to my satisfaction. I understand that I do not 
have to take part and that I may decide to withdraw from the study at any point without 
prejudice. I have had my attention drawn to the document 'Ethical Regulations for the Use of 
Humans in Research'. My concerns regarding this study have been answered and such further 
concerns as I have during the time of the study will be responded to. It has been made clear to 
me that, should I feel that these Regulations are being infringed or that my interests are 
otherwise being ignored, neglected or denied, I should inform the Chair of the Ethics 
Committee of the Department of Exercise and Sport Science, Manchester Metropolitan 
University, Hassall Road, Alsager, Cheshire, ST7 2HL who will undertake to investigate my 
complaint. 
 
 
Signed ............……………………………………....................... Date …….............................. 
 
I certify that the details of this study have been fully explained and described in writing to 
…………................................. and have been understood by him/her and that I consent to 
his/her participation in this study. 
 
 
Signed .................................…………………………………….. Date …….............................. 
  
 
 
 
Centre Number: 
Study Number: 
Patient Identification Number for this trial: 
 
 
CONSENT FORM 
 
Title Project:  
Bone density of the finger (proximal phalange) using peripheral quantitative computed 
tomography (pQCT) scanning and subsequent comparison with Quantitative Ultrasound 
(QUS) with other peripheral site measurements. 
 
 
Name of Researchers: 
 
Mr. Enda Minnock, Doctoral Researcher, DMAS, Cranfield University 
Dr. Peter Zioupos, Senior Lecturer, DMAS, Cranfield University 
Dr. Keith Winwood, Institute for Biophysical & Clinical Research into Human 
Movement, Manchester Metropolitan University 
Please initial box 
1. I confirm that I have read and understand the information sheet 
dated 22 Mar. 07 (version 1.0) for the above study and have had 
the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time giving any reason. 
 
3. I understand that I will be asked questions from a questionnaire. I also understand that 
I will have a scan of my heel bone. 
 
4.    I agree to take part in the above study. 
 
 
 
             
Name of Volunteer    Date    Signature 
 
 
 
             
Name of person taking consent  Date    Signature 
(if different from researcher) 
 
 
 
             
Researcher     Date    Signature 
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INFORMATION SHEET 
Re: pQCT trials and QUS scanning for new finger scanner prototype project 
 
Study title 
Simulated passage of ultrasound through the finger using pQCT scanning, and subsequent 
comparison with Quantitative Ultrasound measurements of the heel bone 
 
What is the purpose of this study? 
The purpose of this study is to determine the utility of the proximal phalanges (first bone of 
the finger) as a site for Quantitative Ultrasound (QUS) scanning. With this information it is 
hoped that a scanning system that investigates the proximal phalanges can be developed 
to get a quick, accurate description of the condition of the skeleton. 
 
Study Hypothesis 
Velocity of Sound (VOS) and Broadband Ultrasound Attenuation (BUA) of bone have been 
studied in order to determine the relationship of Quantitative Ultrasound (QUS) with bone 
parameters. Within the field, it is believed that VOS measurements are determined by the 
density and elasticity of the bone. BUA, on the other hand, is considered to depend on the 
density and microarchitecture. 
The most studied skeletal site in terms of QUS is the calcaneus. Both the VOS and the 
BUA of the calcaneus have been shown to have a significant correlation with the measured 
BMD at the spine and proximal femur. They have also displayed promising ability at 
differentiating between people with osteoporotics fractures and those without. 
Most of the research regarding QUS measurements at the proximal phalanges concern 
VOS. In previous investigations, the VOS has shown a significant correlation with spinal 
BMD. Some researchers have investigated the amplitude of the first arriving peak of the 
ultrasonic wave as it crosses the proximal phalanges. It was found that this measure was 
correlated to the area of the medullary canal of the studied phalanges. 
With aging, and the deterioration of the skeletal condition, the density and geometry of the 
proximal phalanges changes. 
Based on this evidence, it seems that the BUA of the proximal phalanges should be 
correlated to the state of the bone and that the deterioration of the bone may be reflected in 
this measurement. It is hoped that this study will attempt to confirm this belief and also will  
quantify the degree to which BUA changes as the state of the bone changes. 
 
What is Bone Mineral Density (BMD)? 
Bone Mineral Density (BMD) is simply a measure of mineral density in an individuals bones. 
Peak BMD is reached in the third or fourth decade of life. After this peak, there is a natural 
decline in BMD. While this is expected, some people lose bone density a higher rate than 
others. 
 
What is osteoporosis? 
Osteoporosis is defined as having a BMD of less than 2.5 standard deviations below the 
BMD of a young healthy adult at the hip or spine. Those with osteoporosis are at an 
increased risk of suffering a fracture, even with minimal trauma. The manifestations of the 
condition include thinning and weakening of the bones. Osteoporosis is a condition which 
affects large numbers of older people, particularly women. Unfortunately this means that 
more people suffer from fractures (bone breaks) as the bone weakens. We are now 
discovering better ways of both preventing and treating this condition, however we need 
better and easier means of detecting osteoporosis. 
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What is Quantitative Ultrasound (QUS)? 
Ultrasound is a mechanical vibration that travels through a medium. The wave that 
propagates is altered by the material properties and the geometry of the medium. QUS is 
the measuring of the specific parts of the wave in order to quantify the effect of the medium 
(in this case bone). There has been much research at the calcaneus and as a result there 
are a number of commercially available QUS scanning systems such as the CUBA Clinical 
(McCUE PLC) and the Achilles+ (Lunar). A multi-site scanning system is also available to 
measure VOS along the cortex of certain bones, the Sunlight Omnisense (Sunlight 
Ultrasound Technologies Ltd.). Research at the proximal phalanges to date has focussed 
on the through VOS, with one commercially assessment tool, the DBM Sonic (IGEA). 
 
Why have I been chosen? 
You have been chosen because you have volunteered to take part. 
 
Who is organising the study? 
The study is being organised by Cranfield University in association with Manchester 
Metropolitan University. This study will take place over the next three months. 
 
What will happen to me if I take part? 
You will be asked to complete a questionnaire relating to your health and lifestyle. You will 
also be scanned at the heel bone with a commercially available QUS device, the CUBA 
Clinical. This is a completely non-invasive procedure and is painless. 
 
Are there any disadvantages in taking part in this study? 
There are no disadvantages in taking part in this study. If your change you mind you can 
withdraw at any time without saying why. 
 
What are the possible risks of taking part in this study? 
There are no risks at all involved in taking part in this study. 
 
What are the possible benefits of taking part in this study? 
If the scan gives any cause for concern you will be informed. 
 
Confidentiality – Who will know that I am taking part in the study? 
Only the research team will be able to identify you from your questionnaire and scan 
results. All data will be anonymised so that the researchers who are outside the research 
team will not be able to identify you. 
 
Who has reviewed the study? 
The Manchester Metropolitan Ethics Committee has approved this study. 
 
Research in the centre to date 
Research in the centre to date has focussed on the comparison of a number of skeletal 
sites in order to determine which if any are the most representative of the overall skeletal 
condition. There has also been some research into using questionnaires as a possible 
screening tool for osteoporosis. If you would like further information please see: 
R.B.Cook, D.Collins, J.Tucker, P.Zioupos. ‘The ability of peripheral quantitative ultrasound 
to identify patients with low bone mineral density in the hip or spine.’ Ultrasound in Medicine 
and Biology, 31(5): 625-632, 2005 
R.B.Cook, D.Collins, J.Tucker, P.Zioupos. ‘Comparison of Questionnaire and Quantitative 
Ultrasound Techniques as screening tools for DXA’  Osteoporosis International, 16(12): 
1565-1575, 2005 
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What will happen to the results of this study? 
If you would like to be sent a short summary of the results of this study, we would be only 
too delighted to send one to you. If there is any further information that you require please 
call Enda Minnock (01793) 785531 or email e.b.minnock@cranfield.ac.uk. 
22 Mar. 07 [Version 1.0]  Page 4 of 4 
 
 
 
 
 
Centre Number: 
Study Number: 
Patient Identification Number for this trial: 
 
 
CONSENT FORM 
 
Title Project: Simulated passage of ultrasound through the finger using pQCT scanning, 
and subsequent comparison with quantitative ultrasound measurements of 
the heel bone  
 
Name of Researchers: 
 
Enda Minnock, Doctoral Researcher, DMAS, Cranfield University 
Dr Peter Zioupos, Senior Lecturer, DMAS, Cranfield University 
Dr Keith Winwood, Institute for Biophysical & Clinical Research into Human 
Movement, Manchester Metropolitan University 
Please initial box 
1. I confirm that I have read and understand the information sheet  
dated for the above study and have had the opportunity to ask 
questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time giving any reason. 
 
3. I understand that I will be asked questions from a questionnaire. I also understand 
that I will have a scan of my heel bone. 
 
4.    I agree to take part in the above study. 
 
 
             
Name of Volunteer    Date    Signature 
 
 
 
             
Name of person taking consent  Date    Signature 
(if different from researcher) 
 
 
 
             
Researcher     Date    Signature 
 
 
 
 
1 for volunteer   1 for researcher 1 to be kept in the dept 
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Can Questionnaires And 
Quantitative Ultrasound
Be Used To Screen For 
Osteoporosis? Enda Minnock1, Peter Zioupos1, Richard Cook2, David Collins3, Julie Tucker3
1 Biomechanics Laboratories, Cranfield University, Shrivenham, UK;
2 Dept of Oral Rehabilitation, Otago University, New Zealand;
3 Great Western Hospital, Swindon, Wilts., UK
• Introduction •
Osteoporosis affects millions of people every year. With the associated loss 
of bone and resorption of the trabeculae, the most common problem 
encountered is fracture of the hip, spine and wrist, even at low energy levels. 
If detection occurs early enough, changes to diet and lifestyle or a prescribed 
treatment may halt or slow down bone loss. Differing approaches have been 
investigated to detect osteoporosis, or those a high risk of developing it. 
These have tended to concentrate on simple questionnaire based models 
and quantitative ultrasound.
The aim of this study was to determine if combining these two approaches 
could improve on the predicitive ability and specificity, when compared to 
each individual method.
• Methods •
DXA scans were taken at the hip and spine of 
235 postmenopausal Caucasian women. All 
volunteers completed questionnaires covering 
lifestyle, exercise and medical and reproductive 
history. QUS measurements were taken using 
the CUBA Clinical and Sunlight mnisense.
Correlations between all risk factors and QUS 
measurements and the DXA T-scores were 
calculated. Those significant at (P<0.2) were 
included as possible inputs in stepwise 
regression in order to find multivariate models 
for predicting BMD T-score at the lumbar spine, 
femoral neck and total hip. This created two 
models for predicting T-score, one using only risk 
factors and one using a combination of risk 
factors and QUS variables.
• Results •
Area Under the Curve (AUC) values of both 
newly developed tools are shown in Table 1. 
The AUC values of tools which predict 
osteoporosis at the femoral neck and total 
hip using risk factors and QUS were 
significantly greater (P<0.05) than those 
using only risk factors. For the lumbar spine, 
the AUC value of the combination tool was 
only slightly significantly greater (P=0.16) 
than the simple, risk factor based tool. The 
specificities were also greater when QUS 
was used (See Table 2).
• Discussion and Conclusion •
It was seen that the developed assessment tools could be used to
prioritise those requiring DXA scanning. They had high sensitivity and 
specificity values. This would indicate that they have the potential to 
increase the efficiency of current DXA resources. It may also be used as 
a screening tool whereby large numbers of people could be scanned, 
leading to possible prevention of osteoporotic fractures.
Fig 1: Tools such as simple assessments and quantitative ultrasound 
can be used to categorise those at risk of osteoporosis.
Fig 2: Receiver operating characteristic  curves for assessment tools based on risk 
factors (a) and a combination of risk factors and quantitative ultrasound (b).
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Using Quantitative Ultrasound To Predict 
Bone Structure
Enda Minnock1, Keith Winwood2, Peter Zioupos1
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• Introduction •
As people age, cortical bone becomes thinner and trabeculae are resorbed
decreasing overall connectivity. In certain cases the rate of change is greater 
than normal, resulting in osteoporosis and possible fracture. Currently, 
osteoporosis is diagnosed using dual energy x-ray absorptiometry (DXA).  These 
machines are expensive to acquire, maintain and use, they expose patients to 
ionising radiation and they are, in general, non-portable and only suitable for use 
by highly skilled professionals.
Quantitative ultrasound (QUS) may offer a cheaper, simpler technique to assess 
skeletal condition. US has been shown to penetrate the finger via three separate 
pathways1. The amount of energy coming from these pathways was seen to 
change depending on the cortical area2. The aim of this study was to try to 
attempt to quantify the relationship between these.
• Methods •
pQCT scans were taken along the proximal phalanx of 14 volunteers (8F/6M) to 
determine the Cortical Area (CA), Cortical Density (CD) and the geometry of the 
phalanxes. The pQCT images were used to produce a voxel-based model to 
simulate the passage of an ultrasonic wave across the finger using Wave20000 
software. The energies from the different wave components were established. 
These values were then compared to the actual cortical area present to see if 
they were significantly correlated.
• Results •
The challenging aspects of the technique were: 
setting the minimum time of flight and the noise 
threshold level (for triggering the data acquisition) 
and defining the window capturing data after the 
first wave ripples have arrived a the receiver. Once 
these have been established, the combined 
scanning and simulation routine we used here 
showed that measuring the energy of the early 
arriving signal and expressing this as a proportion 
of the total energy correlated well with cortical 
area.
•Discussion & Conclusion •
On the basis of these results, it may be possible to determine 
cortical area using QUS and this in turn may be used to deduce 
overall skeletal condition in an inexpensive and effective manner. 
Also, this technique may be used to monitor bone loss if used to
gauge cortical thinning.
References
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Fig 1: Typical osteoporotic fracture (Colles’ fracture).
Fig 3: Proportion of bone energy versus cortical area of the proximal phalanx for 
simplified bone (a) and bone of varying density (b)
Fig 2: pQCT scan, simulated passage of ultrasonic wave through the 
phalanx and received waveform.
